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Throughout history, humans have been constantly driven by the rising and setting of the sun. Being able 
to anticipate this consistently changing environment is encompassed in our endogenous circadian clock. 
This system allows for the coordination of our physiology and behaviour to suit the environment around 
us. Human studies within the last few decades suggest that disruptions to this system increase the 
prevalence of metabolic disturbance, leading to the development of diseases such as obesity, diabetes, 
cardiovascular disease and their associated co-morbidities. Little is known about the mechanisms by 
which disruptions lead to an eventual degradation in the metabolic system.  
This thesis first sought to characterise the effect that chronic light cycle disruptions have on metabolism. 
To emulate the human condition, I used a mouse model exposed to constantly shifting lighting 
environment, comprised of a 6-hour advance, occurring every 6 days, to chronically disrupt their 
circadian timing system. This treatment caused a gradual increase in body weight of 3.54 ± 0.34g after 
12 phase shifts compared with mice under control lighting conditions gaining 1.97 ± 0.25g. 
Additionally, following the 5th phase shift, light cycle-disrupted animals showed a reversal in their 
diurnal pattern of energy homeostasis and locomotor activity followed by a subsequent loss of this 
rhythm. To investigate potential molecular mechanisms mediating these metabolic alterations, we 
assessed central leptin and insulin sensitivity. We discovered that light cycle-disrupted mice had a 
reduction in central leptin signalling sensitivity, as indicated by a reduction in the number of 
phosphorylated STAT3 immunoreactive cells in the arcuate nucleus of the hypothalamus. Furthermore, 
light cycle-disrupted animals exhibited a marked increase in fasting blood glucose from 108.8 ± 
21.3mg/dl in control animals, to 269.4 ± 21.1mg/dl in animals under light disruption. Peripheral 
hyperglycaemia was accompanied by alterations in central insulin signalling at the level of pAkt and 
IRS1, suggesting that light cycle-disruption has a direct effect on metabolic signalling pathways within 
the brain.  
Secondly, I sought to investigate the effect light cycle disruptions have on whole body glucoregulation. 
Mice were subjected to the same light cycle disruption schedule as previous, and glucose tolerance was 
assessed throughout the experiment. Glucose tolerance of mice under light cycle disruptions was altered 
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from the 9th light cycle shift. Fasting blood glucose was elevated in animals under light cycle disruption 
(143.1 ± 4.8 mg/dl) in comparison to controls (110.2 ± 6.6 mg/dl), however, not to the same magnitude 
as in the previous cohort of mice. The loss in glucose tolerance is likely a direct result of the light cycle 
disruptions given that there was no increase in body weights above controls, in animals under light 
disruptive conditions.  
Lastly, I aimed to assess the effect of disrupting either the light zeitgeber or the food intake zeitgeber, 
on metabolism. Additionally, I sought to ameliorate previously observed metabolic disturbances by 
intervening with strict feeding regimes. Mice were either fed ad libitum, restricted to the dark phase, or 
had a rotating window of food access, throughout the experiment. Of these, half the animals were 
subjected to light cycle disruptions, identical to previous experiments. Animals under light cycle 
disruption fed ad libitum gained 51 ± 5.3% increase in body weight compared to 40.7 ± 4.1% increase 
in controls, as well as an increase in fat mass relative to body weight. Interestingly, a third group of 
mice presented themselves during this study, that had a distinct phenotype difference when compared 
to wildtype animals. Animals deemed ‘NowShift’ were observed to shift their behaviour almost 
instantaneously following a shift in the lighting environment. These animals were also protected against 
light disruption induced weight gain, increasing by only 31.3 ± 6.2% across the experiment, in those 
fed ad libitum. Mice under light cycle disruption that had their food restricted to the dark phase gained 
only 21 ± 3.5% body weight from baseline, in comparison to controls that gained 27.9 ± 4.3% body 
weight from baseline. Animals in this group deemed as ‘NowShift’ were also unaffected by the lighting 
disruptions, gaining only 23.6 ± 3.8% body weight from baseline. Additionally, there were no 
differences in fat mass across all three groups. Animals with rotating access to food showed a reduced 
body weight in comparison to those fed ad libitum, likely due to a reduction in total food intake. These 
animals had a severely disrupted rhythm of food intake; however, little impact was seen in activity 
rhythms. Our findings suggest that light entrains and controls locomotor activity patterns, whereas food 
intake is a crucial entrainment cue for maintaining metabolic health. Forcing synchronisation of the 
food and light zeitgeber through time restricted feeding can ameliorate body weight increases observed 
in animals fed ad libitum. Finally, the spontaneous phenotype of NowShift animals was a surprise, 
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however, the fact that these animals are protected from light disruption induced weight gain raises the 
question of the mechanism behind their genetic advantage. Exome sequencing was performed in these 
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Chapter 1 : Literature review 
1.1 The biological clock 
Rhythms in biology were traditionally accepted as a passive reaction to the changing light level.  It was 
not until 1729 that the first experiment was conducted that led to the discovery of circadian rhythms in 
the absence of light.  French astronomer Jean Jacques d’Ortous De Mairan observed that when placing 
the Mimosa (Mimosa pudica) plant in total darkness, the plant itself continues to fold and unfold its 
leaflets each day, as it would under the gaze of the sun (9). It took over two centuries of work in both 
plants and animals before a free-running rhythm was defined in humans (10). This endogenous rhythm 
was found to vary between species and even between individuals under certain experimental conditions 
such as temperature and light cycle. Thus the term circadian, derived from the Latin terms ‘circa dies’, 
meaning about a day, was proposed in 1959, and  was included in the Merriam-Webster dictionary by 
the turn of the decade (11). In order to understand this endogenous system, its anatomy, its molecular 
determinant and its broader influence on physiology, the following sections will review our current 
knowledge about circadian rhythms.  
1.1.1 Anatomical Location 
Physiological function and behaviour in mammals are under tight temporal control and are subject to a 
predictable daily cycle of oscillations. Sleep-wake cycles, blood pressure, body temperature, renal 
activity, liver metabolism and hormonal secretion are just a few of the many processes that are 
controlled by an endogenous timing system called the circadian clock (12). Circadian clocks can be 
found in a vast array of tissues throughout the body. For correct functioning of the overall circadian 
timing system, all circadian clocks residing in various tissue must be kept synchronised with one another 
and also with the external environment. The exact anatomical location of this proposed central clock 
was found in mammals by ablation experiments and by tracing retinal projections, leading to the 
identification of the suprachiasmatic nucleus (SCN) in the hypothalamus as the locus of this central 
circadian pacemaker (13,14). This centralised clock has been shown to be the omnipotent regulator of 
all daily rhythms in physiology and behaviour (15-17).  
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The SCN is a structure that is situated bilaterally at either side of the third ventricle, directly distal to 
the optic chiasm, each side containing approximately 10,000 neurons in the mouse. It is comprised of 
two anatomically and functionally distinct subdivisions, the core and the shell, which differ in both 
afferent and efferent connections (18). The core region receives information on the external lighting 
environment from the retina, and projects to the shell. The shell only somewhat signals to the core and 
neurons differ in neurochemical content. Within core neurons, ~10% contain vasoactive intestinal 
polypeptide (VIP) and a smaller proportion of neurons contain calretinin, neurotensin and gastrin 
releasing peptide (16). In the shell, neurons contain arginine vasopressin (AVP), angiotensin II and met-
encephalin. Most synapses made within the SCN principally release  γ-aminobutyric acid (GABA) with 
a small proportion releasing glutamate (19,20).  
Primary inputs to the SCN are the retinohypothalamic tract (RHT) as well as modulatory inputs from 
the thalamic intergeniculate leaflet and the midbrain raphe (21). Oscillatory output from the SCN is 
determined by the circadian variation in neuronal firing and neurotransmitter release from its neurons. 
In terms of neuronal firing, SCN neurons are mostly electrically silent at night, start to fire action 
potentials at the beginning of dawn and continue to generate slow and steady action potentials 
throughout the day (22). It has been shown from over-expression experiments that glycogen synthase 
kinase 3 (both α and β isoforms) (GSK3s) are required for the oscillations in neuronal firing in the SCN 
(23). This is achieved by GSK3s regulation of the persistent sodium current, which affects the action 
potentials afterhyperpolarisation in order to increase spontaneous firing without affecting the resting 
membrane potential (24,25).  
The SCN, much like the rest of the brain, contains glial cells that are able to maintain their own circadian 
rhythm in gene expression and have been shown to contribute to the pacemaker function. This circadian 
gene expression profile was first shown by use of Period2:luciferase (Per2:luc) rat models, in which 
astrocytes maintained circadian rhythmicity for days in vitro (26). Outside of the SCN,  along with their 
main supporting role in the cortex, astrocytes have been shown to maintain a functional circadian clock 
(27). More importantly, these astrocytes had a rhythmic release of adenosine triphosphate (ATP) 
throughout the day, which was mediated directly by their circadian gene expression. Interestingly, 
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explants of SCN can entrain astrocyte cultures, both from the SCN and other cortical areas, suggesting 
a local influence of SCN neurons on entraining clock gene expression within glial cells. Deletion of an 
important clock regulating gene, Bmal1, in astrocytes of the SCN specifically, leads to a loss of rhythmic 
locomotor behaviour and cognition in mice, enacted via GABA signalling (28). This deletion was also 
shown to lengthen periods in SCN rhythmicity, suggesting that astrocytes are important for maintaining 
near-to 24h rhythms in locomotor activity (29). Other important astrocytic proteins such as glial 
fibrillary acidic protein (GFAP) were shown to have a circadian rhythm of expression in the SCN of 
mice and, under constant light conditions, expression levels became altered (30). Furthermore, targeted 
knock out of the GFAP gene in the SCN leads to locomotor arrhythmia under constant light conditions. 
As it is well established in SCN neurons, circadian molecular rhythms underlie electrophysiological 
fluctuations throughout the 24h hour cycle, and importantly, this has been described in glial cells, 
however, at an anti-phasic relationship to neurons (31). SCN astrocytes are found to be more electrically 
active during the subjective night in mice, and actually suppress SCN neurons via glutamate signalling.  
It was understood up until the 1990s, given the large focus on measuring behavioural rhythms through 
running wheel activity, that the SCN was the central clock, and the only extra-SCN tissue to contain the 
biological clockwork machinery was the retina and the pineal gland (32). However, following the 
discovery of circadian clock genes, the molecular machinery of the circadian clock was discovered in 
various peripheral tissues. . First identified in fibroblasts cells, using bioluminescence reporting of 
circadian clock genes (33), and later verified in vivo, using the Per2:luc mouse model, allowing for 
analyses of a vast array of tissues within mammals (34). More importantly, the molecular circadian 
clock was confirmed to be present in humans, and similar in function to that of both mouse and rat 
models, using a lentiviral reporter for Bmal1 in human skin biopsies (35).  
1.1.2 Molecular Pacemaker 
The endogenous circadian clock is unique for its ability to maintain an almost 24h rhythm of molecular 
activity, while still allowing for entrainment with the external environment. The self-sustaining and 
cell-autonomous pacemaker is formed by two distinct auto regulatory transcriptional-translational 
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feedback loops (figure 1.1). The central pacemaker within the SCN is able to maintain peripheral 
molecular clocks in a hierarchal manner via both neural and hormonal signals.  
The primary loop is controlled by the CLOCK/BMAL1 dimer, both members of the basic helix-loop-
helix (bHLH) – PAS (Period–ARNT–Single–minded) transcription factor family. CLOCK knockout 
models initially showed that the protein itself was involved in the correct function of the molecular 
clock (36). However, at the time, it was known that CLOCK was a bHLH-PAS protein, and therefore 
was likely to have a partner protein that it would dimerise to, in order to initiate its action in the cell. 
bHLH domains characterise dimerising transcription factors and PAS domains act as a molecular 
‘velcro’ that facilitate the interaction of small molecules and other proteins with the protein containing 
Figure 1.1. Classical transcriptional translational feedback loop of the mammalian circadian clock. 
BMAL1 and CLOCK facilitate transcription of Period (Per) and Cryptochrome (Cry) via the E-box 
domain, which in turn inhibit their own activation, by repression of BMAL1:CLOCK. Transcription of 
Rorα and Rev-erbα by BMAL1:CLOCK enhances or suppresses translation of Bmal1 respectively. PER 
and CRY are broken down by the proteasome, a process activated by Casein kinase 1 isoform epsilon 
(CK1ε) and AMP-activated protein kinase (AMPK) signalling. This cycle has a near 24-hour oscillation 
and in most species, regulated via input from the retina (Ccg: Clock controlled genes, GSK3β: Glycogen 
synthase kinase 3 beta, RRE: Response elements, FBXL3: F-box/LRR-repeat protein 3, βTrCP: F-




it (37). Initial investigation into CLOCK’s potential partner applied a yeast two-hybrid screen using a 
Syrian hamster (Mesocricetus auratus) hypothalamic complimentary DNA (cDNA) library, in which a 
‘bait’ and ‘prey’ protein would interact with one another to give a positive signal, as well as causing the 
transcription of a downstream response element (in this case, HIS3 and  β-galactosidase (lacz)) (38). 
This screen identified 154 positive colonies for both lacz and HIS3, 22 of which were specific for 
CLOCK, and 3 that proved to be bHLH-PAS containing proteins (BMAL1, ARNT and ARNT2). Next, 
binding of the CLOCK-heterodimer to Per gene E-box was investigated using one-hybrid assays in 
which lacz gene was used as the reporter. By themselves, CLOCK, BMAL1, ARNT and ARNT2 were 
insufficient to bind to the E-box region of Per. CLOCK and BMAL1 displayed robust binding to DNA 
containing Per E-box whereas CLOCK and ARNT or CLOCK and ARNT2 did not detectably perform 
in the same way. These results implicate the CLOCK-BMAL1 heterodimer in circadian clock function 
via binding to and driving expression of the Per gene.  
BMAL1 was later confirmed to be a part of the feedback mechanism in vivo using the Mop3-/- mouse 
model, (Bmal1 was initially named Mop3) (39). Bmal1-/- mice were generated by replacing the bHLH 
domain of the BMAL1 protein with a neomycin-resistance gene cassette in a reverse orientation, 
resulting in a truncated form of BMAL1 that does not have any functional relevance. In this study, both 
wild-type and Bmal1-/- mice showed a robust circadian regulation of activity under normal lighting 
conditions. However, Bmal1-/- mice did not show circadian regulation of locomotor activity under 
constant dark conditions. This early study confirmed Bmal1’s involvement in the regulation of the 
central circadian clock, as in absence, the mammalian clock within the SCN did not exhibit any control 
over the well-characterised circadian timing system. 
Initial experiments focused on the effects of the CLOCK and BMAL1 dimer affecting the expression 
pattern of the Period genes (Per1, Per2, Per3) given the fact that mPer1 was the first to be shown as a 
Drosophila homologue to Period (33). Cryptochrome genes mCry1 and mCry2 were then also identified 
as being a part of the negative limb of the molecular clockwork (40). Clock and BMAL1 dimer acts on 
E-box elements to promote the transcription of both Period (Per1, Per2 and Per3) and Cryptochrome 
(Cry1 and Cry2) leading to increased levels of PER and CRY within the cytosol of the cell. After 
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accumulation in the cytosol, PER and CRY heterodimerise, translocate to the nucleus and inhibit 
BMAL1/CLOCK in order to repress their own transcription (41). The secondary limb of the 
intracellular clock involves retinoic acid-related orphan nuclear receptors, Rev-erbα and Rorα, acting 
to inhibit the transcription of Bmal1 (42,43). These two proteins compete to bond to retinoic acid 
response elements within the promotor region of Bmal1 (44). Whereas Rorα will activate the 
transcription of Bmal1 (43), Rev-erbα actually inhibits the process all together. This secondary loop 
contributes to the clocks precision and robustness.  
Both transcriptional-translational feedback loops are involved in the cell-autonomous circadian clock 
that oscillates at ~24h every day. The most integral part of the clock framework that allows for this 
correct 24h timing is the post-translational modifications that are made to core clock proteins. In order 
to initiate a new transcriptional cycle and determine the period of the clock, degradation of PER and 
CRY is essential. PER is a specific substrate for both casein kinase I epsilon (CKIε) and casein kinase 
I delta (CKIδ), which phosphorylate this molecule, leading to rapid degradation in the proteasome 
(45,46). As well as this, both CKIε and CKIδ were shown to cause nuclear translocation of the PER3 
protein. Both these kinases have a direct effect on the inhibition of PER inhibited transcriptional activity 
of Bmal1:Clock, however, CRY inhibition is unaffected, suggesting both CKIε and CKIδ exclusively 
phosphorylate the PER protein. Phosphorylation of CRY1 and CRY2 is conducted by 5' adenosine 
monophosphate-activated protein kinase and a sequential Dual specificity tyrosine-phosphorylation-
regulated kinase 1A/GSK-3β cascade respectively leading as well to ubiquitination of these proteins by 
F-box/LRR-repeat protein 3 and eventual degradation (8).   
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1.1.3 Entrainment of the SCN 
Given the rhythmic characteristics of almost all environments on earth, it is essential to not only have 
the ability to anticipate these changes, but also to be able to entrain to them, to continue functioning in 
time with one’s environment. Throughout the animal kingdom, endogenous biological rhythms 
entrained to the light cycle can fluctuate during a 24-hour period. For example, in C57BL/6 mice, a 
common laboratory strain, the endogenous clock oscillates at approximately 23.6 hours on average, in 
the absence of lighting cues (47). Humans on the other hand have an average clock cycle of 
approximately 24 hours and 11 minutes, however, this can vary greatly between individuals (48). 
Therefore, it is imperative to have a system in place that is able to be entrained to environmental timing 
cues, to maintain the correct timing of physiology and behaviour. The most notable of these cues is the 
changing light environment, but others include temperature, humidity, feeding activity and social 
activity to name a few. These entraining stimuli are defined as zeitgebers, a term coined by Jürgen 
Aschoff in 1960, meaning ‘time giver’ in German (49). These zeitgebers allow for daily adjustment of 
the endogenous clocks within an organism, without them, leading to ‘free running’ activity, which 
corresponds directly to the intrinsic oscillation of the molecular clock itself.  
In mammals, the SCN receives direct synaptic input from specialised photosensitive ganglion cells 
(ipRGCs) of the retina via the RHT, to convey signals of light intensity to the SCN (50). These tracts 
synapse at retinorecipient neurons within the SCN, while also projecting to other non-perceptual visual 
areas (51). These ipRGCs utilise the photopigment melanopsin (OPN4) to enable light perception by 
the retina. Melanopsin is a pigment that is most responsive to short wavelength (~480nm) blue light 
(52). This has been exemplified by studies in both humans and mice where loss of both rod and cone 
photoreceptors, did not affect the correct circadian response to lighting cues (53,54). Information from 
these specialised cells is then conveyed to the SCN via the RHT. Light activation of ipRGCs causes the 
release of neurotransmitters glutamate and pituitary adenylate cyclase activating polypeptide (PACAP) 
from the synaptic terminals that directly innervate SCN neurons (55). The neuropeptide PACAP does 
not have a direct effect but rather modulates the glutamate signal from the pre-synapse. Glutamate acts 
at both α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and N-methyl-D-aspartate receptors 
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which both directly and indirectly causes an influx of Ca2+ ions into the postsynaptic neuron causing 
activation of an array of kinases that ultimately increase intracellular cyclic AMP (cAMP) (56). cAMP 
in turn causes the phosphorylation of cAMP response element binding protein (CREB) which 
translocates to the nucleus to cause transcription of genes containing cAMP response element (CRE) 
(57,58). Of significance are the clock genes, Per1 and Per2 which both contain CRE in their promotor 
regions. Light at the retina causes an increase in their transcription which then feeds into the clock in 
order to cause entrainment of the transcriptional-translational feedback loop (59,60).  
One might therefore assume that if a phase shift was administered to an animal, this would lead to rapid 
entrainment of the circadian oscillator to the new light/dark cycle.  This, however, is not the case. 
Entrainment of the SCN to a new lighting cue is slow, taking multiple days to adjust whether it is 
advanced or delayed in phase. It has been recently shown that this is primarily due to a negative 
feedback mechanism within the induction of CREB dependant transcription (61). Work from the 
laboratory of RG Foster in 2013 show that the CRTC1-SIK1 pathway is integral in regulating CREB-
mediated clock gene expression within the SCN. CRTC1 was shown to translocate to the nucleus 
following phase-shifting stimuli and act as a coactivator of CREB-driven transcription of Sik1 and Per1. 
SIK1 then phosphorylates and deactivates CRTC after some time, which blocks further CREB-driven 
Per1 transcription. Importantly, they show that reducing SIK1 activity in the SCN greatly decreases the 
time required for entrainment to a new lighting stimulus. Overall, this CRTC1-SIK1 feedback system 
works to limit the impact of an entraining stimulus to the central circadian clock.  
Despite these zeitgebers having the ability to entrain the clock, it is of importance as to when these 
occur in the subjective day, particularly in the case of light exposure. If a nocturnal rodent was awoken 
early from its sleep, then venture out from its burrow, under light conditions, this would be 
disadvantageous to its survival. Thus, the response from the endogenous clock being exposed to light, 
is a phase delay, in order to cause the rodent to wake up later in the subsequent day. If, however, the 
animal stays away from its burrow too long, and into the first moments of daylight, this would cause a 
phase advance to the animals’ endogenous clock. Photic signals become virtually ineffective during the 
subjective day time (62). However, during the subjective night, these signals can either have a phase 
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advancing effect or phase delaying effect, depending on the timing of the signal itself. The differential 
response of biological clocks to a certain stimulus can be described by a phase response curve (PRC) 
(63). PRCs are models to describe how a biological clock will respond to a stimulus given the phase, or 
time at which the stimulus is applied.  
Nocturnal rodents are a very common model for circadian research, however, they have their 
limitations. One question is how nocturnal animals can entrain to a light cycle, given the fact that they 
only appear from their burrows at night. In order to tackle this problem, PJ DeCoursey in 1986 
investigated this mimicking a burrow, under laboratory conditions (64). Flying squirrels (Glaucomys 
volans) caught in the wild were observed to peer out of their darkened burrows during the early hours 
of the morning. If they saw light at the end of the tunnel leading out of their burrow, they responded by 
going back to sleep once again. However, in the absence of light, animals immediately exited their 
burrow to initiate wheel running activity and subsequent feeding. This study provides evidence on 
theories about photoentrainment of nocturnal animals in the 1980s. Whereas wild nocturnal animals can 
find shelter in burrows or nests during the daylight hours, this is not the case in most laboratory animal 
models. The general guidelines for housing animals only allow for bedding material to be placed in 
cages, however, no shielding to light conditions occurs, thus completely ablating any opportunity to 
observe light sampling behaviour. In addition to this, most experiments conducted on nocturnal animal 
models are done so during the light phase, purely down to practicality reasons, to allow experimenters 




1.1.4 Suprachiasmatic Nucleus Output 
Despite the molecular machinery being 
present in almost all cells in the body, the 
SCN remains to be the master pacemaker 
for the entire circadian timing system 
itself. In order to confer correct 
synchronisation of the solar day, to the 
peripheral clocks throughout the body, 
there are a number of signalling 
modalities that are utilised by the SCN. 
Humoral and neuronal signals directly 
from the SCN, control surrounding brain 
regions, which in turn control a plethora 
of behavioural and unconscious function (figure 1.2). Efferent projections from the SCN core primarily 
target local areas of the hypothalamus and thalamus (65). The major bulk of SCN output is directed 
towards areas that contain mainly interneurons, this being the medial preoptic area (MPOA), 
dorsomedial nucleus of the hypothalamus (DMH) and subparaventricular nucleus of the hypothalamus 
(subPVN). Direct connections with neuroendocrine neurons also exist but are few in number. These 
neurons reside in the paraventricular nucleus (PVN), arcuate nucleus and MPOA, and pre-autonomic 
neurons in the PVN and are associated with secretion of hormones including corticotrophin-releasing 
hormone, thyrotropin releasing hormone, thyroid hormone and gonadotropin releasing hormone (66-
69). Via these pathways, the SCN controls one of the most important oscillatory behaviours, sleep. 
Through this action, the SCN, therefore, indirectly controls the rhythms of other behaviours such as 
feeding or activity, given the fact that it is impossible to do these while asleep.  
 
In addition to neuronal output, the SCN also releases AVP locally within the brain, in a circadian manner 
(70). This rhythm is sustained following complete isolation by circular knife cuts, of the SCN, 
 Figure 1.2 Suprachiasmatic nuclei (SCN) output in 
nocturnal and diurnal rodents. In nocturnal animals, 
connections from hypothalamic nuclei are primarily 
inhibitory, and vice versa in diurnal animals (DMH: 





implicating release of AVP occurs within the SCN itself. Complete ablation of the SCN reduces CSF 
AVP below a detectable limit. This is different to what is found in the SON and PVN, the two major 
sites of AVP containing neurons that secrete the hormone into peripheral tissue. Secretion of AVP from 
these cells has been shown to not follow a circadian rhythm (71).  
The SCN has an influence on the sensitivity of the adrenal gland to ACTH signalling via neuronal 
pathways. It has been shown that neurons containing AVP or VIP from the SCN synapse directly to 
preautonomic neurons within the PVN (72). Light induced stimulation of this pathway causes an 
increase in corticosterone levels in both the plasma and brain, despite any change in ACTH levels. This 
is coupled with constant levels of adrenaline and noradrenaline and implicates a direct inhibition of 
neuronal output to the adrenal cortex by light activation within the SCN. Subsequently, this has an effect 
on the circadian oscillator residing within the adrenal cortex, as Per1 expression within this tissue has 
been shown to be altered in animals subjected to a light pulse (73).  
In addition to the control of the adrenal gland via the autonomic nervous system, the SCN also controls 
the rhythmic production of melatonin from the pineal gland, via synapses with preautonomic neurons 
in the PVN (74). Melatonin is synthesised from the amino acid tryptophan which undergoes four 
separate enzymatic reactions, with serotonin being the intermediatory product following the second step 
(75).  Arylalkylamine N-acetyltransferase (AANAT), the enzyme that catalyses the third step in 
melatonin’s production, is thought to be the rate limiting enzyme that gives melatonin its circadian 
profile. This is due to its diurnal pattern in enzymatic activity, with the lowest point during the light 
phase (76). The elimination half-life of melatonin in the body varies between species, at 19.8 minutes 
in rats (77), 34.2 minutes in monkeys and 48 minutes in young human males (78). Fibres of the SCN 
innervate parvocellular autonomic neurons in the PVN, which in turn project to the upper thoracic 
intermediolateral cell column, wherein preganglionic fibres synapse with postganglionic fibres in the 
superior cervical ganglion (SCG), which in turn innervate the pineal gland (79). During the light phase, 
GABAergic inputs from the SCN to the PVN block the glutamatergic output to the IML (80). Within 
the pineal gland itself, melatonin production is stimulated by the release of norepinephrine from 
postganglionic neurons originating in the SCG (81). The SCN-pineal neural circuit is an extremely well-
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studied and robust mechanism with clear and definitive input (light) and output (melatonin). 
Interestingly, ablation of the SCN causes complete loss in the diurnal pattern of melatonin release, 
suggesting that that the pineal gland does not contain its own intrinsic oscillator, and relies solely on 
the timekeeping of the SCN (80). However, the molecular clock machinery is present in almost all tissue 
types, with the pineal gland being no exception. This further suggests the existence of a clock machinery 




1.2 Synchronisation between central and peripheral oscillators 
Early studies on the biological clock focussed on the SCN as the sole director and proprietor of internal 
biological rhythms. The only two other places that were thought to show circadian rhythms were the 
retina and the pineal gland. It wasn’t until the discovery of the molecular clockwork that biological 
clocks were found in almost all tissue types within mammals. While the SCN remained to be the 
orchestrator of the system as a whole, confirmed by transplanted SCN in ablated animals dictating 
circadian period (15), the field of biological rhythm research opened to a wider context to include the 
body as a whole.  
1.2.1 Melatonin 
Release of melatonin from the pineal gland plays an important role in synchronising both central and 
peripheral clocks through type 1 and 2 melatonin receptors (MT1 and MT2) (82). Interestingly, the first 
patent for the use of melatonin was in the stimulation of cashmere growth from cashmere goats in 1989 
(83). It was until 1995 that the first patent for melatonin as a low-dose sleep aid was registered in 1995 
(84). As mentioned previously, the circadian input into the pineal gland is extremely robust, therefore, 
melatonin has classically been believed to be the main hormone to cause entrainment of central and 
peripheral clocks. MT1 and MT2 are membrane-bound G-coupled receptors that are expressed 
throughout the body. MT1 receptors activate the Gi and Gq/11 pathway, modifying the activity of 
adenylate cyclase and are expressed in the brain, cardiovascular system, immune system, testes, ovary, 
skin, liver, kidney, adrenal cortex, placenta, breast, retina, pancreas and spleen (85,86). MT2 on the 
other hand is similar to MT1 and shares 60% homology in amino acid sequence (87). This variant also 
activates the Gi pathway, inhibiting adenylate cyclase activity, and is expressed in immune system, 
brain (hypothalamus, SCN), retina, pituitary, blood vessels, testes, kidney, gastrointestinal tract, 
mammary glands, adipose tissue, and the skin (86). It is evident from these studies that melatonin 
receptors are widely expressed and therefore must have some kind of functional significance in their 
respective tissues. In terms of peripheral function, I will briefly focus on those associated with 
metabolism. Recently, melatonin receptors have been found in the pancreatic islets, suggesting a role 
in insulin production (88). This genome-wide association study found in a group of individuals that a 
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particular mutation in the MT2 receptor gene was associated with an increased risk of type II diabetes 
(T2DM). Additionally, a study in rats showed that pinealectomy, thereby ablating melatonin secretion, 
increased the concentration of circulating blood glucose (89). Pinealectomy has also been shown to be 
responsible for both impaired insulin secretion and action within adipocytes (90). 
Centrally, melatonin has been shown to influence the SCN, given the high concentration of melatonin 
receptors within the SCN itself. Exogenous administration of melatonin has been shown to have the 
ability of phase-shifting neuronal firing rates within the SCN (91). This is promising as a treatment for 
blind individuals that suffer a certain type of circadian related sleep disorder.  In these particular 
individuals, the pathways between the retina and the brain are no longer present or damaged, meaning 
that light information signals from ipRGCs can no longer be transmitted (92). In more common cases 
of blindness, light can suppress melatonin, thereby providing a circadian cue to these individuals. Due 
to this discovery, blind patients are no longer enucleated (removal of eye) due to the eyes playing a 
critical role in circadian entrainment. Melatonin can be administered at certain times of the day to 
entrain the circadian clock, voiding the necessity of direct retinal input (93). In addition to this, 
melatonin has been proven to alleviate the symptoms of jetlag in some individuals if administered at 
the right time of day (94). 
1.2.2 Glucocorticoids 
Glucocorticoids are a class of steroid hormones that have tissue specific effects on gene transcription 
and cell processing. Dysregulation of this complex signalling system seems to have a strong effect in 
the pathologies of obesity and diabetes (95). As mentioned previously, the adrenal cortex, where 
synthesis of glucocorticoids occurs, is under circadian control, primarily form the central circadian 
clock within the SCN. Due to this oscillatory output of glucocorticoids, and the fact that they have a 
strong influence on energy balance and metabolism, it has been suggested that they may contribute to 
the entrainment of peripheral clocks. Administration of exogenous glucocorticoids has been shown to 
affect circadian gene expression in rat fibroblast cells and transiently change the phase of clock genes 
in the liver, kidney and heart (96). Interestingly, and unlike the central pacemaker, the phase-resetting 
effect of glucocorticoids was shown to persist throughout the entire light/dark cycle. Glucocorticoids 
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bind to the glucocorticoid receptor (GR) within the cytosol, after which the complex translocates to the 
nucleus and binds to glucocorticoid response elements (GRE) in the promotor region of target genes to 
regulate expression levels. Administration of glucocorticoids to mesenchymal stem cells has been 
shown to have an effect on a number of clock genes including Per1, Per2, E4bp4, and Timeless (95,97). 
In animals that are subjected to phase shifts, it is believed that glucocorticoids are the main system that 
cause entrainment of peripheral oscillators (98). Animals subjected to a 6-hour phase shift show 
heterogeneity between tissue clock entrainment, however, manipulation of the adrenal clock altered the 
speed in which peripheral clocks were entrained. 
1.2.3 Food Entrainment  
Food cues have a large impact on 
the entrainment of metabolically 
active peripheral clocks. Various 
restricted feeding paradigms have 
shed light on the fact that food 
entrainment has a larger impact 
on peripheral clocks, without 
altering the central pacemaker 
within the SCN (figure 1.3) 
(6,99,100). Interestingly, entrainment of these peripheral oscillators by food is dependant on the 
periodicity of these cues. Hamaguchi et al., showed that peripheral oscillators including the pancreas, 
liver and digestive system were able to be entrained to a recurring feeding paradigm of 22-25 hours 
(101). However, food cues were not able to have an effect if the regular cycle of feeding was 15-21 
hours in duration. Instead, peripheral clocks followed that of the central circadian pacemaker that is 
adjusted to the 24-hour lighting cues.  
Figure 1.3. Peak Per1 expression is altered during restricted feeding 
(RF) in a tissue specific manner. Specifically, restricted feeding 
alters Per1 expression in the liver without affecting expression in the 
SCN or lung. Bars along top indicate light (open bar) and dark (black 





1.3 Circadian rhythms and metabolism1.3.1 Clock 
The clock gene (circadian 
locomoter output clock kaput 
gene) was first identified by Dr. 
Takahashi in 1994, using 
forward mutagenesis screening 
of mice treated with N-ethyl-N-
nitrousourea (102). The most 
pronounced phenotype for homozygous clock mutants is a 3-4 hour increase in free-running period, 
compared to wild type controls (103). Under constant dark conditions, these mice exhibit an oscillatory 
behavioural rhythm that is approximately 27-28 hours in duration. This regular oscillatory rhythm 
breaks down after a few weeks in constant dark, leading to arrhythmic activity in these mice. Clock 
mutants also display a range of abnormalities in circulating metabolites including triglycerides, 
cholesterol, glucose as well as the hormone leptin (Table 1.1). 
Clock mutants also effect the expression levels of other clock-derived genes. Rhythmic bmal1 
expression is severely dampened throughout central and peripheral tissue, with a severely dampened 
peak-trough amplitude, as opposed to its rhythmic expression in wild-type controls (104). However, 
total mRNA expression appeared to be maintained at a similar level to that of the peak expression level 
in wild-type animals. Additionally, rhythmic mPer2 mRNA expression was dampened throughout the 
central and peripheral tissue, however, mRNA levels remained at that of the trough levels seen in wild-
type controls.  
1.3.2 Bmal1 
The discovery of the involvement of BMAL1 in the circadian clock arose from the identification of one 
part of the transcriptional heterodimer that partnered with CLOCK (38). BMAL1 is the protein product 
of the ARNTL gene, consisting of 626 amino acids and acts as a transcription factor that contains a 
basic helix-loop-helix (bHLH) and two PAS domains. bHLH domains characterise dimerising 
transcription factors and PAS domains (Per-Arnt-Sim) act as a molecular ‘velcro’ that facilitate the 
Table 1.1. Metabolic parameters in Clock mutant mice. All 
metabolic parameters apart from insulin levels, are elevated in Clock 
mutant mice (3) 
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interaction of small molecules and other proteins with the protein containing it (37). CLOCK and 
BMAL1 both belong to the bHLH-PAS protein family. CLOCK was first identified in 1997 as being 
integral in the feedback mechanism that dictated the endogenous circadian clock of mammals (38). 
Given the nature of this protein, CLOCK was thought to have a transcriptional cofactor to form a 
heterodimer to cause transcriptional effects. Identification of this cofactor was conducted by  a yeast 
two-hybrid system in which a library of cDNA from the Syrian hamster (Mesocricetus auratus) 
hypothalamus was used to identify CLOCK-interacting proteins (38). Using a section of LEXA bound 
CLOCK as the ‘bait’, 3 possible proteins were found to interact with CLOCK, BMAL1, ARNT and 
ARNT2. Anatomical expression of the corresponding mRNA showed that BMAL1 was the most likely 
candidate given it’s a similar expression pattern to mper1, and clock (sites include the SCN, pars 
tuberalis and various cells of the retina). CLOCK and BMAL1 heterodimerise in order to cause 
transcription of genes containing E-Box domains in their promotor region. These genes include mper1/2 
and cry1, transcription of which produces the gene products PER1/2 and CRY1. PER and CRY in turn 
inhibit the activity of the CLOCK-BMAL1 complex within the nucleus, thereby indirectly inhibiting 
their own transcription.  
The Bmal1 knockout was first published in the year 2000 (39). These mice were generated by replacing 
the bHLH domain of the BMAL1 protein with a neomycin-resistance gene cassette resulting in a 
truncated form of BMAL1 that does not have any functional relevance. Wheel-running activity in these 
mice was accessed for phenotypic changes in the circadian clock. Both wild-type and Bmal1+/- mice 
showed a robust circadian regulation of activity under both LD and constant dark conditions. In contrast, 
Bmal1-/- mice did not show circadian regulation of locomotor activity under constant dark conditions. 
Under LD conditions, Bmal1-/- mice have reduced total activity with highly variable activity patterns 
between individual mice. Similar to Clock/Clock mutant mice, clock gene expression is blunted and 
non-rhythmic under constant dark conditions, as observed by mper1 and mper2 mRNA expression. This 
early study confirmed the involvement of BMAL1 in the regulation of the central circadian clock, as in 
absence, the mammalian clock within the SCN did not exhibit any control over the well-known 
circadian molecular clock.  
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1.3.3 Glucose regulation 
Previous research has identified daily variations in glucose homeostasis and insulin sensitivity within 
humans (105-107) as well as rodents (108,109). The molecular components and integration of various 
systems to control this rhythm are still, to this day, poorly understood. It is believed that the daily rhythm 
in feeding activity in mammals heavily impacts these daily fluctuations, which itself is largely 
determined by the central circadian clock. Research conducted in 1999 by la Fleur and colleagues aimed 
to identify the impact of SCN lesions on the daily fluctuations of various metabolites (110).  Rats with 
intact SCN under an ad libitum, 36 hour fasting, and scheduled feeding regimen all showed a rhythmic 
pattern of glucose levels throughout the 24h cycle tested. Insulin levels in these animals also showed 
fluctuations over the dark/light cycle. In contrast, SCN lesioned animals showed no diurnal regulation 
of blood glucose levels, and insulin levels were overall lower throughout the 24h cycle. Given the fact 
that SCN lesioned animals do not display rhythmic glucose regulation, although they do show 
fluctuations in time with feeding bouts, suggests that the SCN directly influences glucose homeostasis, 
instead of indirect influence via rhythmic feeding activity. This study suggests that this control is likely 
mediated much the same way as the pineal and adrenal glands, via SCN controlled autonomic input to 
glucose regulating tissue. Additionally, stimulation of the SCN has been previously shown to cause 
hyperglycaemia (111), and blockade of autonomic neurons suppresses this effect (112).  
The natural progression of this hypothesis is the investigation of glucose tolerance in animals, which 
was conducted by the same group in 2001 (113). Glucose tolerance is a measure of the speed at which 
an organism clears exogenous glucose from the circulating blood. Impaired glucose tolerance is 
suggestive of a pre-diabetic state, which indicates a failure of tissue to uptake glucose, suggesting the 
Table 1.2. Bmal1-/- mice have a disruption in the daily variation in glucose and triglyceride levels in 




onset of insulin resistance. In this study, following an one hour fast, rats with intact SCN were subjected 
to an intravenous glucose tolerance test (IVGTT) in which a glucose bolus was injected followed by 
serial blood sampling, which occurred 6 hours apart within a 24-hour cycle. Results from SCN intact 
animals displayed evidence for a diurnal variation of glucose tolerance, where glucose tolerance peaked 
two hours following lights off (ZT14) and was the lowest at 2 hours following lights on (ZT2). This 
increase in uptake of glucose at ZT14 coincides with an increase in plasma glucose levels, as described 
previously (110). In contrast, SCN lesioned animals displayed no variation in glucose tolerance between 
these two time points, despite fasting blood glucose levels being the same between these two groups. 
Interestingly, however, insulin levels at these time points between SCN-intact and lesioned animals 
were significantly lower in the lesioned animals, despite improved glucose tolerance. Authors suggest 
that this is evidence for the SCN to play an insulin-independent role in glucose homeostasis. 
Despite these promising results that provide evidence for a direct control of the SCN of glucose 
homeostasis, the fact that the SCN is in close proximity to satiety centres (i.e., ARC, ventromedial 
hypothalamus (VMH) and DMH) potentially confounds these results. Genetic approaches to this 
situation were undertaken in 2004 where glucose tolerance was analysed in either clock mutant (clock 
Δ19) or bmal1 knockout mice (Bmal1-/-) (2). Initial results confirmed previous studies, displaying a 
daily variation in serum glucose levels in wild-type animals that peaked at the onset of lights on and 
troughed at the beginning of lights off (108,109). Glucose tolerance in HFD fed but not chow fed wild-
type mice was different between ZT1 and ZT 13. This is in contrast to what was seen in the previous 
study in rats, where glucose tolerance was different between the onset of the light period and onset of 
the dark period. In Bmal1-/- mice, no difference in serum glucose occurred between ZT4 and ZT16 (refer 
to Table 1.2) suggesting a loss of diurnal variation in glucose regulation as a product of this global 
knockdown.  
These mice also exhibit multiple metabolic deficits (3). Most notably is the complete loss of a diurnal 
eating pattern that wild type mice usually display, as well as a marked increase in food intake. This 
increase in food intake leads to an increase in body weight, most of which is accredited to an increase 
in visceral adiposity in Clock mutants fed either a low fat or high fat diet. Histological analysis of this 
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tissue shows adipocyte hypertrophy caused by lipid engorgement in both low and high fat fed Clock 
mutants.   
Mitogen-activated protein kinase (MAPK) has been shown to interact with the circadian molecular 
clock at BMAL1 to cause phosphorylation at multiple sites (114). These include Ser-527, Thr-534, and 
Ser-599 in vitro. Additionally, constitutively active MAPK causes an inhibition of the BMAL1-CLOCK 
induced transactivation of genes containing E-box elements, whereas MAPK mutants as well as 
BMAL1 Thr-534 mutants, have no effect.  
1.3.4 Food entrainable oscillator (FEO) 
Feeding activity is tightly synchronised to locomotor activity in animals, initially described by Curt 
Richter in 1922: ‘Spontaneous activity of mammals is very intimately related to the food habits of the 
animal’. During the dark phase in nocturnal animals, activity is increased, and these animals are active, 
and therefore food intake is increased in a laboratory setting. Entrainment of this feeding activity comes 
via the central pacemaker, located in the SCN of the hypothalamus. Food anticipatory rhythms (FAA) 
can be measured in mice that are restricted to a certain feeding window. This is characterised by an 
increase in activity and body temperature, prior to the normal window of availability of food. However, 
this FAA can be entrained by not only the SCN, but also by the process of food itself. Mice that are 
kept under an altered lighting condition (18h light, 6h dark) and have food access restricted to a short 6 
hour window during the light phase, show pronounced FAA activity prior to feeding onset (115). Under 
constant darkness, animals are no longer provided with any lighting cues in order to entrain their central 
circadian pacemaker. Therefore, this endogenous oscillator is allowed to ‘free-run’, and in mice, this is 
at a period of approximately 23.6 hours. The FEO is then far more pronounced in its output, given the 
absence of correctional input from the SCN. This is illustrated in figure 1.4, as FAA can be seen under 
light/dark conditions, denoted by blue bars on the actogram, as well as in the absence of light. 
Remarkably, despite the vast array of knowledge known about the central circadian pacemaker within 
the SCN, very little is known about the FEO; its anatomical location, genes that influence its timing as 
well as mechanistic pathways of both input and output are still yet to be discovered. Study’s attempt to 
identify the anatomical location of the FEO have been as yet unsuccessful. The FEO has been shown to 
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run independently from any input from the SCN, suggesting that it is anatomically independent of this 
locus (116,117). Given the fact that food is the main entrainer of this oscillator, it was proposed that 
afferent signals from the gut would be the major input pathway. However, experiments in which animals 
underwent subdiaphragmatic vagotomy, removal of part of the vagus nerve, revealed no interruption of 
FAA rhythms in these particular animals (118).  
  
Figure 1.4. Food anticipatory rhythms (FAA) 
in mice under either a light/dark environment, 
or in the absence of light. A: Normal 
interaction of the suprachiasmatic nucleus 
(SCN) and FAA. B: FAA in the absence of 
SCN input. C: Wheel running activity in mice 
with intact SCN, FAA in blue, food access in 
shaded grey. D: FAA in mice with an SCN 
lesion, FAA persists (blue bars)  and precedes 




1.4 Activity rhythms 
Rhythmic behaviour such as socialising, activity and feeding is controlled both directly and indirectly 
by the central circadian clock. In a laboratory setting, running wheel behaviour in nocturnal animals is 
a good indication and the most accessible signal of their circadian timing system. In 1976, Daan and 
Pittendrigh published a series of papers on their methods and the characteristics of animal running wheel 
behaviour (119-123). Here they describe the circadian characteristics of four common laboratory 
strains, the period (τ) of their free running rhythms, the dynamics surrounding entrainment, and most 
importantly, the equipment and methods used to undertake this task. Most importantly, these 
publications asked the question of whether it was viable to use nocturnal rodents to study circadian 
rhythmicity. What was the magnitude of inter- and intra-variability in the animals, and therefore what 
characteristics were owed to systematic sources within the species themselves? This later allowed the 
design of forward genetics approaches to identify circadian mutants and hence the fundamental 
molecular clockwork (124-126).  
Activity monitoring in laboratory animals is widely used today to identify the timing of the endogenous 
circadian clock. The reason for this is the close link between the SCN clockwork, its output, and 
locomotor rhythms. Lesions of the SCN lead to a total loss of rhythmic activity patterns (127). Long 
term in vivo recordings of mCry1 and mPer1 show their expression pattern to be closely linked to wheel 
running activity, as well as the entrainment of molecular and activity clocks following a change in light 
cycle (128). Wheel running activity was essential for the pioneering work of identifying circadian genes 
using forwards genetics. The ability to identify perturbations in both the entrained and free running 
activity of animals led to further investigations to the gene that was affecting them.  
1.4.1 Running wheel activity 
Mice exert a relatively high amount of activity when given the chance to run on a wheel. On average, 
mice can run for 3 – 7 hours per day, amounting 4 – 20 km total distance (129,130). The act of voluntary 
wheel running in mice is thought to satisfy playing, escaping, or metabolically driven stimuli. This is 
in no way a response of mice held in captivity, as seminal work by Meijer and Robbers in 2014 led a 
simple experiment that examined wheel running behaviour of animals in the wild (131). Cages with 
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running wheels were installed into an urban or natural setting, with no reward stimulus in place. 
Experimenters observed various different animals using the running wheels, including mice, slugs, 
small rats, frogs and snails. Of these, mice made up the majority of cases, and showed extensive running 
activity in the absence of any stimulus, and in a similar manner to that of laboratory animals. This 
experiment lasted for almost 3 years, with the overwhelming finding that mice in particular, enjoy 
running on wheels.  
Mice will begin running immediately on running wheels, once the absence of light occurs within their 
cage. Running will continue throughout the dark phase, often in ~150 second bouts of activity, separated 
by short breaks (129). The frequency of this activity will diminish across the night, however, running 
wheel speeds maintain an average of ~2.7 – 4 km/h (132). Factors such as sex, age, and running wheel 
design can have an impact on distance ran, and speed of running amongst animals. Patterns of running 
wheel activity are also distinct between individuals of a certain species and are maintained for the 
duration of their life cycle. Animals that are given access to running wheels, naturally undergo 
adaptations to those that do not have access. After some time on a running wheel, mice have better 
endurance capacity, as indicated by increased VO2max, and increased time to exhaustion (133). Another 
major impact of voluntary wheel running is the increase in food intake and water consumption in mice, 
by ~20 % (134,135).  
Access to running wheels increases body temperature in the early hours of the night, likely due to the 
immediate initiation of voluntary wheel running. In this way, it causes a shift in the acrophase of body 
temperature across the 24h cycle (135). On a genetic level, access to running wheels caused an advance 
in clock genes Bmal1 in the liver and Per1/2 in white adipose tissue (WAT), with a trend of 
advancement in most others genes in various tissue (135). Mice have been shown to benefit from ad 
libitum wheel access when challenged with a 12 hour light inversion, as opposed to those with wheel 
access restricted to a 12 hour period (136). Under low light level inversion (~1.5 lux, as opposed to 
~150 lux used in our own laboratory) mice with ad libitum access to running wheels entrain both general 
locomotor and running wheel activity by approximately ~1 hour per day. Whereas those with wheel 
access only available during the new light period following the shift, maintained running wheel activity 
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in the light phase, and general locomotor activity remained mostly in the light phase, with no strong 
correction into the dark phase. Low light was likely used in the scenario in order to allow for animals 
to still run during the light phase, as light above ~75 lux causes light masking in mice, inhibiting normal 
running behaviour (137). 
1.4.2 General locomotor activity 
General locomotor activity is influenced by the size of cage that an animal is kept in (138). The ultradian 
rhythm in locomotor activity is much stronger in animals housed in larger cages, and this becomes 
dampened with a decrease in cage size.  
1.4.3 Effect of mutations 
Clock 
The gene Circadian Locomotor Output Kaput (Clock) is appropriately named due to its mutation 
causing either a lengthening of the free running period in heterozygous mutants, or a loss of rhythmicity 
in homozygous mutants (102). This only occurs under free-running conditions, in constant darkness, 
and no significant effect can be seen when a lighting stimulus is provided. Additionally, no effect on 
total running wheel activity is seen in either het- or homozygous Clock mutants. Hence, Clock is 
important for maintaining the circadian rhythm of the biological clock but is not essential when adequate 
zeitgebers are present. Under non-photic stimuli, heterozygous Clock mutants responded differently to 
wildtype animals (139). Calorie restriction causes a phase advance of running wheel activity in wildtype 
animals, but no effect is seen in mutants. Additionally, introduction to a novel running wheel during the 
light phase causes an advance in wildtype animals, but a delay in Clock mutants.  
Bmal1 
Activity levels are reduced in general, within Bmal1 mutants (39). Under free running conditions, these 
mutants display no circadian pattern of activity, due most likely to a loss in circadian rhythms in the 
SCN itself. Similarly, animals that are deficient in a functioning dpg gene, which is rhythmically 
controlled by BMAL1, show a reduction in activity, but maintain rhythmic activity under constant 




Homozygous mutants of mPer2 are able to entrain activity rhythms to a light dark cycle (141). However, 
under constant darkness, or free running conditions, homozygous mutants display a short period of 
activity of 22.1 ± 0.4h. However, following 2 to 18 days in constant darkness, mPer2 mutant mice lose 
all rhythmicity in running wheel activity.  
Cry1/2/3 
Double knockout of both mCry1 and mCry2 lead to an immediate loss of circadian rhythmicity in the 
absence of lighting cues (142). In the same study, knockout of mCry1 only, led to a shortened free 
running period of 22.51h, and knockout of mCry2 only, led to a lengthening of the free running period 
to 24.63h. Animals with non-functional CRY1 display very long free running rhythms (28 hours), as 
well as a ‘rhythm splitting’ phenomena, as two large activity bouts occur in the 28h period (143). In 
this study, Cry1 mutants also showed an instantaneous activity entrainment phenotype when shifted 




1.5 Disruptions to circadian rhythms and metabolism 
Circadian clocks evolved under the rhythmic lighting cue of the sun, however, the modern world is now 
able to function at all hours of the day thanks to the invention and development of light emitting 
instruments. It is now commonplace for us to experience disruptions to our circadian system. This is 
particularly true for those of us who undertake shift work, as well as frequent travellers who are 
subjected to multiple jetlags, or individuals who experience social jetlag. In principle, any perturbation 
to our normal circadian rhythm, such as eating a meal at the incorrect time, or being exposed to bright 
light at night, has an impact on our rhythmic physiology. Many studies have looked at the effect of these 
disruptions on the health risk of the individual, with strong correlation to metabolic disease risk (144-
153). When an individual is disrupted, behavioural and biological processes can become out of sync 
with one another. These behaviours include the sleep/wake cycle, food intake, physical activity and 
socialising habits. A recent review of the literature conducted by Antunes et al., collated all available 
studies that focused on shift work and its associated risk on an individual’s health (154). Results from 
numerous papers showed a detrimental effect of shift work on various risk factors including increased 
BMI, altered metabolism, cardiovascular complications and altered glucose and lipid homeostasis, 
ultimately leading to an increased prevalence of obesity, diabetes and cardiovascular diseases. They 
suggest that all these risk factors, either directly or indirectly, can be attributed to a disruption to one’s 
biological timing, caused by the environment they find themselves in.   
Social jetlag is also becoming more prominent, especially in the working age group. Social jetlag is 
defined as a difference in middle sleep time during the working week as opposed to the weekends. This 
pertains to individuals who are waking up for work in the early hours of the morning during the week, 
and enjoying a sleep in on the weekends, due most likely to sleep loss during the week (150). This is 
defined as an individuals preferred timing of sleep and activity, known as their chronotype. Those with 
a late chronotype are believed to have the largest difference in sleep patterns when comparing their 
work and free days, whereas the opposite is true for early chronotypes (155). Complications arise in 
these individuals as sleep is lost due to the discrepancies between their circadian and social clocks. 
Research into this phenomenon suggests that social jetlag is associated with an increased BMI, stating 
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that those that ‘live against the clock’ have an increased risk to develop obesity, and this is apparent in 
~70% of the world’s population (156). An important cohort study has also shown a dose dependant 
prevalence of obesity and diabetes in individuals who experience social jetlag (148).  
Jetlag caused by transmeridian travel also contributes to the multitude of circadian disruptions 
experienced in today’s modern society. Recent technological advancements, specifically in high-speed 
air travel, have allowed human beings to travel across many different time zones in a matter of hours, 
arriving at destinations that have an environmental solar period that differs to that of their pre-existing 
endogenous rhythm. This causes a mismatch between internal timing and external environment that is 
known as Jetlag (94). This is a disorder that is characterised primarily by insomnia and daytime 
sleepiness and varies in severity based on several factors including the number of time zones crossed, 
direction of travel and the individual’s age. Research on frequent travellers has shown that on average, 
it is estimated that the endogenous circadian clock entrains with the external environment one day per 
time zone crossed (157,158). This entrainment also varies based on the direction of travel, as well as 
the travellers own endogenous rhythm. A cross-sectional study identified eastward travel as more 
detrimental to physical performance, as opposed to westward travel (159). 
Circadian health is extremely important in maintaining a healthy metabolism. The idea of a ‘circadian 
syndrome’ has been put forward by Paul Zimmet and others, suggesting that the common denominator 
associated to metabolic health risk factors is a disruption to our circadian timing system (160). Although 
there is a vast amount of evidence to support the idea that disrupting our endogenous timing system is 
detrimental to our health, the mechanism by which this happens is still unknown. Animal models have 
attempted to make sense of this, providing evidence for specific facets of the metabolic system that 
become compromised. The general idea is that a mismatch in central and peripheral signals, as well as 
signals conveyed from organ to organ, become desynchronised, leading to a general downturn in 
metabolic efficiency.  
Light cycle disruptions have a direct impact on the molecular clockwork within neurons of the SCN. 
Importantly, a shift in light cycle causes a dissociation of oscillating genes within the SCN itself (161). 
Two regions of the SCN were shown to entrain at different rates. rCry1, rPer1 and rPer2 expression 
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patterns in the ventrolateral SCN, often referred to as the core, shift rapidly to the new light cycle. 
However, the dorsomedial SCN, or the shell, shifts much slower, an area in which the origins of SCN 
afferents are concentrated. This rapid shift in the core is due to direct inputs from the retina, which form 
synaptic contacts with cells of this region, whereas the shell receives information from the retina 
indirectly via the core (162). Within the SCN, mRNA in situ analysis of clock genes following a 6h 
phase shift show that mPer reacts rapidly to an advance, and expression pattern moves quickly to match 
the new light cycle (163). mCry expression moves slower, in time with the resetting of activity to the 
new light cycle (approx. 1 hour per day). During a phase delay of 6h both mCry and mPer rapidly move 
expression pattern in synchrony, to fit the new light cycle. These results were confirmed by a later study 
that shows an 8h phase advance of light cycle cause a similar shift in mPer1 and mPer2, with Bmal1 
and Dbp being initially dampened in oscillation amplitude, but entrained on the 4th day following the 
shift (164). Long term in vivo recordings of mCry1 and mPer1 show their expression pattern to be 
closely linked to wheel running activity (128). Following a phase advance in light of 8h, mCry1 and 
mPer1 took 6d to entrain to the new light cycle, however, activity onset took approximately 10 days to 
entrain. The effect of the SCN is clearly seen here as a hierarchal order in which gene expression is 
entrained prior to other behavioural rhythms.  
 
1.6 Leptin 
Leptin is an adipose-derived hormone that regulates appetite and energy metabolism. Given its high 
importance in energy metabolism, it is tightly regulated by the circadian timing system (165). It is 
therefore a hormone that can be affected by circadian disruptions and one that can be studied to better 
understand how circadian disruptions effect metabolism. 
 In the 1950’s a mutation in a gene related to appetite and energy metabolism was first described as 
giving mice a phenotype of excessive food intake and gross obesity (166). This so called ob/ob gene 
was later mapped in the 1990s by Rudolph Leibel and Jeffrey M. Friedman (167) and later, the gene 
product was described by Friedman as the hormone Leptin (168). This discovery was amidst rising 
prevalence of obesity within the western world and therefore was a very important finding at the time 
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(169). Due to the fact that leptin is secreted from the WAT, it is therefore plausible to label adipose 
tissue as an endocrine gland. That being said, secretion of leptin must therefore be under some form of 
control. Studies looking at the secretion profile of leptin have shown that leptin plasma levels follow a 
circadian rhythm, with a rise that is seen during the night (170). Control of this rhythm has been shown 
to be entrained more directly with meal timings, rather than the rhythmic output of the circadian clock 
(171), however, rhythmic oscillations are lost when the SCN is not present (172). Leptin levels in obese 
individuals are also much higher than lean individuals, which is most likely due to the increase in fat 
mass and therefore, leptin-producing adipocytes in an individual (173). Leptin has been shown to 
possess a multitude of functions not only as the main appetite suppressor but also in glucose 
homeostasis, circulatory-, reproductive- and immune function as well as many more (174).  
In recent years, it has come to light that leptin has an essential role in glucose metabolism based on its 
co-signalling with insulin within the hypothalamus. Insulin is secreted by pancreatic β-cells in response 
to short term changes in blood glucose levels in order to promote uptake of glucose in the periphery. 
Centrally, insulin acts on the insulin receptor (IR) within various areas of the CNS, and more 
specifically is found within the hypothalamus in neurons containing agouti-related peptide (AgRP) and 
pro-opiomelanocortin (POMC) neuropeptide. This has strong implications for its co-action with the 
hormone leptin. Along with activation of the JAK-STAT pathway, leptin also plays a role in activation 
of the phosphoinositide 3-kinase (PI3K) pathway. Binding of leptin to its receptor (OB-R) has been 
suggested to cause activation of IRS by the JAK2 component, which in turn activates PI3K and causes 
synthesis of PIP3 from PIP2 (175). An increase in PIP3 levels leads to activation of phosphoinositide-
dependant kinase-1 (PDK1) and in turn, activation of Akt. Activated Akt has many different roles 
including the activation of molecules that regulate glucose homeostasis and energy metabolism. Insulin 
signalling converges with leptin signalling at the PI3K molecule. When insulin binds to its receptor, 
insulin receptor substrate (IRS) becomes phosphorylated and proceeds to activate PI3K signalling, 
modulating the signalling cascade as described previously.  
Leptin has been shown to have a high impact on glucose tolerance in mice lacking leptin (Lepob/ob mice) 
(176). Glucose tolerance tests were conducted in Lepob/ob mice that were either on a low-fat diet, or high 
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fat diet. Lepob/ob mice on low fat diet, when treated with leptin prior to a glucose tolerance test, showed 
a far better glucose metabolism than those given vehicle treatment. This effect was not seen in high fat 
diet fed mice. This shows a positive modulation of leptin signalling on whole body glucose homeostasis, 
that is abolished in animal models of leptin resistance as is the case for mice on a high fat diet. 
Conversely, insulin has also been shown to have a direct chronic effect on the levels of circulating 
leptin. In animal models of hyperinsulinemia, circulating leptin levels have been shown to be increased 
as well as production rate of leptin mRNA within that was increased in white adipose tissues (177). In 
addition to its effect on glucose homeostasis within the central nervous system, specifically the 
hypothalamus, leptin has also been found to be involved in the processing of insulin signals in the 
periphery. Leptin has been shown to have an effect on glucose transport within the periphery (178). In 
a study by Burcelin and colleagues in 1999 using leptin deficient (Lepob/ob) mice, experimenters showed 
an increase in glucose uptake to brown adipose tissue, the brain and heart following an intravenous 
injection of leptin (178). However, this effect was not seen in skeletal muscle or white adipose tissue. 
Liu and colleagues in 1997 (179) found that mice lacking leptin had an inhibition of glycogen synthesis 
when administered exogenous leptin. This implicates leptin to have a role at a basal level in the 
regulation of glycogen synthesis. Another study looking at the effect of leptin within the liver showed 
that administration increased the output of bile from the liver (increasing Bmax) thereby showing an 
increase in energy movement (180).  
Leptin also plays a major role in the feedback to adipocytes that produce it. When caloric intake 
becomes too high so as to induce fat cells to grow much larger, an acute increase in leptin acts to induce 
ectopic fat (181). This is the storage of triglycerides within organs, specifically the liver, skeletal 
muscle, heart and pancreas. This then causes further dysfunction of these particular tissues leading to 
overall physiological stress. An in vitro experiment looking at leptin production by adipocytes in 
response to food induced hormones, such as insulin and cortisol, showed that leptin is secreted in a 
dose-dependant manner in relation to these hormones (182). This effect was also modulated by the 
introduction of cortisol, which increased this effect three-fold. This implies that the secretion of leptin 
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in an already compromised system, for example diet induced obesity, causes a much greater increase in 
plasma leptin levels and thus further causing the process of ectopic fat storage.  
1.6.1 Leptin Signalling 
Produced rhythmically by the adipose tissue, leptin crosses the blood brain barrier and binds to OB-R 
within specific regions of the brain. These region include the ARC, the DMH, the VMH and the PVN 
(183,184). These areas were identified and published by Scott et al., in 2009 where experimenters used 
a mouse model that expressed Green Fluorescent Protein specifically at sites of leptin receptor 
expression, results of which can be found in figure 1.5 (183).  Within the ARC specifically, the leptin 
receptor is expressed on neurons that co-express either neuropeptide Y (NPY)/agouti-related peptide 
(AgRP) or POMC (figure 1.6) (185). NPY acts as a neurotransmitter within the brain and during intake 
Figure 1.5. Series of line drawings illustrating the distribution of leptin receptors within the central 
nervous system. Particular areas of interest to this paper are the ventromedial hypothalamus (VMH) 
and paraventricular nucleus (PVN) found in C, the arcuate nucleus of the hypothalamus (ARH) and the 




of food, acts as an orexigenic signal that increases the amount of food consumed (186). NPY is inhibited 
by leptin signalling and in mice lacking NPY, leptin causes a far greater decrease in food intake and 
therefore increased weight reduction (186). AgRP is a neuropeptide whose main purpose is the 
antagonism of the melanocortin-3 receptor and melanocortin-4 receptor within the brain which 
suppresses the melanocortin signalling system and therefore stimulates food intake (187). Thus, these 
NPY/AgRP producing neurons are effective in stimulating appetite and suppressing metabolism and 
energy expenditure. POMC on the other hand is a pre-cursor of melanocortin peptide that is released 
from neurons within the ARC (188). Following leptin signalling, POMC neurons release POMC to 
reduce food intake (189). Electrophysiological studies have also shown that NPY/AgRP neurons have 
direct inhibitory synaptic inputs to POMC neurons (190). Through inhibition of NPY/AgRP neurons 
via leptin administration, inhibition of POMC neurons by NPY neurons are further disinhibited. 
These NPY/AgRP and POMC neurons are known to project to the lateral hypothalamic area, which is 
an area associated with regulating body weight, feeding and metabolism(191,192). Leptin binds to its 
receptor, OB-R, on these neurons, a class I cytokine receptor that is associated with Janus Kinase 2 
(JAK2) (193). Following extracellular binding of leptin, JAK2 is activated and begins to phosphorylate 
tyrosine residues of the OB-R, one of them being Tyr1138. Signal Transducer and Activator of 
Transcription 3 (STAT3) binds to this site and becomes phosphorylated itself, then proceeding to 
dimerise with other phospho-STAT3 molecules and translocate to the nucleus to activate expression of 
target genes. Suppressor of Cytokine Signalling 3 (SOCS3) is also expressed via this process, which 
acts as a negative feedback mechanism, that feedbacks to STAT3 to reduce its activity in the cell (194). 
The SOCS3 protein competes for the binding site at phosphorylated Tyr985 of the OB-R in order to cause 
inhibition of the JAK-STAT signalling cascade (194).  
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Both NPY and POMC neurons work in balance with one another in order to regulate the intake of food 
through the peripheral signal of leptin. The signalling of leptin stimulates catabolic pathways and 
inhibits anabolic pathways via this mechanism. At a state of energy surplus with high leptin levels, 
POMC neurons are secreting POMC in order to decrease appetite, while NPY/AgRP neurons are 
suppressed. In contrast, during times of low energy- and low leptin levels, NPY/AgRP are secreted in 
order to increase appetite while POMC neurons are suppressed. Leptin plays a pivotal role in the balance 
in secretion of these metabolically active neuropeptide secretions. 
1.6.2 Leptin Signalling in Obesity 
Obesity in the western world is reaching epidemic proportions, with few solutions being found due to 
underlying pathophysiological alterations (195). In the 1990s, the discovery of leptin sparked much 
optimism around its use to cure obesity and various other eating disorders, as mice lacking the functional 
gene were obese. However, further investigation into this particular hormone in models of human 
obesity yielded discouraging results, as obese individuals did in fact have an intact ob gene that was 
72% more expressed then those of a lean phenotype (196). Furthermore, a randomised control trial 
Figure 1.6. Representative diagram showing the signalling pathway of the Leptin Receptor (OB-R) in 
normal (left) and hyperleptinemic conditions (right). Leptin binds the OB-R and causes activation of 
the Janus Kinase 2 (JAK2) which in turn causes phosphorylation of Signal Transducer and Activator of 
Transcription-3 (STAT3) which then dimerise and travel to the nucleus to cause transcription of target 
genes, including Suppressor of Cytokine Signalling 3 (SOCS3) which feeds back to the OB-R to cause 
inhibition of leptin signalling. In hyperleptinemic conditions, such as diet induced obesity, increased 
circulating leptin concentrations causes an increase in STAT3 activated transcription of SOCS3 which 




assessing the benefit of exogenously administered leptin on obese patients, yielded disappointing results 
(197). This led the field to believe that leptin resistance occurred in these individuals, therefore negating 
the effects of leptin itself. In obese mice models fed with a high fat diet, the arcuate nucleus has been 
shown to be selectively resistant to leptin signalling (198). Many theories surround this phenomenon, 
most notably is hypothalamic inflammation causing a decrease in leptin sensitivity within the 
hypothalamus, as well as an increase in circulating leptin due to increased fat content within the 
periphery, to cause desensitisation of the signalling pathway. The hallmark of obesity is an increased 
body weight due to increased fat mass, resulting in increased circulating leptin (170). Having found 
increased leptin signalling within the arcuate nucleus of the hypothalamus, experimenters found a lack 
of leptin-induced signalling in the same regions, when mice had been subjected to a high fat diet. This 
change was seen as early as six days into the treatment and an additional study found this within the 
first day of high fat diet feeding (199). In addition to this finding, mRNA levels of SOCS3, were found 
to be increased within the arcuate nucleus of these high fat diet fed mice. This leads to the hypothesis 
that increased circulating leptin causes increased SOCS3 expression centrally, which eventually 
desensitises the signalling pathway (200). This is possible as leptin signalling has been shown to be 
retained in diet-induced obese mice (201).  
New avenues of research have demonstrated that products of a diet high in fat content can cause 
inflammation within central neuronal structures, which leads to dysfunction. It is known that tissue 
exposed to an environment in excess of nutrients, is susceptible to cellular inflammation as seen in 
muscle, liver, vasculature and other peripheral regions (202). This activation of inflammatory pathways 
within cells itself is likely mediated via Toll Like Receptor 4 (TLR4) that in turn activates the IKKβ-
NFκB transcriptional pathway (203). This inflammatory pathway causes leptin resistance via the 
induction of the SOCS3 molecule that acts to downregulate the associated JAK-STAT signalling 
cascade of the leptin receptor. Components of the high fat diet have been shown to directly activate this 
pro-inflammatory cascade within the central nervous system much in the same way as the periphery 
(204). This therefore provides some evidence to the fact that nutrient excess and saturated free fatty 
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acids, contained within high fat diets, have the ability to disrupt central leptin signalling and therefore 
lead to leptin resistance which inevitably leads to metabolic dysfunction and obesity.  
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1.7 Insulin  
Leptin is not the only metabolically controlling hormone that is linked closely to the clock. Insulin 
shows circadian like patterns of release and function (108,205) and is therefore another viable candidate 
linking circadian disruptions and metabolic disease.  
1.7.1 Insulin Structure and synthesis 
Insulin is the main anabolic hormone in all mammalian species, involved in facilitating cellular glucose 
uptake, regulating carbohydrates and maintaining lipid and protein metabolism to name a few (206). Its 
discovery was amongst growing concerns over diabetes type 1 which, at the time, almost certainly led 
to death. Controversy revolves around the discovery of insulin itself, however, the 1923 Nobel Prize in 
Physiology or Medicine was awarded to a group in Toronto who, in 1922, were able to successfully 
extract and purify the substance from canine pancreatic tissue, and cure a diabetic patient of their 
hyperglycosuria and subsequently, their diabetes (207). Nicolae Paulescu, a Romanian scientist claimed 
to have been the first person to isolate insulin in 1921, which he called pancreine, but was unable to 
purify the substance to something that could be used in human patients.  
The role of insulin in the regulation of blood glucose levels is achieved by a number of mechanisms; 
uptake of glucose into peripheral muscle and adipose tissue, increasing glycogen stores in the liver and 
muscle, and inhibition of gluconeogenesis in the liver. Additionally, insulin has effects on satiety, and 
loss of insulin leads to hyperglycaemia, dyslipidaemia and T2DM. Insulin is produced and secreted by 
the islets of Langerhans, a region within the pancreas that contains its endocrine (hormone producing) 
cells. Specifically, beta-islet cells (β-cells) produce insulin and constitute 65-80% of all cells. Synthesis 
of this protein hormone begins from the transcription of the insulin gene into a single polypeptide called 
preproinsulin (208). This 110-amino acid precursor contains a hydrophobic N-terminal signal peptide, 
which associates with cytosolic ribonucleoprotein signal recognition particles, in order to facilitate the 
translocation of preproinsulin to the rough endoplasmic reticulum (209). During this process, the N-
terminal peptide is cleaved yielding proinsulin (210). Within the endoplasmic reticulum, proinsulin 
undergoes folding and addition off three disulphide bonds and is then packaged into immature secretory 
vesicles within the Golgi apparatus. Proteases that cleave proinsulin into insulin and C-peptide are 
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packaged along with proinsulin within the secretory granules (211). Insulin and other products are then 
held within secretory granules awaiting stimulation and exocytosis of its content. The mature insulin 
hormone exists as two chains, an α- and β-chain, connected by two disulphide bonds (212).  
Many factors contribute to the regulation of insulin biosynthesis, both transcriptional and translational. 
Glucose metabolism remains the most important physiological event that stimulates insulin gene 
transcription (213). Fasted animals injected with exogenous glucose show a 3-fold increase in the 
transcription levels of proinsulin, an effect that is blocked by pharmacological inhibition of transcription 
(214). Additionally, the insulin gene contains a number of discrete sequence elements within its 
promoter region that are sites for transcription factor binding. One such element is the cyclic AMP 
response element (CRE), in which there are four sites within the insulin gene promoter region (215). At 
these sites, a variety of transcription factors can bind to and regulate insulin gene expression, of which 
all belong to the transcriptional factor family of CRE binding protein (CREB). Regulation of translation 
is most effectively controlled by the levels of nutrients available to β-cells. β-cells enhance their overall 
speed of protein translation in response to the dephosphorylation of eukaryotic initiation factor 2a 
(eIF2a) via protein phosphatase 1 (216). Exposure of β-cells to high glucose causes a reduction in the 
ratio between phosphorylated eIF2a and unphosphorylated eIF2a.  
1.7.2 Insulin Secretion 
Insulin secretion is tightly 
regulated in order to meet 
metabolic demand. Secretion of 
insulin is mainly driven by 
glucose-stimulated release 
(figure 1.7). In order to do this, 
β-cells reside within the 
endocrine region of the pancreas, 
surrounded by numerous 
fenestrated capillaries that allow 




for nutrient exchange between the vasculature and the β-cells themselves. This allows β-cells to sense 
the nutritional state within the vasculature quickly, to initiate an immediate response (217). Insulin 
release occurs in two distinct phases, an early phase that is likely the result of preformed insulin from 
the β-cells being released, occurring within 10 minutes of stimulation. This is followed by a fall in 
insulin and a subsequent slower late phase of insulin release that is characterised by a steady increase 
in insulin levels over the period of one hour. Glucose-stimulated insulin-release (GSIS) is initiated by 
the entrance of glucose into the β-cells via Glucose transporter 2 (GLUT2), a membrane bound 
transporter that allows glucose entrance via facilitated diffusion (213). The GLUT2 transporter itself 
has a low substrate affinity, ensuring high glucose influx. Once glucose has entered the cell, it is 
phosphorylated by the enzyme glucokinase in order to form glucose-6-phosphate (G6P) (217). 
Glucokinase is the rate-limiting step in β-cell glucose metabolism, given its unique characteristic in 
which there are no products of its function that inhibit its activity, as is the case in many other kinases. 
Glycolysis of G6P leads to the production of pyruvate, which is then oxidised within the mitochondria 
of β-cells in the tricarboxylic acid cycle, producing ATP from ADP. This change in ATP/ADP ratio 
leads to the closing of an ATP-sensitive K+ channel on the cell surface, leading to depolarisation of the 
entire cell. Voltage-gated Ca2+ channels then open in response to this change in membrane potential, 
leading to the influx of calcium ions into the cell. Increased intracellular calcium then activates 
microtubule-mediated exocytosis of insulin-containing secretory granules. 
An additional glucose-regulated signal can occur via the formation of glycerol-3-phosphate (Gly3P), in 
which G6P is metabolised into dihydroxyacetone phosphate, an integral molecule in the generation of 
Gly3P (218). Gly3P generates lipid metabolic coupling factors including long-chain acyl-CoA and 
diacylglycerol (DAG) that has been shown to augment insulin secretion. Long-chain acyl-CoA is an 
essential protein in the formation of insulin-containing granule fusion, and DAG activates protein kinase 
C, which is implicated in insulin secretion (219). This pathway is independent of mitochondrial 
metabolism, although still generates factors that contribute to insulin secretion. Free Fatty Acid (FFA) 
metabolism also influences insulin secretion, and has been shown to potentiate GSIS in states of 
diabetes (220). The intracellular metabolism of FFA also leads to the synthesis of long-chain acetyl-
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CoA and DAG and increases insulin secretion in an identical manner. Finally, alpha cells of the 
pancreatic islets also play a role in regulating glucose homeostasis by release of glucagon. Glucagon 
performs the opposite effect to insulin within the periphery, stimulating catabolism by increasing 
gluconeogenesis in the liver and glycolysis (221). Insulin and glucagon work in tandem as an entire 
feedback loop, where a decrease in glucose levels causes release of glucagon, and an increase causes 
release of insulin 
1.7.3 Circadian Rhythms in the Liver 
Transcriptional profiling technology began to take hold in the early 2000s, shortly after the discovery 
of the central circadian pacemaker and its functional mechanism. These new technologies allowed for 
the identification of other areas within the periphery that may be under circadian control. At this time, 
it had already been established that the metabolic system was under some kind of circadian control, and 
that alterations or disruptions in molecular timekeeping led to metabolic deficits.  
Hepatic gluconeogenesis is essential in the maintenance of glucose homeostasis in mammals. 
Elevations in circulating glucagon trigger cAMP mediated phosphorylation of CREB, leading to the 
activation of gluconeogenesis within the liver. The circadian clock has also been shown to have a role 
in the regulation of this process. CREB activity during fasting is modulated by Cryptochromes (Cry1 
and Cry2)  (222). Glucagon administration into fasted mice, increased CREB expression between ZT10-
13, 40 times higher than at ZT22-1, suggesting a rhythmic gating of CREB activity. This result was 
reflected in gluconeogenic gene expression (G6Pase and Pck1), showing highest expression at ZT13 in 
response to glucagon. CRY protein is at its highest levels between the night-day transition, at around 
ZT22-1, suggesting that CRY acts as a brake on gluconeogenesis. In biochemical reconstitution studies, 
it was found that CRY inhibited accumulation of cAMP indirectly via suppression of the associated G 
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protein coupled receptor. Interestingly, Cry has also been shown to have a complimentary effect by the 
repression Pck1 via glucocorticoid receptor-dependant transcription (223), therefore having an active 
effect on the regulation of gluconeogenesis.  
1.7.4 Hormonal Regulation of Insulin Secretion 
Melatonin 
Identification of the melatonin receptor in pancreatic β-cells led to an investigation as to their purpose 
in insulin secretion (224,225). However, there are mixed reports as to the exact function of melatonin, 
as some report an inhibitory (226), neutral (227) or stimulatory effect (228) on insulin secretion. 
However, the general consensus shows an inhibitory effect of melatonin, specifically in clonal β-cells. 
Additionally, chronic melatonin administration in diabetic rats lead to a reduction in hyperinsulinemia 
in vivo (229). The melatonin receptor exists as two isoforms, melatonin receptor 1 (MT1) and MT2. It 
is not entirely known which receptor is expressed on β-cells, with a number of mixed reports that 
initially show MT1 and not MT2 being solely expressed in β-cells (224,225). Immunohistochemical 
analysis of pancreatic islet cells in either MT1 or MT2 null mice gave the best indication of localisation 
of these receptors (4). Using a triple-staining technique, investigators found that WT mice expressed 
Figure 1.8. Wild-type mouse islets showing triple immunostaining for MT1 (A), insulin (B) and 
glucagon (C) and merged in D. This analysis shows MT1 expressed exclusively in glucagon-containing 
cells. MT2 (E), insulin (F), glucagon (G) and merged in H, shows MT2 immunostaining is restricted to 
insulin containing cells. (4) 
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MT1 receptors exclusively in glucagon-containing cells (α-islets), whereas MT2 receptors were 
exclusively expressed in insulin containing cells (β-islets) (figure 1.8). This was confirmed in MT1 null 
mice in which no immuno-staining was found in islets for MT1, but MT2 staining was still restricted to 
insulin containing cells. This result was in line with previous mRNA analysis of pancreatic islets in 
both rodents and humans, where MT1 mRNA was detected in α-cells, however, in contrast to a lack of 
MT2 mRNA at all (230). This is likely due to a low level of MT2 mRNA, whereas Nagorny et al. could 
show at a protein level, that this receptor was present.  
Interestingly, melatonin production in both humans and rodents occurs during the subjective night phase 
of the 24h light cycle, however, rodents are nocturnal whereas humans are diurnal, suggesting a 
divergence of receptor function between these species. Isolated human islets treated with melatonin has 
been reported as causing an increase in insulin secretion (230), whereas in rodents, melatonin causes a 
repression of insulin secretion (224,225). Ramracheya et al. showed an increase in calcium influx in 
human α-cells, suggesting a paracrine effect on neighbouring β-cells. The presence of melatonin 
receptors in pancreatic islets has implications for a link between disruptions in sleeping patterns and 
circadian disruptions, with T2DM. However, the exact function and influence that this has on the insulin 




Figure 1.9. A review by Marroqui et al. summarises the extensive number of possible mechanisms by 
which leptin exerts an inhibitory effect on β-cell insulin secretion.  Leptin binds the ObRb receptor on 
β-cells in order to cause inhibition of glucose metabolism, activation of the PI3K pathway and inhibition 




Leptin is an adipocyte-derived hormone that interacts with insulin secretion within various tissues 
throughout the body, including the CNS (232). In addition to this, leptin has been shown to be an 
important regulator of pancreatic β-cell function, specifically influencing insulin gene expression, 
insulin secretion, apoptosis and β-cell growth. A multitude of studies have investigated the exact 
mechanism as to how leptin interacts with β-cells, the general consensus being that it acts to inhibit β-
cell insulin secretion. However, each study proposes various differing pathways by which leptin has 
this effect (figure 1.9). Leptin has been reported to activate KATP channels in β-cells of ob/ob mice, 
counteracting the effect of an increased ADP/ATP ratio that leads to insulin secretion (233). In rat cell 
lines and mouse pancreatic β-cells, this activation of KATP channels by leptin was associated with the 
activation of the PI3K pathway, to cause a reorganisation of the actin cytoskeleton, thereby causing 
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KATP channels to open (234,235). Leptin treatment to insulin secreting cells in culture has also been 
shown to reduce glucose transport into the cell itself, thereby reducing the activating signal of insulin 
secretion (236). However, contradictorily, leptin has also been shown to decrease glucose-induced 
expression of uncoupling protein 2 (UCP-2) (237). A reduction in UCP-2 will increase the amount of 
ATP produced from ADP, thereby increasing insulin exocytosis. Interestingly, β-cell specific BMAL1 
knockout mice show an increase in UCP-2 leading to uncoupling of the mitochondrial respiration, 
thereby disrupting insulin secretion in these animals (238). Perhaps this displays a link between the 
necessities of receiving a leptin signal at a certain time to the β-cells endogenous rhythm, to carry out 
effective insulin secretion.  
Leptin has also been shown to have an effect on insulin gene expression. Incubation of isolated islet 
cells with 1-10nM of leptin was enough to cause a decrease in proinsulin mRNA (239,240). This 
suppression, however, seems to be determined by the concentration of glucose at the time of infusion. 
In a number of in vitro models, proinsulin levels were effected by leptin in glucose levels ranging from 
11-25mM, however, at lower concentrations (5-7mM), no effect was seen (241,242). The mechanism 
by which insulin gene transcription is regulated is via the JAK/STAT pathway that is activated by leptin 
binding to OB-R. Leptin activates the STAT3 protein which promotes DNA binding of STAT3 proteins 
within isolated rat cells (232). This activation of genes includes the upregulation of SOCS3, which in 
turn is responsible for the downregulation of the insulin gene (243). This is confirmed by leptin receptor 
knockout in pancreatic islets, leading to a decrease in Socs3 mRNA accompanied by an increase in 
proinsulin mRNA (244). Borges and others found that knocking out insulin receptors in leptin receptor 
expressing neurons led to an increase in light-phase food intake, fat mass, glucose oxidation and a 
reduction in fat metabolism during the light-phase (245). This indicates that a loss in insulin receptor 
signalling in OB-R expressing cells causes a shift from hepatic glucose production to triglyceride 




In this thesis I aim to understand the relationship between circadian rhythms and metabolism. Evidence 
collected in the literature review suggests that perturbations to circadian timing have an array of effects, 
most commonly related to metabolism. These negative effects on metabolism have been scarcely 
documented, therefore I first aim to characterise the effects of lighting disruptions on metabolic health. 
Experiments in this thesis are based around a lighting disruption paradigm that chronically alters the 
lighting environment, to induce disruptions to the circadian timing system. Using this paradigm, I 
initially sought to investigate the effects of these lighting disruptions on various metabolic parameters. 
Finding a negative effect on body weight homeostasis, glucose regulation and energy metabolism, I 
looked further to attempt to elucidate the mechanism by which lighting disruptions caused these 
metabolic perturbations. This was achieved by analysing various signalling pathways within the 
metabolic regulating regions of the hypothalamus. After addressing these two initial objectives, I 
attempted to reinstate rhythmic metabolic processes by way of strict feeding regimes. Analyses of 
feeding behaviour in light disrupted animals fed ad libitum showed a mismatch in the timing of food 
intake and activity rhythms. By reinstating feeding rhythms by way of temporal restriction, animals no 
longer showed metabolic deficits in any of the parameters previously measured. Finally, a spontaneous 
phenotype present in a cohort of animals presented itself during one of the final experiments. Whilst 
other animals showed a slow entrainment to a new lighting environment following a shift (shifting by 
approximately one hour per day), these animals had an almost instantaneous entrainment to the new 
lighting environment. Therefore, the final objective was to attempt to characterise the phenotype in 
these animals, as well as identify a possible genetic variant within this cohort of animals. Whilst the 
exome sequencing data remains inconclusive, these animals were unaffected by lighting disruptions in 
the way that other animals were, showing no change in body homeostasis and fat mass.  
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Chapter 2 : Chronic light cycle-disruption alters central 
insulin and leptin signalling as well as metabolic markers 
in male mice 
2.1 Introduction 
The prevalence of obesity and the associated condition, type 2 diabetes (T2DM), is rapidly increasing 
worldwide and represents a growing health concern (195,247). It has been well established that the 
brain plays a major role in regulating energy and glucose homeostasis. This occurs via transduction of 
afferent signals that reflect the body fat and energy stores, with the key signals being hormones leptin 
and insulin, secreted from fat tissue and the pancreas, respectively. Both hormones have been shown to 
act on neurons in the mediobasal hypothalamus, predominately in the arcuate nucleus (ARC), the 
ventromedial hypothalamus (VMH) and the dorsomedial hypothalamus (DMH), which are key neuronal 
centres for regulation of energy homeostasis (248). Leptin binds to the long signalling form of its 
receptor in the mediobasal hypothalamus which causes subsequent activation of the associated Janus 
kinase 2 (JAK2) and autophosphorylation of the receptor (249). This promotes the recruitment of the 
main transcription factor of the leptin pathway, signal transducer and activator of transcription-3 
(STAT3), which becomes phosphorylated by JAK2. Once phosphorylated, STAT3 (pSTAT3) 
dimerizes and translocates to the cell nucleus where it activates a range of target genes (250). The 
consequence of increased leptin signalling to these metabolically regulating areas is a decrease in food-
seeking behaviour and an increase in catabolic activity (185). Neurons in the mediobasal hypothalamus 
that express the leptin receptor also co-express the IR, and it is now well established that insulin action 
in the brain regulates whole-body metabolic function including glucose homeostasis (251-254). Insulin 
binds to its receptor on target neurons to cause activation of the insulin receptor substrate (IRS), 
phosphatidyl inositol 3 kinase (PI3K) and Akt pathway (255). Activation of this pathway conveys the 
central glucose lowering effects of the hormone by activation of ATP-dependant KATP channels 
expressed in POMC and NPY/AgRP neurons (256). Accumulating evidence suggests that this event 
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results in suppression of hepatic glucose production via activation of the hepatic branch of the vagus 
nerve (252,257,258).  
Metabolism and the hormones that are involved in its regulation, follow a daily rhythm of activity that 
is synchronised by the internal circadian timing system. Evolution on earth has developed under the 
constant rising and setting of the sun and as such, biological processes have developed an intrinsic 
oscillator that predicts these changes in order to coordinate physiology and behaviour in an efficient 
manner (259). In mammals, the central circadian pacemaker, located within the suprachiasmatic nucleus 
(SCN) of the hypothalamus, receives information of the changing light environment from the retina. 
Within SCN neurons, a transcriptional-translational feedback loop forms the molecular clockwork of 
the central pacemaker. The primary loop is comprised of three period genes (Period 1-3), two 
cryptochrome genes (Cryptochrome 1,2) and the transcription factors CLOCK and BMAL1 that form 
interacting feedback loops that oscillate at approximately 24 hour cycles (7). The secondary loop 
involves REV-ERBs and RORs that either supress or stimulate Bmal1 respectively (43). This cluster of 
neurons synchronises peripheral clocks throughout the body via both neural and hormonal signalling. 
It is well established that the clock coordinates metabolic responses and couples food intake and energy 
expenditure with the 24 hour day/night cycle (260). For example, mutations in Clock and Bmal1 lead 
to profound metabolic phenotypes, and key metabolic pathways display a circadian rhythm (261). 
Furthermore, misalignments of this rhythmic output to the external solar day typically brought about by 
shift work, or frequent transmeridian air travel (jetlag), has been shown to increase the prevalence of 
obesity and T2DM (148,150,152,153,156,262). 
Basal plasma leptin and insulin levels exhibit a circadian rhythm with levels peaking during the dark 
phase in mice (172) and humans (173). However, only relatively recently it was shown that leptin 
appears to be a clock-controlled gene within the adipose tissue, with a circadian pattern of expression 
coordinated by the BMAL1/CLOCK complex (263). Furthermore, circadian misalignment for 8 days, 
typical for a shift work regimen, has been shown to augment peripheral markers of insulin resistance 
particularly in male participants (149). These recent findings provide important cues into how disruption 
to the circadian timing system may be linked to the dysregulation of energy- and glucose homeostasis.  
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In the current study, we analysed whether chronic light cycle-disruption altered central responses to the 
hormones leptin and insulin, and whether changes in the central actions of these hormones may explain 
circadian misalignment-induced metabolic disruptions. Therefore, mice were exposed to 12 6-hour 
phase shifts, i.e. an advance of the 12h light/12h dark cycle by 6 hrs, every 6 days (light cycle-disrupted 
(CD) mice) whereas a different cohort of mice were kept in a constant 12h light/12h dark cycle (LD 
mice). Various metabolic markers and central leptin and insulin signalling were assessed. This 
intervention led to an increase in body weight after the 10th phase shift, perturbed energy expenditure 
and locomotor activity and reduced leptin sensitivity within the arcuate nucleus. Furthermore, central 
insulin signalling via the PI3K pathway was increased accompanied by a dramatic increase in fasting 
plasma blood glucose suggesting a profound derangement in glucose regulation. We conclude that 
chronic light cycle-disruption leads to altered leptin and insulin signalling which may explain the 
striking association of light cycle-disruption and impaired metabolic health.   
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2.2 Materials and Methods  
2.2.1 Animals 
C57BL/6J mice were obtained from the University of Otago breeding facility. All mice were male and 
between 12 to 15 weeks of age and housed individually under standard housing conditions in the 
absence of running wheels. All mice had access to food and water ad libitum and were fed a control 
chow diet named low fat diet (LFD), with 10% of energy coming from fat (kcal) except for the 
comparison of blood glucose levels where a separate cohort of mice were fed a high fat diet (HFD) with 
60% of energy derived from fat (D12450B, D12492 respectively, Research Diets, Brunswick, NJ, 
USA). All mice were weighed daily during the initial hours of their lights-on cycle (between ZT 2 and 
ZT 4) by a single investigator throughout the experiment. Food intake of mice was recorded at the same 
time, by weighing total amount of food available in the cage hopper, from experimental day 37 onwards 
until the termination of the experiment.  The University of Otago Animal Ethics committee approved 
all procedures involving animals. 
Mice were maintained in either a normal 12h light/12h dark (LD) cycle or exposed to a disrupted light 
cycle (light cycle-disrupted; CD) which consisted of an advance of the 12h light/12h dark cycle by 6 
hrs every 6 days for 72 days (12 phase advances) (fluorescent lamps, ~150 lux at the level of the cage 
floor, measured by Digitech light meter (catalogue number: QM1587)). Phase advances occurred during 
the dark phase in which the period of lights off was shortened to 6 hours instead of 12, thereby causing 
a phase advance. Before mice were placed into different groups they were body-weight matched. Mice 
under CD conditions were housed in a separate room with identical environmental conditions from the 
LD animals in order to accommodate for differential lighting conditions. Both rooms were protected 
from accidental external light entry and access was limited to the light phase.   
2.2.2 Metabolic Measurement 
Following the fifth phase shift (after 30 day/night cycles) a cohort of animals were moved to a 
multichannel respirometry system (3721 mouse cages, Promethion Line, Sable Systems, Las Vegas, 
NV) for 3 days while the remaining animals remained in the longitudinal study. Due to the potential 
interference that would occur from moving animals to different cage environments located in different 
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rooms, we performed metabolic measurements in this separate cohort of mice. Mice remained in the 
same cage throughout the experiment (without cage changes at least one week prior to metabolic 
measurements) to allow minimum disruptions by moving animals between different environments. The 
advantage of the Sable Systems Promethion Line is the absence of a housing acclimation effect as no 
novelty-induced increase in spontaneous activity within the first several days of housing was observed 
(264). The air flow in the cages was adjusted to 2000 ml/min and monitored continuously. The system 
allowed continuous measuring of O2 consumption (VO2), CO2 production (VCO2), respiratory exchange 
ratio (RER), energy expenditure (EE), food intake (by hopper weight attached to MM-1 load cell), body 
weight (by in-cage enrichment device attached to MM-1 load cell) and locomotor activity (via infrared 
sensors) at a sample rate of 60/min. No running wheels were present within these cages throughout the 
duration of the experiment. Data collected from the metabolic measurements were analysed with the 
ExpeData data analysis software (Sable Systems Int., Las Vegas, NV).   
2.2.3 Plasma Leptin, Insulin and Glucose Levels 
Blood was collected prior to transcardial perfusion, via the inferior vena cava, following a 24h fasting 
period of the mice, two light cycles following the final phase advance from ZT 2 to ZT 4. This time 
point was chosen since metabolic measurements revealed that animals lose diurnal rhythmicity for two 
full light cycles following a phase advance, with no obvious diurnal variation in all measures recorded. 
Blood was collected only from those animals that had been under different lighting conditions for the 
entire 12-week experimental period. Blood was heparinised and stored on ice following collection. 
Within 1hr, samples were centrifuged at 1500 rpm for 15 minutes at 4°C. Blood plasma was then 
collected and samples stored individually at -80 °C until appropriate tests were performed. Plasma 
glucose was measured with a glucose assay kit (Crystal Chem Inc, Illinois, USA, catalogue number 
81692). Plasma leptin (265) and insulin (266) levels were measured by a mouse ELISA kit. 
2.2.4 Immunohistochemistry 
To analyse leptin and insulin signalling within the hypothalamus, mice were fasted for 24 hours and 
received either leptin (1.25 mg/kg body weight), insulin (1.0 mg/kg body weight) or vehicle (phosphate 
buffer saline solution, PBS) injection intraperitoneally; 30 minutes prior to transcardial perfusion in the 
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case of leptin and 15 minutes prior to perfusion in the case of insulin. Five minutes prior to transcardial 
perfusion, mice were anesthetized with pentobarbital (Narcoren; Merial GmbH) and the procedure was 
performed as described elsewhere (267). Animals were perfused between ZT 2 and ZT 4 on the day of 
perfusion. Perfused brains were removed and post-fixed in the same solution overnight and then 
transferred to a 30% sucrose solution in 0.1 mol/L PBS until they had sunk. Brains were frozen in 
cooled isopentane, and sectioned in the coronal plane at 35 µm. Sections were collected in four series 
using a cryostat, with alignment of brains taking place prior to sectioning of the hypothalamus.  Once 
sectioned, brain tissue were stored in cryoprotectant at −20 °C. For analysis of the impact of light cycle-
disruption on leptin signalling, the number of pSTAT3 positive neurons was determined by 
immunohistochemical analysis. Immunohistochemistry for pSTAT3 (Tyr705) (268) was performed in 
one set of the brain sections in accordance with a previously described protocol involving several 
antigen retrieval steps (269). Insulin signalling was measured by performing immunohistochemical 
analysis of pAkt (Ser473) (270) and pIRS (Ser612) (271) as described elsewhere (267). Furthermore, 
immunohistochemistry was carried out to measure phosphorylated glycogen synthase kinase 3β 
(GSK3β), a downstream target of AKT using an anti-phospho-GSK3 (Ser9) (272). Phosphorylation 
of GSK3 at Ser9 is critical to inactivate the enzyme. Immunoreactive (ir) pSTAT3, pAkt, pIRS and 
pGSK3 cells were examined using an AX70 Provis light microscope (Olympus, Tokyo, Japan). Ir cells 
were captured using the SPOT RT Colour Camera (Diagnostic Instruments Inc., Sterling Heights, MI, 
USA) attached to the microscope, using identical settings for analysis. The number of pSTAT3, pAkt, 
pIRS and pGSK3 ir cells were counted using Adobe Photoshop (Adobe Systems Inc., CA, USA) 
within one of the bilateral halves of the ARC (as well as DMH and VMH for pSTAT3) by two 
investigators who were each blinded to the treatment. Identification of these particular brain regions 
was carried out by reference to a brain atlas that had been used to align brain sections during the cutting 
process. An outline of the brain region of interest was made, followed by the counting method. At least 
three sections that had been identified to contain a region of interest, were used to count cell numbers. 
These three sections were matched as closely as possible across all brain samples to ensure continuity 
across different animals. The method employed by both investigators was a subjective threshold of 
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positive cell signalling that was agreed upon prior to counting. This threshold was maintained 
throughout the counting process to maintain consistent. Following the counting process, number of cells 
counted between each investigator was averaged, and then doubled to give a number of positive cells 
per brain section.  
2.2.5 Statistics 
Data were analysed by one- or two-way analysis of variance (ANOVA), followed by a Holm-Sidak post-
hoc test to check for significance between groups, where appropriate. All data analysis was completed 
using Prism (Graphpad Software, La Jolla, CA, USA). Body weight and food intake data were treated 
as non-independent data, therefore analysis corrected for multiple comparisons in these data sets. This 
is the function of the Holm-Sidak test, to correct for non-independent data analysis. Results are 
presented as mean ± standard error of the mean (SEM). Results with a P-value equal to or of less value 
than 0.05 were considered significantly different. 
2.3 Results 
2.3.1 Effect of light cycle-disruption on body weight 
We tested whether repeated lighting shifts lead to an increase in body weight in CD mice compared 
with mice maintained on a non-shifted day/night cycle. Light cycle-disrupted mice revealed a relatively 
large fluctuation in body weight with trends towards an increase in body weight around the 1st, 3rd, 5th, 
7th and 11th phase shift compared with LD mice. LD mice gained 1.97 ± 0.25g whereas CD mice gained 
3.54 ± 0.34g over the 72-day period (two-way ANOVA; F (1, 4728) = 271.4, P < 0.001), a difference that 
was attained from the 10th phase shift onwards (P = 0.038) (figure 2.1A, B). A separate cohort of mice 
were kept under the LD cycle but fed HFD as a reference to compare effects of CD.  These mice showed 
a marked increase in body weight in comparison to those fed LFD, which became significantly different 
from 5th day onwards (Initial LFD: 29.1 ± 0.5g; Initial HFD: 28.7 ± 0.8g; Final LFD: 30.9 ± 0.6g; Final 
HFD: 47.2 ± 0.8g; P < 0.01). The body weight differential between the two LFD fed groups attained 
significance after the 10th phase shift (59th day) (LD vs CD mice; P = 0.028) and remained significantly 
different thereafter (figure 2.1A). At the termination of the experiment, CD mice had an average 12 ± 
2% increase in body weight as opposed to a 6 ± 1% increase in mice under control lighting conditions. 
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These findings were independent of any changes in cumulative food intake for the final half of the 72-





Figure 2.1. A: Body weight trajectory of mice fed a low-fat diet (LFD) and subjected to either a control 
12hr light/dark cycle (LD cycle) or one that was phase advanced by 6 hrs every 6 days (light cycle-
disrupted, CD cycle). Vertical grey lines indicate time points at which the light cycle for CD animals 
was advanced by 6 hrs. B: Comparison of body weights between LD and CD mice from initial body 
weight to final body weight at the termination of the experiment. C: Cumulative food intake of LD and 
CD mice from the 37th day onwards to the termination of the experiment, vertical lines indicate time 
points at which CD mice had their light cycle advanced by 6 hrs. After the 5th phase shift, a cohort of 
mice were placed in metabolic cages (n = 50 for each group until 5th phase shift, n = 40 for each group 





2.3.2 Prolonged light cycle-disruption abolishes diurnal variation of metabolism 
We hypothesised that the increase in body weight observed in CD animals may be brought about by a 
temporal misalignment of metabolic parameters. To assess this possibility during the period when the 
metabolic disturbances were developing, we moved a cohort of mice into metabolic cages for a thorough 
analysis of the temporal relationships between light, food intake, physical activity and energy 
expenditure following the 5th phase shift.  In LD animals, we saw a robust diurnal regulation of energy 
expenditure, food consumption and activity across all three tested cycles, with peak values for each 
parameter during the dark phase. In contrast, CD animals displayed a complete reversal of these 
parameters in the first cycle, followed by total loss of diurnal variation in the subsequent two cycles. 
Food intake in LD animals was increased during the dark, compared with the light phase across all three 
tested light cycles (first, ∆1.49 ± 0.33g, P < 0.001; second, ∆1.91 ± 0.33g, P < 0.001; third, ∆1.85 ± 
0.33g, P < 0.001) (figure 2.2A). In contrast, during the first cycle, CD animals consumed more food 
during the light, as opposed to the dark phase (∆-0.74 ± 0.22g, P = 0.062), an effect which subsided 
over the subsequent two cycles (second, ∆-0.16 ± 0.24g, P = 0.61; third, ∆0.63 ± 0.17g, P = 0.097). 
Differences in food intake between animals under LD or CD conditions were found to be different in 
the first two cycles, but not the third (difference from LD to CD food intake; day 1, ∆-1.24 ± 0.32g, P 
= 0.0015; night 1, ∆1.0 ± 0.32g, P = 0.01; day 2, ∆-0.96 ± 0.32g, P = 0.011; night 2, ∆1.1 ± 0.32g, P = 
0.0049; day 3, ∆-0.54 ± 0.32g, P = 0.096; night 3, ∆0.67 ± 0.32g, P = 0.079) (Fig 2.2A). Despite these 
day/night and inter-group differences however, cumulative food intake was similar in LD and CD 
animals across the three tested cycles (LD mice: 9.29 ± 0.85g, CD mice: 9.25 ± 0.43g, two-way ANOVA: 
F (1, 14) = 0.96, P = 0.34) (figure 2.2B) 
 RER, a ratio of both oxygen consumed and carbon dioxide produced, showed diurnal fluctuations in 
LD mice, in which RER is increased during the active (dark) phase and decreased during the resting 
(light) phase, while CD mice displayed an out-of-sync RER profile (figure 2.2C). Energy expenditure 
in LD animals showed a diurnal variation that peaked during the night and reached the lowest point 
during the day (F (1, 14) = 96.43, P < 0.001) with no significant interaction between both parameters 
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(F (2, 28) = 1.42, P = 0.25) (figure 2.2D). Two way ANOVA revealed that CD animals showed no day-
night variation in energy expenditure across the three cycles (F (1, 14) = 2.02, P = 0.17), however, there 
was a significant interaction (F (2, 28) = 111.6, P < 0.001) combined with an effect of cycle number (F 
(2, 28) = 25.63, P < 0.001) to confirm that this varied differently throughout the three day period as 
mice became accustomed to the new light-dark cycle. Over the course of the three days, average energy 
expenditure between LD (0.0144 ±   0.0002 kcal/hr/g) and CD (0.0153 ± 0.0004 kcal/hr/g) mice was 
not significantly different (P = 0.11) (figure 2.2E). 
As expected activity profiles of LD animals followed a diurnal rhythm, with increased activity during 
the dark phase (ZT 12 – 24; 193.70 ± 15.01m) compared with the light phase (ZT 0 – 12; 78.02 ± 
11.76m) (figure 2.2F). This is further illustrated in figure 2.2H, demonstrating that total distance 
travelled is significantly increased from day to night, specifically within LD animals (F (1,14) = 51.13, 
P < 0.001). In CD animals, locomotor activity followed an inversed pattern compared with LD animals, 
which was particularly pronounced immediately after the shift and attenuated thereafter (figure 2.2G). 
During the first cycle, CD mice revealed increased activity during the light- as opposed to the dark 
period (∆146.4 ± 16.1m, P < 0.001) (figure 2.2H). In the subsequent 2 cycles, CD animals lost any 
diurnal variation in locomotor activity (cycle 2, ∆-0.04 ± 16.3m, P = 0.99; cycle 3, ∆-33.6 ± 16.3m, P 
= 0.089). As a consequence, locomotor activity is different between LD and CD animals on the first 
day, first night, second night and third night (difference from LD to CD activity: first day, ∆-151 ± 
22.3m, P < 0.001; first night, ∆132.9 ± 22.3m, P < 0.001; second day, ∆-49.1 ± 22.3m, P = 0.06; second 
night, ∆87.0 ± 22.3m, P < 0.001; third day, ∆25.3 ± 22.3m, P = 0.025; third night, ∆64.9 ± 22.3m, P = 
0.013) Total locomotor activity across all three cycles was not significantly different between LD (407.6 





Figure 2.2. Metabolic effects of a prolonged phase shift in light cycle-disrupted (CD) mice in comparison with 
control (LD) mice. A: Food intake following the 5th phase shift at 12h intervals. B: Cumulative food intake 
across all three cycles following the 5th phase shift. C: Three-cycle trace of respiratory exchange ratio (RER) 
in both LD and CD animals; CD animals display a disrupted pattern in RER. D: Average energy expenditure 
(EE) of LD and CD animals across all three cycles at 12hr intervals, following the 5th phase shift. E: Average 
energy expenditure across all three days of the experimental window; between LD and CD animals, energy 
expenditure is unchanged. F: Total locomotor distance of LD animals across all three cycles following the 5th 
phase shift. H: Total locomotor distance of CD animals across all three cycles following the 5th phase shift; CD 
animals show greater activity during the lights-on period from ZT 0 – ZT 12, contrasting with LD animals G: 
Total locomotor distance of both LD and CD animals across all three cycles at 6 hr intervals. The normal 
dark/light difference in food intake, energy expenditure and locomotor activity were lost in the 2 days following 
the 5th 6hr phase advance in CD mice. I: Sum of locomotor distance across all three cycles. (n = 8 for each 
group, data show mean ± SEM, *, P < 0.05; **, P < 0.01; ***, P < 0.001 within light cycle groups; #, P < 0.05 





2.3.3 Effects of light cycle-disruption on hormone and glucose levels  
Having established that light cycle-disruption leads to a significant increase in body weight and 
profound alterations in energy expenditure, we sought to determine whether this manipulation alters 
plasma glucose, leptin or insulin levels.  Previous work has shown that these hormones are secreted in 
a rhythmic pattern (173,205). Blood samples were taken from animals prior to perfusion, at ZT 2 – 4, 
and in the case of the CD animals, this occurred two full light cycles after the 12th phase shift. In animals 
treated with insulin prior to blood collection there was a significant decrease in fasting blood glucose 
levels as a response to exogenous insulin (figure 2.3A). In LD animals, insulin reduced blood glucose 
levels by 80 ± 3% and in CD animals by 88 ± 8% compared with vehicle treated animals. We found a 
striking difference in fasting blood glucose levels between our LD (108.8 ± 21.3mg/dl) and CD (269.4 
± 21.1mg/dl) animals treated with vehicle (P < 0.001) (figure 2.3A). When comparing this to a cohort 
of mice that had been given HFD for the same duration as mice on LFD, the elevation in blood glucose 
levels induced by CD (269.4 ± 21.1mg/dl) exceeded those induced by the HFD (125.3 ± 18.1mg/dl) (P 
= 0.001) (figure 2.3A). No differences in fasted plasma leptin levels were observed between LD (10.4 
± 1.95ng/ml) and CD (10.3 ± 1.301ng/ml) animals (P = 0.96) (figure 2.3B). No difference in fasting 






Figure 2.3. Blood was collected from all animals directly prior to perfusion. A: Fasting blood glucose 
levels in control (LD) animals fed either a high fat diet (HFD) or low-fat diet (LFD) and light cycle-
disrupted (CD) animals fed LFD. Animals were treated with either vehicle or insulin (1.0 mg/kg body 
weight) i.p. injection 15 mins prior to perfusion and blood collection. ELISA analysis of LD and CD 
animals treated with vehicle to assess the concentration of both leptin (B) and insulin (C) showed no 
difference between groups (n = 8 for each group, data show mean ± SEM, **, P < 0.01; ***, P < 0.001 
within light cycle groups; ##, P < 0.01 between light cycle groups; scale bars = 100µm). 
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2.3.4 Light cycle-disruption and its effect on hormone signalling in the hypothalamus  
In order to assess central signalling, animals were challenged with either a vehicle, leptin or insulin 
injection prior to perfusion. Between our vehicle and leptin-treated animals, two-way ANOVA revealed 
that leptin treatment led to an increase in the number of poshpo-STAT3 (Tyr 705) immunoreactive (ir) 
cells within the arcuate nucleus (ARC) (F (1, 27) = 65.71, P < 0.01), dorsal medial hypothalamus 
(DMH) (F (1, 27) = 35.82, P < 0.01) and ventromedial hypothalamus (VMH) (F (1, 27) = 31.5, P < 
0.01) (figure 2.4A/B, 2.4C/D and 2.4E/F respectively). However, comparing the LD and CD mice, two-
way ANOVA revealed that CD animals had a decreased number of leptin-responsive cells, specifically 
within the ARC (F (1, 26) = 65.71, P = 0.0408) with no significant interaction between light cycle and 
treatment (F (1, 26) = 1.76, P = 0.192) (figure 2.4B). Two-way ANOVA revealed no difference between 
LD and CD animals in the number of leptin responsive pSTAT3-ir cells in both the DMH (F (1, 27) = 
0.099, P = 0.755) (figure 2.4D) and VMH (F (1, 27) = 0.0216, P = 0.884 (figure 2.4F) and no interaction 
between both parameters. 
Having established that the effect of leptin to induce pSTAT3 is reduced in CD animals, together with 
the observation of strikingly elevated blood glucose, we next investigated whether central insulin 
signalling is altered by this manipulation. Insulin signalling was assessed by measuring the number of 
pAkt-ir (Ser473) and pIRS-ir (Ser612) cells, both being part of the IRS-Akt insulin signalling pathway. 
Two-way ANOVA revealed that administration of insulin, significantly increased the number of pAkt-ir 
cells within the ARC, in both LD and CD animals compared with vehicle treatment (F (1, 35) = 133.3, 
P < 0.001) (figure 2.5A, C). Between these groups, the main effect of the light cycle was found to be 
significant (F (1, 35) = 12.1, P = 0.0014), such that insulin treated CD animals showed significantly 
increased pAKT-ir cell number (217.9 ± 18.2 cells) in comparison with LD animals (123.4 ± 20.8 cells) 
(P < 0.001). The phosphorylation of IRS at Ser612, occurring upstream of the Akt pathway, showed 
differing results to those seen in pAkt.  Two-way ANOVA revealed a significant effect of interaction (F 
(1, 32) = 4.189, P = 0.049), where insulin treatment reduced the number of pIRS-ir cells in the ARC, 
exclusively within LD animals (vehicle-treated, 420.6 ± 43.6 cells; insulin-treated, 284.8 ± 33.6 cells; 
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P = 0.041) and not CD animals (vehicle-treated, 407.8 ± 25.6; insulin-treated, 412.5 ± 25.2; P = 0.991) 
(figure 2.5B, D).  
Glycogen Synthase Kinase 3 beta (GSK3) plays a role in the insulin feedback loop in the brain, as 
well as the proteasomal degradation pathway of the molecular clockwork a (see figure 1.1) (273). No 
change in pGSK3-ir cell number was observed in response to insulin treatment or repeated light cycle 






Figure 2.4. Immunohistochemical analysis of whole brain coronal sections through the 
hypothalamus to analyse the phosphorylation of signal transducer and activator of 
transcription-3 (pSTAT3) at Tyr705. Quantified pSTAT3-ir cells in the arcuate nucleus 
(ARC) (B), ventromedial hypothalamus (VMH) (D) and dorsomedial hypothalamus 
(DMH) (F) of control (LD) and light cycle-disrupted (CD) mice treated with either i.p. 
vehicle or leptin (1.25 mg/kg body weight) 30 mins prior to perfusion, with representative 
photomicrographs of the ARC, VMH and DMH (A, C, E, respectively). Response to leptin 
treatment exclusively in the ARC was decreased in CD mice in comparison to LD mice (n 
= 8 for each group, data show mean ± SEM, **, P < 0.01; ***, P < 0.001 within light cycle 




Figure 2.5. Immunohistochemical analysis of whole brain coronal sections through the arcuate nucleus 
(ARC) to analyse the phosphorylation of both Akt (Ser473) and Insulin Receptor Substrate (IRS) 
(Ser612). A: Quantified pAkt-ir cells in the ARC of LD and CD mice treated with either i.p. vehicle or 
insulin (1.0 mg/kg body weight) 15 mins prior to perfusion.  C: Representative photomicrographs of 
pAkt staining in the ARC. B: Quantified pIRS-ir cells in the ARC of LD and CD mice treated with 
either i.p. vehicle or insulin, with representative photomicrographs below (D). pAkt signalling was 
increased in CD animals following insulin treatment, and pIRS signalling was decreased in LD animals 
treated with insulin (n = 8-10 for each group, data show mean ± SEM, *, P < 0.05; ***, P < 0.001 






Figure 2.6. Immunohistochemical analysis of whole brain coronal sections through the arcuate nucleus 
(ARC) to analyse the phosphorylation of GSK-3 (Ser9). A: Representative photomicrographs of 
pGSK-3-ir cells in the ARC of LD and CD mice treated with either i.p. vehicle or insulin (1.0 mg/kg 
body weight) 15 minutes prior to perfusion. B: Quantified pGSK-3-ir cells in the ARC of LD and CD 
mice. No change in pGSK-3 signalling was observed between animals following insulin treatment, (n 





The circadian timing system has an important function in regulating almost all key metabolic pathways, 
disruption of which increases the risk to develop metabolic impairments (148,150,263). To mimic a 
chronic jetlag paradigm in mice, we chose to phase advance the regular 12 hour light, 12 hour dark 
cycle by 6 hours every 6 days. This is based on a previous study that showed that aged mice subjected 
to repeated phase advances reveal increased mortality as compared with mice exposed to phase delays, 
suggesting a more profound effect of phase advances on biological processes (275).  
Animals housed under constantly rotating light schedules (CD mice) showed a gradual increase in body 
weight over the 72-day experimental period. Weight fluctuations were noticeable due to the high 
frequency of body weight measurements (daily), in particular following shifts in lighting schedule. This 
suggests for the first time, a possible acute effect of lighting shifts, on body weight regulation that is 
shortly after compensated for with a return to lower body weight. Therefore, a culmination of body 
weight dysregulation throughout the experimental period, caused by lighting shifts, likely explains the 
overall increase in body weight.  After the 10th phase shift, the body weight difference between LD and 
CD mice attained statistical significance with a further gradual increase in the latter group.  This 
confirms that light cycle-disruption in these animals is sufficient to cause dysregulation of body weight 
leading to weight gain. An increase in body weight after bi-directional light cycle-disruption in mice 
has been reported by Kettner et al., who rotated mice between rooms with different light cycles resulting 
in weekly 8hr phase advances alternating with phase delays (263). To avoid the potential confound of 
stress induced by moving animals between rooms under differing lighting schedules, we maintained 
animals in their home room and simply changed the light cycle in that room. We therefore show 
metabolic derangements in mice, caused solely by a uni-directional light cycle disruption. 
Analysis of potential metabolic derangements induced by phase shifts revealed contrasting results in 
LD and CD animals. A previous pilot experiment in which animals were subjected to an identical phase 
shifting paradigm revealed that body weight trajectories started to diverge from the 5th phase shift 
onwards which was the rationale to conduct metabolic measurements during this period. In LD mice, a 
robust diurnal rhythm in activity, food intake, and energy expenditure was observed, with elevated 
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metabolism and locomotor activity during the dark phase. Interestingly, prolonged light cycle-
disruption completely reversed this rhythm during the first light cycle in CD mice, without changing 
overall energy expenditure, food intake or locomotor activity in a 24hr period. This was followed by a 
complete loss of day-night differences in energy expenditure and locomotor activity during the 
following two light cycles, demonstrating that light cycle-disruption completely impairs the rhythmic 
regulation of energy expenditure and locomotor activity during the observed three days. Although 
locomotor activity was increased during the dark phase in CD mice compared with LD mice, overall 
locomotor activity over 24 hours between these groups was not altered during this first day or the 
following 2 days. Despite being introduced into a new lighting environment following this phase shift, 
general locomotor activity, as measured by infrared beams, remained increased during the first light 
period suggesting that it is not strongly influenced by light masking. Indeed, the intensity of light 
masking differs between running wheel activity and general locomotor activity because running wheel 
activity is almost completely ablated by light, whereas general locomotor activity still persists at lower 
levels in a light environment (276). Disruption to mice activity has been previously reported by 
Casiraghi et al., under 6h phase advances but not phase delays (277). These findings confirm that phase 
advances lead to a dysregulation of the circadian system for a period of time where all clocks must be 
entrained following a shift into a new lighting environment. During this time, metabolic processes and 
locomotor activity become desynchronised, and after chronic circadian misalignment, this 
dysregulation appears to accumulate resulting in detrimental effects on the system as a whole. Future 
studies are required to identify how long these changes persist following different l disruption 
paradigms.   
Leptin levels undergo a diurnal rhythm, with levels peaking at night in mice and humans (172,173). 
Furthermore, recently it was discovered that leptin is a clock-controlled gene and its transcription, and 
likely its release from adipocytes is controlled by BMAL1/CLOCK, with chronic jetlag disrupting this 
rhythm (263). These findings make it likely that the increase in body weight and alterations in energy 
expenditure brought about by light cycle-disruption are mediated by a loss of leptin sensitivity. As 
central leptin resistance is a hallmark of obesity, we analysed whether light cycle-disruption leads to 
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altered responses to leptin in key hypothalamic centres known for their implication in neuroendocrine 
control of body weight. We measured molecular leptin sensitivity at the level of pSTAT3 as analysing 
expression levels of the leptin receptor appeared not to be very conclusive to determine alterations in 
leptin sensitivity (36). Indeed, we found a reduced number of leptin-induced pSTAT3-ir cells in the 
ARC in CD compared with LD mice, while levels in the VMH and DMH did not change. This 
corroborates the importance of the leptin resistance in the ARC as mediating body weight gain, i.e. 
molecular leptin insensitivity was confined to the ARC after high fat feeding for 6 days (198). By 
assessing leptin signalling at different time points during the duration of high-fat feeding, we recently 
confirmed this latter observation, in that while it was possible to detect reduced sensitivity to leptin in 
the VMH after 10 days of high-fat feeding, there was much more profound leptin resistance in the ARC 
throughout the time-course of exposure to the high fat diet (199). Leptin has been reported to lead to a 
rapid phosphorylation of pSTAT3 with maximal responses within the ARC occurring within 30 min 
and a return to normal levels within 4 hours post injection. For these reasons and because we did not 
previously observe any further increase in pSTAT3-ir cells in the VMH and DMH after 2 hours (199) 
we chose this 30 min time point for the present study. Importantly, our data showing a partial loss of 
leptin-induced signalling in the ARC contrast with a previous study that reported that chronic jetlag 
leads to a complete loss of leptin responses in the ARC (263). The reason for this discrepancy may be 
the duration of analysis of pSTAT3 after leptin injection (at 30 min vs 5 and 14 hrs), methodological 
differences (counting of individual pSTAT3 immunoreactive cells vs densitometric analysis of the 
immunohistochemical image) or differences in the light cycle misalignment paradigm (6 hrs phase 
advance vs 8hr phase advance followed by a delay).   
Evidence suggests that disruption of circadian rhythms (most profound in shift work and social jetlag) 
increases the risk of developing T2DM (145). The underlying mechanisms and the key sites of origin 
of this mechanism, however, are poorly understood. Insulin is secreted from the pancreatic islet cells in 
a circadian manner that responds to predicted meal times as well as the intake of food (278). Genes 
involved in both glucose sensing (Glut2) and insulin production (insulin) have been shown to exhibit a 
circadian pattern in expression (278). After the discovery of the Clock gene by Joseph Takahashi (36) 
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the importance of the circadian clock machinery for regulating daily glucose homeostasis soon became 
apparent. For instance, homozygous Clock mutant mice display hyperglycaemia and hypoinsulinaemia 
(3). However, this mutation led only to a relatively moderate increase in blood glucose from 130 ± 
5mg/dl in wildtype mice, to 161 ± 7mg/dl. In comparison, after 12 phase shifts we detected an increase 
in fasting blood glucose nearly 3-fold higher than normal levels and much higher than in our cohort of 
mice that was maintained on a control light cycle, but fed HFD. Blood was collected at a single time 
point at 2 light cycles following a phase shift, in which we saw this dramatic increase in blood glucose. 
Blood glucose levels and glucose tolerance differs throughout the day (279) and therefore it is possible 
that these elevated blood glucose levels can be explained by the CD animals being ‘out of phase’ 
compared with the controls,. However, the levels at which we see glucose in these light cycle-disrupted 
animals far surpass the daily variation that has been described in 24h fasted mice of the same strain 
(280). Additionally, daily variation in glucose levels, as reported by several other sources never 
surpassed 180mg/dl in control and wild type mice (281-283). These data suggest that light cycle-
disruption has a more pronounced detrimental effect on the regulation of blood glucose than on body 
weight.  Indeed, the effect on blood glucose was worse than that observed after feeding a high-fat diet 
for a long period of time. Interestingly, these elevated blood glucose levels were not accompanied by 
an increase in circulating insulin levels, suggesting reduced pancreatic insulin production as a result of 
possible beta cell dysfunction. It has been shown that β-cell specific Bmal1 knockout leads to a loss of 
glucose-stimulated insulin secretion caused by the accumulation of reactive oxygen species and 
subsequent mitochondrial uncoupling (238).  Furthermore, CD mice also demonstrated a normal 
response to exogenous insulin, in terms of its ability to reduce elevated glucose levels, suggesting that 
CD mice were not profoundly insulin resistant. Given circadian disruption is associated with reduced 
sleep in humans, it is conceivable that potential effects of this treatment are secondarily mediated by 
sleep loss. An elegant study by Leproult et al. revealed that circadian misalignment, independent of 
sleep loss, increases markers of insulin resistance and inflammation in humans (149).  In this study, the 
authors employed a protocol in which all patients were exposed to sleep restriction, with the difference 
that one group was in alignment with nocturnal bed times and the other group were only allowed to 
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sleep during rotating bed times, ensuring no differences in overall sleep times. In males exposed to the 
circadian misalignment protocol, an exacerbation of insulin resistance and inflammation was detected. 
Clock and Bmal1 mutant mice display drastic reduction in glucose-induced insulin secretion and defects 
in size and proliferation of pancreatic islets (261). Interestingly, down-regulation of Per or Cry 
expression results in the opposite phenotype. Per2 mutant mice exhibit an increase in glucose-
stimulated insulin secretion and reduced insulin clearance (284) while Cry1/2 mutant mice are 
hyperinsulinemic (285). Since Per and Cry knockout would result in an increase in Clock and Bmal1 
expression, these results corroborate the key function of the clock in regulating glucose homeostasis 
and that tight circadian control is vital for a healthy glucose metabolism.  
It is contentious as to whether a disrupted rhythm of the pancreas clock or of other body clocks, 
particularly a disruption of synchrony between the central SCN clock and e.g. the liver, contributes to 
abnormal gluco-regulation. Our findings of abnormally high glucose coupled with a lack of elevated 
insulin, are in conjunction with the discovery that BMAL1 ablation in the pancreas (261,286) or in beta 
cells (238) causes T2DM. This confirms the importance of reduced insulin secretion by the pancreas 
under light cycle-disrupted conditions, however, it is also possible that the communication between the 
hypothalamus and the liver clock plays an important role in circadian control of glucose homeostasis. 
As the liver is the predominant source of endogenous glucose it would be surprising if hepatic glucose 
output was not controlled by the central circadian timing system. We and others have previously shown 
that the hypothalamus has a key function in regulating whole body glucose homeostasis (257,267,287). 
It is believed that central regulation of glucose homeostasis is predominantly mediated by autonomic 
innervation of the liver by the hypothalamus (288,289). Interestingly, it has been shown that SCN 
derived (involving the PVN as an intermediate) sympathetic innervation of the liver is crucial for the 
generation of circadian regulation in circulating glucose levels (290). For instance, electrical stimulation 
of the SCN led to hyperglycaemia, which could be blocked by intraperitoneal administration of α and 
β-adrenergic blockers (111,112). It is likely that the influence of the SCN on regulation of glucose 
homeostasis is direct and independent of the feeding rhythm, since the circadian rhythm in plasma 
glucose has been shown to be maintained during fasting (110).  
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In our study, we have shown for the first time that light cycle-disruption leads to alterations in central 
insulin signalling. Insulin signalling was particularly confined to the ARC due to the high number of 
pIRS1 and pAkt-ir cells found in this region and the absence in others. Insulin injection 15 minutes 
prior to perfusion has been shown to cause a maximal activation of insulin signalling pathways within 
the ARC of the hypothalamus (267) and unpublished observations. This brain region also plays a pivotal 
role in glucose-sensing (252,257,291). Insulin binds to its receptor, activating downstream pathways 
including phosphorylation of IRS, which in turn causes the activation of Akt via the PI3K pathway 
(175). Whereas IRS phosphorylation at serine 307 promotes insulin sensitivity (292), phosphorylation 
at serine 612 via the ERK1 pathway, causes a suppression of binding to the PI3K substrate (293), 
effectively inhibiting signal transduction via the IRS1 molecule. We show that in LD animals, insulin 
treatment led to a reduction in Ser612 pIRS1 within the ARC. This insulin-induced phosphorylation, 
however, did not occur in CD animals, suggesting that these animals are resistant to insulin’s action at 
this level of the pathway. Interestingly, we found at the signalling molecule downstream of IRS1, 
phosphorylation of Akt was greatly increased in CD animals compared to LD within the ARC, 
following insulin treatment. The number of insulin-induced pAkt-ir cells was upregulated in this brain 
region of CD animals, despite the absence of elevated insulin levels in the periphery within this group, 
which suggests a selective increase in insulin sensitivity in this brain region at the level of Akt. We may 
speculate that a loss in insulin sensitivity at the level of IRS1 is therefore compensated for at the level 
of Akt. Multiple signalling pathways interact within the cascade of insulin signalling, therefore a vast 
array of signalling molecules may be accommodating this function. GSK3 has been shown to play a 
role in the insulin signalling pathway, via a specific feedback mechanism acting on IRS1 itself (294-
296), however, we found no differences in the phosphorylation of this molecule, indicating that its 
activity within the ARC between control and light cycle disrupted animals (figure 2.6) was not changed. 
Various other molecules have shown potential for acting on the insulin signalling pathway, including 
phosphatase and tensin homolog (PTEN) (297,298), TNFα (299) and ERK1.  Future studies are required 
to delineate the precise mechanisms underlying altered central insulin signalling during light cycle-
disruption. It is plausible however, that the differences observed in both leptin and insulin sensitivity in 
the current study is in relation to secondary effects as the CD mice are heavier. 
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Very recent findings revealed that the central nervous system alters insulin secretion and insulin 
sensitivity during certain conditions like cold exposure (300) and pregnancy (301). This discovery 
suggests for the first time that central regulation of whole-body glucose homeostasis involves 
autonomic regulation of insulin secretion at the pancreas and is not only restricted to brain-mediated 
effects on the liver. It is therefore plausible that the failure of CD mice to increase insulin levels to 
compensate for hyperglycaemia might be mediated by brain-derived alterations in insulin signalling 
that may modulate the secretion of insulin by the pancreas. Although our findings clearly suggest that 
light cycle-disruption leads to alterations in central insulin sensitivity accompanied with a striking 
elevation in circulating blood glucose, future studies are required to delineate the underlying 
mechanism, as it is possible that the change in light cycle directly affects central leptin and insulin 
signalling, rather than indirectly associated with the body weight change.  
Our study has been performed on males. Leptin as well as insulin sensitivity differs between males and 
females (64). Chronotypes also differ between sex (in humans) which also depends on the age (65). 
Future studies are required to delineate whether similar effects of repeated light cycle changes observed 
in this study also occur in females.   
Our data corroborate the importance of the circadian timing system in maintaining metabolic health. 
Our repeated light cycle-disruption paradigm led to an increase in body weight and to augmented 
regulation in energy homeostasis, locomotor activity and an increase in fasting blood glucose. These 
profound metabolic changes were associated with reduced leptin sensitivity and alterations in insulin 
signalling within the ARC of the hypothalamus. These data suggest that circadian misalignment of any 
sort, as occurring during jet lag, shift work or social jetlag impairs neuroendocrine regulation of body 
weight and central regulation of glucose homeostasis, thereby explaining the elevated risk of developing 




Chapter 3 : Glucose regulation in chronic light-disrupted 
mice 
3.1 Introduction 
Energy balance is an essential process, regulation of which is tightly controlled to ensure efficient 
energy usage. The circadian timing system plays an essential role in orchestrating metabolic processes 
throughout a 24h cycle. The central clock within the suprachiasmatic nucleus (SCN) is the master 
pacemaker for the entire system, which peripheral tissue clocks are entrained to via both neural and 
hormonal cues (12). When the system itself experiences a perturbation to normal timing, whether it be 
a disruption at the level of the SCN by ill-timed lighting, or at the local peripheral tissue level, by 
untimely food intake, this causes a desynchrony between the various endogenous molecular clocks 
(161). In humans, this is common in individuals who undertake shift work, are exposed to light at night, 
or experience transmeridian jetlag or social jetlag. Many studies have shown that these disruptions to 
our internal circadian system can lead to more severe pathologies, in particular an increased prevalence 
of obesity, diabetes and cardiovascular disease (145,146,148,150,151,156,302).  
Following the consumption of food, carbohydrates are converted to glucose via different metabolic 
processes. Once glucose has entered the blood stream, glucose turnover is initiated via the clearance of 
this monosaccharide into metabolically active tissue. The main form of transport is via Glucose 
Transporters (GLUT) 1-4 (303). These are a group of membrane proteins that mediate the passive 
transport of glucose molecules across the plasma membrane. These glucose transporters are found in 
most tissue types including muscle and fat cells, pancreatic β-cells, erythrocytes, endothelial cells of 
the blood–brain barrier and neurons. Active transport of glucose is carried out by sodium-glucose 
transport proteins (SGLTs) which are found in intestinal mucosa and in the proximal tube of the nephron 
(304). SGLTs transport glucose against its own concentration gradient, assisted by the cotransport of 
sodium ions, the gradient of which is created by Na+/K+-ATPase pumps on the cell membrane (305). 
The primary function of SGLTs is to retain glucose within the body and blood stream. SGLTs do not 
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take part in the uptake of glucose into metabolically active tissue, such as skeletal muscle, as this is 
carried out by GLUTs 1-4. 
Following a feeding event, leading to a rise in blood glucose levels, several steps occur that lead to its 
clearance from the blood. Initially, glucose enters β-cells in the pancreas, via GLUT2 channels, relative 
to extracellular glucose levels. This activates various intracellular pathways that ultimately result in the 
release of insulin from β-cells into the blood stream. Insulin then binds to insulin receptors (IR) 
throughout the body, leading to various effects. In adipose and skeletal muscle tissue, IR signalling 
causes translocation of GLUT4 to the membrane, allowing the influx of glucose molecules, down their 
concentration gradient, to cross from the extracellular to the intracellular space, thus completing glucose 
clearance from the blood (306,307). Glucagon is also involved in glucose homeostasis. Synthesised and 
released from α-cells of the pancreas in response to a reduced concentration of extracellular glucose, 
glucagon acts primarily on the liver to stimulate glycogenolysis and gluconeogenesis. By this process, 
the liver releases glucose into the blood stream in order to elevate blood glucose levels and supply 
energy to peripheral and central tissue (308).  
In diabetes mellitus type II (T2DM), insulin signalling to peripheral tissues is impaired, leading to an 
impairment in glucose uptake. Initially this is compensated for by an increase in the rate of insulin 
secretion from the pancreas, however, insulin resistance develops soon after, and an eventual decrease 
in the rate of insulin secretion from the pancreas. The mechanism of insulin resistance is not known, 
however, several risk factors such as obesity, genetic predisposition, diet and circadian disruption, have 
been associated with an increase susceptibility to develop T2DM (309,310). Glucose tolerance and 
insulin secretion is controlled in a circadian manner, and varies throughout the 24h cycle (106,262). 
Perturbations in an individual’s daily rhythm have been shown to impact both insulin responsiveness in 
cells receiving its signal, and secretion from the pancreas, in response to timed meals 
(144,146,149,311). In humans, this has been shown to be caused specifically by misalignment of 
internal biological timing, instead of any effects of sleep loss (149). Conversely, both obesity and 
diabetes have an impact on internal biological rhythms by dysregulation of molecular clock genes, 
hormonal rhythms and rhythmic metabolic control (312). In a way, this is a common paradox in 
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metabolic health, in which a spiralling cascade of problems exacerbates the next, leading to eventual 
functional decline. Previous studies have aimed to explore the effect of circadian perturbations on the 
glucoregulatory system in mice. In 2017, Figueiro and others subjected mice to a light cycle that was 
shifted by 12 hours, multiple times over a 21 week period (313).  Glucose tolerance recorded at a single 
time point following the final light cycle shift was impaired in these mice, in comparison with their 
glucose tolerance prior to the cycle shifts. A separate study by Zhong and others recently reported a 
difference in glucose tolerance in female mice, following a 4 week shift work-like regime (314). 
Glucose tolerance was assayed throughout multiple groups, to record at several different time points; 
ZT0, ZT6, ZT12 and ZT16. Only at ZT 0 was glucose tolerance improved in shift work exposed mice 
in comparison with controls. Despite this unexpected result, this study illustrates the effect that the 
circadian timing system can have on glucose tolerance, and why it is essential for an efficient 
glucoregulatory system.  
We highlighted the effect that multiple lighting shifts caused a dramatic increase in fasting blood 
glucose levels, confirming the effect of internal desynchrony on the glucoregulatory system (246). In 
order to investigate this further, and perhaps identify the mechanism by which this occurs, we initially 
sought to study the effect of these light cycle disruptions on glucose tolerance. The development of 
glucose intolerance is often accompanied with the development of peripheral insulin resistance 
(315,316). Disruptions to the circadian timing system have also been shown to lead to impairments in 
glucose homeostasis. Is it therefore a change in insulin responsiveness in peripheral tissues that leads 
to eventual breakdown of the glucoregulatory system? Or is it in fact the release of insulin from the 
pancreas that becomes impaired? Evidence for both these possibilities can be found in the literature, as 
circadian disruptions affect β-cell function (238,317) as well as impacting on peripheral tissue glucose 
uptake (318,319). In this study, we sought to identify whether light cycle disruptions have a negative 





3.2.1 C57BL/6 Mice 
32 C57BL/6 male mice were obtained from the University of Otago breeding facility at Taieri. Upon 
arrival at the Hercus Taieri animal facility, these animals were 12 weeks of age. Sixteen mice were 
placed under a control 12-hour light, 12-hour dark lighting environment (LD mice), whereas the other 
16 were subjected to multiple light cycle disruptions (CD mice), in which a 12-hour light, 12-hour dark 
cycle was advanced by 6 hours every 6 days. Each light cycle advance occurred during the dark phase 
of the sixth day following the last, reducing the total time of darkness from 12 hours to 6. Lights would 
therefore turn on 6 hours earlier than under control lighting conditions at each phase shift, causing a 
phase advance. The first phase shift occurred on day 6 of the experiment, 6 days after we performed a 
baseline intraperitoneal glucose tolerance test to test glucose tolerance under normal lighting conditions, 
as a point of reference. 
Within each lighting condition, 8 mice were fed a low-fat diet (LFD) with 10% of energy coming from 
fat (kcal), and the other 8 fed a high fat diet (HFD) with 60% of energy derived from fat (D12450B and 
D12492, respectively; Research Diets, Brunswick, NJ, USA). Mice were weighed every 6 days, on the 
5th day following each phase shift, to allow mice to acclimate to the new lighting cycle. This allowed 
for general monitoring of body weight at a low temporal resolution, as daily measurement of body 
weight had already been conducted in a previous experiment (246). 
Termination of the experiment occurred on the 112th day from ZT 3 to ZT 6. This was 6 days following 
the 18th phase shift. Animals were euthanised via decapitation and trunk blood was collected 
immediately. Mouse brains were then removed and frozen on dry ice immediately, before storage at -
80°C. Following tissue collection, trunk blood samples were centrifuged at 16,100 RCF for 15 minutes 
at 4°C. Serum was then collected and stored at -80°C for later use. 
3.2.2 Glucose Tolerance Tests 
As we discovered in the previous study that light cycle disruption led to extremely high basal blood 
glucose levels, we now sought to investigate whether they may affect glucose excursion or tolerance as 
75 
 
well (246). In order to do this, intraperitoneal glucose tolerance tests (ipGTT) were conducted in order 
to analyse glucose excursion.   
An initial ipGTT was first performed at experimental day 0, to assess baseline glucose tolerance. This 
was followed by subsequent ipGTT’s every 18 days thereafter, with the exception of the last. An 18-
day interval was chosen in order to allow for animals to fully recover from the previous ipGTT. Previous 
experiments in our laboratory have shown that ipGTT causes a transient decrease in body weight, likely 
due in part to the fasting period required, as well as the procedure itself having an impact (287). IpGTT’s 
were performed 24 hours following a phase shift in the case of the CD mice, with the exception of the 
final ipGTT. Prior to each ipGTT, mice were fasted overnight, and had food removed from cages for 
13.5 hours. This included the 30 minutes prior to lights off, the entire 12-hour dark phase, as well as an 
hour after lights on when ipGTTs began. The first six ipGTT’s were performed as described, however, 
the seventh and final ipGTT was performed on experimental day 106. This day was chosen as it was 5 
light cycles following the prior phase shift for CD animals instead of the previous 24 hours after each 
phase shift. It is known that blood glucose levels and blood glucose tolerance in mammals, fluctuate 
throughout the 24h cycle, with the nadir of glucose tolerance in rodents being between the hours of 
ZT0-ZT2 (106,109,113,280,320). In both control and CD mice, glucose tolerance tests were conducted 
between ZT0 and ZT3, when glucose intolerance is anticipated to be maximal, given a normal circadian 
pattern. However, because CD mice had just been subjected to a 6h advance of their light cycle, they 
are therefore supposedly 6h out-of-phase in their physiology with the new light cycle. This means that 
performing an ipGTT at ZT0 would be at their physiological time of CT18 (Circadian Time; less 6 
hours). Based on the literature, glucose tolerance tests revealed that mice had improved glucose 
tolerance at ZT18 in comparison to ZT0 (113). Therefore, it is possible that the previous results from 
GTT 1-6, in which control and CD cycle animals maintained similar glucose tolerance, was in fact due 
to this mismatch of timing. In order to control for this difference, the final ipGTT was performed 5 days 
following the prior light cycle shift. This way, CD mice will have 5 days to re-adjust to the new light 
cycle, and therefore have an internal physiological rhythm that is more in line with the animals under 
the control light cycle. Thus, any differences seen in glucose tolerance between the two groups is most 
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likely a direct result of the multiple phase advances in lighting schedule for the CD mice, instead of a 
mismatch in physiological rhythms.  
On the day prior to the ipGTT, food was removed from cage hoppers, mimicking an overnight fast. This 
occurred at ZT 11, 1 hour prior to lights off. IpGTT’s were performed 30 minutes following lights on, 
on the respective day. All animals were therefore fasted, for mostly during the dark period, 13.5 hours 
prior to an ipGTT. At time point 0 of the ipGTT, mice were intraperitoneally injected with a glucose 
bolus of 1.5 g/kg of body weight. The glucose solution used for injection was 25% glucose in 0.4% 
saline. A blood sample at time point 0 was extracted prior to injection of the glucose bolus. Following 
the initial injection, serial blood samples were then taken from the tail tip of animals at 15, 30, 60, 90, 
120, 150, 180 and 210 minutes. Blood was measured using an Accu-chek Aviva blood glucose monitor 
(Roche Diagnostics, Burgess Hill, UK). Results are displayed as blood glucose (mg/dl) over time, and 
area under the curve (AUC) calculated using the trapezoid rule (321).  
3.2.4 Serum glucose assays 
Fasting blood glucose levels were analysed in C57BL/6 mice, using serum acquired during termination. 
A mouse glucose assay kit purchased from Crystal Chem (catalog no. 81692; Crystal Chem Inc., Elk 
Grove Village, IL, USA) was used for analysis. This kit induced a chemical reaction by converting all 
α-D-glucose, present within the serum sample, into the stereoisomer β-D-glucose catalysed by 
mutarotase. β-D-glucose is then oxidised by β-D-glucose oxidase, yielding D-gluconic acid and 
hydrogen peroxide (322). Hydrogen peroxide then reacts with a chromogen in order to yield a red 
precipitate, which can be measured by absorbance at 505nm. This is directly proportional to the glucose 
concentration present in the sample. Absorbance was measured at 490nm however, using a VICTORX 
Multilabel Plate Reader (Part Number 2030-0050, PerkinElmer, Inc., Waltham, MA, USA), due to the 
limits of this particular plate reader. Absorbance results were then compared with a standard curve, to 
give accurate measurements of glucose concentration.  
3.2.5 Statistics 
Mice body weight and food intake were analysed using two-way repeated measures ANOVA. This was 
followed by a Holm-Sidak post-hoc test to check for significance.  
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Serum glucose data were analysed using Prism software (GraphPad Software, La Jolla, CA), using two-
way ANOVA, with both light cycle and diet being the two independent variables, and glucose 







3.3.1 Body weight and food intake 
Contrary to previous study, under similar parameters, which an effect on body weight was seen within 
12 phase shifts, there were no differences in body weights caused by the light cycle disruptions. Control 
animals and CD animals were weighed every six days and continued to maintain a similar body weight 
to one another (figure 3.1A). In animals fed LFD, there was no variation in body weight due to light 
cycle (two-way ANOVA; F (1, 13) = 0.243, P=0.629), however, body weights increase significantly 
throughout the duration of the experiment within each group (two-way ANOVA; F (17, 221) = 47.37, 
P<0.001) and no interaction effect was observed (two-way ANOVA; F (17, 221) = 1.244, P=0.231). In 
animals fed HFD, there was no variation in body weight due to light cycle (two-way ANOVA; F (1, 14) = 
Figure 3.1. A: Body weight trajectory of mice either under a control light-dark cycle (LD Cycle) or one 
that was advanced by 6 hours every 6 days (CD Cycle) throughout the entire experiment. Mice were fed 
either a low fight diet (LFD), or a high fat diet (HFD). Arrows indicate when an intraperitoneal glucose 
tolerance test was performed. B: Initial and final body weights of each group. C: Cumulative food intake 
for animals fed either a LFD or HFD, displayed in grams (#P < 0.05, ## P < 0.01, ### P < 0.001 between 
LD and CD animals fed a HFD). D: Total kcal intake throughout entire experiment. (n = 8 for each group, 
values displayed as mean ± SEM, **P < 0.01, ***P < 0.001) 
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0.0729, P=0.7911), however, body weights increase significantly throughout the duration of the 
experiment within each group (two-way ANOVA; F (17, 238) = 212.4, P<0.001) and no interaction effect 
was observed (two-way ANOVA; F (17, 238) = 0.633, P=0.863). When comparing LFD fed animals with 
HFD animals, diet had a significant effect on body weight (two-way ANOVA; F (1, 27) = 86.18, P<0.001), 
with HFD fed animals being 12.36 ± 1.88g heavier than LFD fed animals, with no effect by either light 
cycle (two-way ANOVA; F (1, 27) = 0.289, P=0.595) or interaction between the two variables (two-way 
ANOVA; F (1, 27) = 0.0609, P=0.806) (figure 3.1B).  
Food intake was recorded throughout the experiment, at the same time as body weight was measured, 
and are shown as cumulative food intake throughout the entire experiment (figure 3.1C). Animals fed 
LFD maintained a similar food intake throughout the experiment between LD and CD mice (two-way 
ANOVA; F (1, 13) = 0.00125, P=0.972). HFD fed animals showed a difference in cumulative food intake 
throughout the study between LD and CD cycle (two-way ANOVA; F (1, 14) = 7.072, P=0.0187), 
specifically at phase shift 5, 6, 7, 11, 16 and 17 (figure 3.1C). However, total cumulative food intake of 
LD animals fed HFD (1434.80 ± 19.21 kcal) did not differ significantly (∆82.7 ± 43.2kcal, P = 0.128) 
from CD animals fed HFD (1352.10 ± 29.64 kcal) (figure 3.1D). HFD fed animals consumed 
significantly more kcal than animals fed LFD under both LD cycle (∆240.3 ± 43.2 kcal, P < 0.001) and 
CD cycle (∆180.5 ± 44.7 kcal, P = 0.0016) (figure 3.1D) conditions.  
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3.3.2 Glucose tolerance tests 
The initial glucose tolerance test that was performed on the day of experimental commencement, 
revealed no differences in glucose tolerance throughout any of the groups (Table 3.1, figure 3.2).  The 
second GTT revealed a significant effect of diet on glucose tolerance that continued for the duration of 
the experiment. High fat diet fed animals had an impaired glucose tolerance in comparison to animals 
fed a LFD. By the 4th GTT, there was a significant effect of light cycle on glucose tolerance. The 6th 
and 7th GTTs also showed a significant effect of light cycle on glucose tolerance in which animals 
exposed to a disrupted light cycle had significantly impaired glucose tolerance in comparison to those 
on a control light cycle.  
Source of Variation: Interaction Diet Light Cycle 
GTT 1 F(1,26) = 0.7422 
P=0.396, n.s 
F (1, 26) = 0.481, 
P=0.494, n.s 
F (1, 26) = 3.754, 
P=0.0636, n.s 
GTT 2 F (1, 26) = 9.275, 
P=0.0053, ** 
F (1, 26) = 26.88, 
P<0.0001, **** 
F (1, 26) = 0.0393, 
P=0.844, n.s 
GTT 3 F (1, 25) = 0.207, 
P=0.652, n.s 
F (1, 25) = 46.04, 
P<0.0001, **** 
F (1, 25) = 1.011, 
P=0.324, n.s 
GTT 4 F (1, 27) = 0.00782, 
P=0.930, n.s 
F (1, 27) = 47.24, 
P<0.0001, **** 
F (1, 27) = 5.259, 
P=0.0298, * 
GTT 5 F (1, 25) = 2.229, 
P=0.147, * 
F (1, 25) = 42.16, 
P<0.0001, **** 
F (1, 25) = 0.4663,  
P=0.501, n.s 
GTT 6 F (1, 25) = 1.471, 
P=0.236, n.s 
F (1, 25) = 37.46, 
P<0.0001, **** 
F (1, 25) = 5.054, 
P=0.0336, * 
GTT 7 F (1, 24) = 0.259, 
P=0.615, n.s 
F (1, 24) = 54.39, 
P<0.0001, **** 
F (1, 24) = 5.816, 
P=0.0239, * 
Table 3.1. Two-way ANOVA was completed for the area under the curve (AUC) of each individual 
glucose tolerance test (GTT). Results display the F Statistic and the P-value for the source of variation 
either from the interaction of the two independent variables, the effect of diet and the effect of light 






Figure 3.2. Glucose tolerance 
tests were performed in mice 
throughout the experiment 
approximately 3 weeks apart. 
Baseline measurements prior to 
the initiation of the experiment 
served as reference (GTT1). 
Animals on different diets differed 
in glucose tolerance significantly 
by GTT3. A difference was found 
in glucose tolerance between the 
two light cycles at GTT7 (LFD: 
low fat diet, HFD: high fat diet, 
LD Cycle: control light/dark 
cycle, CD Cycle: light cycle 
disruption) (n = 6-8 for each 
group, values shown as mean ± 
SEM; *P < 0.05, **P < 0.01, ***P 
< 0.001 between diets. #P < 0.05, 




3.3.3 Fasting blood glucose levels 
Previous work had shown a dramatic increase in fasting plasma glucose levels following chronic light 
cycle disruption (246). Therefore, in addition to glucose tolerance tests, fasting blood serum levels were 
also measured, in order to make a comparison with this previous study. Trunk blood was collected 
following decapitation, to be later spun in a centrifuge followed by collection and storage of blood 
serum. At this time point, all groups of animals had been fasted overnight.  
Once again, in C57BL/6 mice we found an increase in fasting blood serum glucose levels between 
animals on a control light cycle (110.2 ± 6.6 mg/dl), and those subjected to multiple lighting advances 
(143.1 ± 4.8 mg/dl) (two-way ANOVA; F (1, 15) = 6.634, P = 0.0211) (figure 3.3). Diet did not affect 
fasting blood serum glucose levels (two-way ANOVA; F (1, 15) = 3.902, P = 0.0669), and there was no 
interaction between the two independent variables (two-way ANOVA; F (1, 15) = 0.00970, P = 0.922). 
Multiple comparisons revealed no significant differences between any individual groups.  
3.4 Discussion 
Previously in ‘Chapter 2’, it was demonstrated that multiple light cycle disruptions led to a dramatic 
increase in fasting blood glucose levels, with an absence of increased blood insulin levels. Remarkably, 
fasting blood glucose levels were increased almost 3-fold in animals under chronic light cycle 
disruption, compared to those under a control light cycle. Additionally, fasting blood glucose levels 
were 2-fold higher than animals fed a high fat diet, suggesting an extreme effect of light cycle 
disruptions on the glucoregulatory system. Therefore, the present study aimed to investigate long-term 
Figure 3.3. Glucose levels in blood plasma of mice at 
the termination of experiment. Mice on an LD cycle 
had reduced blood plasma glucose levels in 
comparison with mice exposed to a CD cycle, 
regardless of diet (Two-Way ANOVA, P = 0.021) (n = 6-





changes in glucose tolerance, in animals subjected to chronic light cycle disruptions. To do so, animals 
were subjected to a similar paradigm in which 12h light/12h dark cycles were advanced by 6h every 6 
days, with glucose tolerance tests performed at regular intervals to assess the animal’s ability to control 
glucose metabolism.   
From our previous work, and indications in the literature, an effect seen from disrupting the endogenous 
timing system through light cycle shifts, is an increase in body weight gain (246,263,323). Contrary to 
this data we found that animals under light cycle disruption did not display any differences in body 
weight, when compared to controls. Expanding on our previous work, we challenged animals with a 
HFD, which we hypothesised would potentially exacerbate body weight differences that we had 
previously reported in light cycle disrupted animals. Despite animals fed a HFD gaining considerably 
more weight above animals fed LFD, no difference between control and light cycle disrupted animals 
of the HFD fed group was seen.  
The lack of differences in body weight between light cycle groups is most likely due to an additional 
parameter that was introduced to this experiment. Glucose tolerance tests were performed at 18-day 
intervals, to assess the animal’s ability to maintain glucose homeostasis under disrupted lighting 
conditions, with a temporal resolution. To perform these tests, a fasting period of 13.5 hours (food was 
removed 30 minutes prior to lights off, then ipGTTs were performed an hour after lights on) was 
required, over the dark period, prior to the test taking place. This is loosely comparable with an 
intermittent fasting (IF) regime in which animals would be fasted for 10-48 hours, with intervals of 
feeding in between fasting bouts (324). Whereas in our animals, fasting periods were short and 
infrequent. Despite this, IF regimes have been shown  to be highly beneficial for metabolic health, by 
improving glucose homeostasis, promoting weight loss, improving circadian health and even improving 
modifiable lifestyle behaviours, such as sleep (Reviewed here (325)). We identified circadian effects 
on body weight in our previous study, however, these were induced after several light cycle shifts, and 
the magnitude of the body weight difference between circadian disrupted and control mice was 
relatively small.  
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Animals fed a LFD did not differ in food intake across the experiment. This is in line with previous 
work from our own laboratory (246), as well as similar studies (263). The two groups of animals fed a 
HFD did not differ in total food intake by the end of the experiment, however, small fluctuations were 
seen within the experimental timeline. Evidence in the literature suggests that diurnal variation in food 
intake becomes compromised under chronic light cycle disruptions (323). In the current study, it was 
impossible to discern whether or not this is occurring, due to the limited time resolution of food intake 
measurements. However, it seems that this is most likely the case, given the fact that we have previously 
shown this to occur under a similar paradigm (246). Directly following a lighting shift, the diurnal 
rhythm in food intake is initially reversed, with the majority of food consumed during the day. On the 
second day after the shift, the diurnal difference in food intake was completely lost to eventually re-
emerge to a certain extent by the third day. What’s important to note is that total food intake between 
our control and light cycle disrupted groups does not change. It is likely the fact that feeding rhythms 
are altered, which leads to the metabolic alterations that we observe. 
Insulin is secreted from the pancreatic islet cells in a circadian manner that responds to predicted meal 
times as well as to the intake of food (278). Insulin acts in peripheral tissue to modulate glucose 
homeostasis, via a range of actions including the stimulation of glucose uptake into metabolically active 
tissue. Several hormones that have an effect on insulin secretion, are secreted in a circadian manner, 
controlled indirectly by the SCN. Melatonin, which is said to decrease insulin secretion in nocturnal 
rodents, is secreted rhythmically by the pineal gland, following indirect stimulation by the SCN (326). 
The glucocorticoid cortisol causes a reduction in insulin secretion and is under control of the 
hypothalamic-pituitary axis, which is in turn, regulated in a rhythmic manner by the SCN (327). Growth 
hormone (GH) release is regulated indirectly by the SCN’s control of the sleep wake cycle and has an 
effect on the sensitivity to insulin in the periphery, including muscle and liver tissue (328,329). GH 
levels are increased during sleep and come to a zenith at sleep onset in humans (330). In night shift 
workers, this pattern of GH secretion remains to be consistent (331). Even following a shift from night-
sleeping activity, to day-sleeping activity, GH is still released at the onset of sleep in these individuals, 
with the only affect appearing to be a reduction in GH pulse frequency throughout the sleep period. 
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Along with hormonal control, neural control is thought to have an effect on insulin secretion. The pre-
autonomic area of the paraventricular nucleus (PVN) is an important target of SCN afferents. Inhibition 
of PVN neuronal activity abrogates the feeding-induced plasma glucose and insulin responses (332). 
Food intake, however, remains to have the strongest influence on insulin secretion, whereas hormonal 
and neuronal signals have been shown to modulate its effect. A mismatch between food intake and this 
circadian-controlled modulation is therefore likely to have a detrimental effect on glucose homeostasis.  
We disrupted the internal timing system in animals by subjecting them to multiple lighting shifts. We 
then performed multiple glucose tolerance tests throughout the study. The timing of these tests was 
originally planned for the day following a lighting shift in circadian disrupted mice. This time point was 
selected due to previous results in chapter 2. In chapter 2, animals were terminated the day following 
the final lighting shift, at which point, blood samples were also taken. Blood glucose levels in these 
samples were almost 3-fold higher in disrupted animals, in comparison to controls. Therefore, this time 
point was selected to mimic as closely as possible, the experimental conditions in chapter 2. When 
assessing glucose tolerance in these animals, we find that those subjected to lighting shifts eventually 
reach a significant impairment in glucose tolerance, just prior to the termination of the experiment. 
However, the final ipGTT that took place was performed at a different time to the others. After reaching 
a significant difference in glucose tolerance between the control and light disrupted animals at GTT6, 
we slightly altered the timing of the 7th GTT. Based on the literature, the previous timings of our GTTs 
may have compromised our results, due to the effect of multiple fasting periods required throughout the 
study. Froy and others found that intermittent fasting affected peripheral clock genes, dependant on 
when food was reintroduced to the mice, either during the day time or the night (333). Under daytime 
food reintroduction, circadian amplitudes were dampened, likely due to a mismatch of peripheral and 
central clocks, leading to an advancement of mPer2 and mClock liver expression as well. Whereas night 
time feeding led to an increase in amplitude of circadian clock genes, similar to those seen under ad 
libitum feeding. Two studies showed that fasting alters the level of expression of clock genes mPer1 
and mPer2, but not the phase of expression (334,335). This has implications for our own study, in which 
food was re-introduced to animals following the ipGTT, at approximately ZT3. At this time, animals 
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would have been fasted for a total of approximately 15.5 hours, meaning that a large proportion of total 
food intake across the day, would take place at ~ZT3. Based on what Froy and others have shown, this 
would theoretically cause a dampening of circadian gene expression, and a phase shift in the expression 
rhythm of mPer2 and mClock, to advance the expression profile within the liver. This kind of disruption 
to the circadian timing system is something that we should aim to avoid, as the biggest impact of this 
will be in the control animals, causing a possible confounding result. Animals under the CD cycle would 
theoretically benefit from this fasting and refeeding schedule, as it encourages peripheral tissue clocks 
to reset faster, following an advance in the light cycle.  
The initial 6 ipGTTs took place 24h following a shift in the lighting schedule. From the literature, we 
know there is a circadian rhythm in glucose tolerance, with the nadir at ZT0 – ZT2 and peak tolerance 
at ZT18 (113). Peripheral clocks take a few days to readjust to new lighting schedules, (approx. 
1hour/day), therefore animals under CD cycle would still be entrained to the previous light cycle, at 
least in peripheral tissue. In the initial 6 ipGTTs, it is likely that we were measuring differences in the 
diurnal rhythm of glucose tolerance, instead of any changes caused by the chronic light cycle 
disruptions. Despite this possibility, we still found that mice under light cycle disruptions had altered 
glucose tolerance across the experiment. Therefore, we made the decision to perform the final ipGTT 
5 days following the previous light shift, allowing animals under light cycle disruptions to entrain to 
the new light cycle. If the theory is correct, this meant that we were able to measure the differences in 
glucose tolerance caused by the multiple lighting shifts. With this final ipGTT, we still found a 
difference in glucose tolerance between control animals and those subjected to multiple lighting shifts. 
Importantly, a reduction in glucose tolerance in mice subjected to light cycle disruptions was observed 
in the absence of any changes in body weight. Our data therefore suggest that light cycle disruptions 
have a direct impact on the glucoregulatory system.  
Our results for glucose tolerance are in line with similar studies. Figueiro showed glucose tolerance 
impairment in mice subjected to a shift-work like schedule (313). However, glucose tolerance was 
measured at a singular time point, directly following a phase shift, similar to the experimental paradigm 
of our initial 6 ipGTTs. Zhong and others very recently reported a difference in glucose tolerance in 
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female mice, following a 4 week shift work-like regime (314). However, they actually showed an 
improvement in glucose tolerance at ZT0 only, in comparison with controls. When tissue was harvested, 
the timing of Clock, Bmal1 and Cry1 expression in the liver of these animals was slightly advanced 
from controls, owing most likely to the recent phase delay 5 days prior. It is difficult to compare this 
study to our present study, given the fact that glucose excursion varies between female and male animals 
(336). In all studies mentioned above, evidence for glucose intolerance or alteration in glucose 
excursion was shown to be induced by light cycle disruption, however, the mechanism for this is still 
unclear. In these studies, a general mismatch in timing and coordination of hormonal, neural and food 
intake cues, caused by lighting disruptions, is usually attributed to the impairment of glucose tolerance. 
We have previously shown dramatic increases in fasting blood glucose levels, in absence of any type 
of insulin response, possibly due to multiple light cycle disruptions. However, it remains unclear 
whether this is occurring acutely at different times, or whether it is a long-term effect on insulin 
secretion itself.  In this study we find that there is an accumulating deterioration of glucose tolerance 
caused by multiple lighting shifts, suggesting this is a long-term effect on the glucoregulatory system. 
However, the exact mechanism by which this happens is still unclear.  
Following the termination of the study we were able to sample fasting blood glucose levels, using the 
same method as in ‘Chapter 2’. We found that results from the present study are generally in line with 
our previous study, animals under light cycle disruptions have an increased fasting blood glucose level 
in comparison to those under control conditions. We found the effect to be less pronounced in the 
current study, at least for those animals fed a LFD. Several factors may have contributed to this. In the 
previous study, animals were fasted for 24 hours prior to termination, whereas in the current study, mice 
were fasted overnight. Secondly, no body weight changes occurred in the animals of the current study, 
due to reasons described above. This may well suggest that in the previous study, high fasting blood 
glucose levels were secondary to changes in body weight caused by light cycle disruptions.  
Several limitations were apparent in the current study, including the multiple fasting periods that were 
necessary. Performing an initial baseline ipGTT, followed by a singular ipGTT towards the end of the 
experiment would have removed these multiple fasting periods. We may expect that animals under light 
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cycle disruption would gain weight above the controls, similar to our results in “chapter 2”, given the 
absence of the ipGTTs and fasting periods. This may have meant that there would be a larger 
consequence of light cycle disruptions, on the glucose tolerance of these mice. Additionally, altering 
the timing of the ipGTTs should be considered for future experiments. Initially, we performed ipGTTs 
24 hours following a phase shift. Allowing for animals to entrain to a shift in the light cycle of several 
days (i.e., 1 day per hour shift) would allow for more accurate comparison between control and light 
cycle disrupted animals.   
In conclusion, the present study provided a more in-depth analysis of glucose tolerance in animals under 
light cycle disruptions. We found an eventual difference in glucose tolerance, and fasting glucose levels 
in C57BL/6 mice, despite any differences in food intake or body weight gain. Fasting glucose levels in 
these animals were also reduced, possibly due to the previous differences in food intake. Further studies 
around the glucoregulatory system, and the role of melatonin in maintaining a healthy metabolism under 
light cycle disruption are needed to be conducted, however, the current research opens up new avenues 




Chapter 4 : Food entrainment under light cycle-disruption 
abrogates weight gain  
4.1 Introduction 
Disruption to the human circadian timing system can lead to metabolic dysfunction. Both light and food 
are important cues, or zeitgebers, for entraining endogenous clocks, and contribute to metabolic health. 
Individuals who are exposed to incorrect timing of cues, such as in shift work, jetlag, bright light at 
night and social jetlag, have a higher risk of developing type II diabetes, obesity and cardiovascular 
diseases (146,148-150,152,153,156,311). These long-term health effects of incorrect circadian timing 
have been proven, however, the mechanism by which this occurs is unclear. In these individuals, the 
internal synchrony of their cyclic oscillators becomes misaligned with both external cues and with one 
another. This results in internal desynchrony in which behavioural, metabolic, hormonal and neuronal 
variables, cycle out-of-phase. The two most important zeitgebers for metabolic health have been proven 
to be lighting and food intake (338).  
Disruptions to the lighting environment cause deficits in both leptin and insulin signalling, leading to 
increases in bodyweight, fasting blood glucose levels and metabolic dysfunction (246,263). Incorrect 
timing of food intake also causes metabolic derangements, specifically without altering the intrinsic 
timing of the central circadian clock in the suprachiasmatic nucleus (SCN) (99). Food timed during the 
light phase in nocturnal animal models, causes shifts in particular clock genes within peripheral tissue. 
Furthermore, short term time-restricted feeding during the resting phase causes an increase in body 
weight (339), and has been shown to lead to central leptin resistance (340). Forced activity during the 
resting phase in rats, and subsequent disruption to food intake, produces desynchrony in regions of the 
hypothalamus, with the exception of the SCN and PVN (341). Using a Per1-luc reporter mouse line, 
persistent rhythms have been identified in the arcuate nucleus (ARC), SCN, pituitary gland and pineal 
gland, following excision from the brain (342). The arcuate nucleus is one of the most important regions 
controlling body weight homeostasis and energy expenditure (188). The presence of an isolated 
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circadian rhythm in this region suggests that correct circadian timing is imperative for a correctly 
functioning metabolism. 
Evidence in the literature suggests that disruptions to the lighting environment in which laboratory 
animals are kept in, are often accompanied with disruptions in food intake. This has been shown to be 
detrimental, and can cause internal desynchrony which leads to a compromised metabolism (339). 
These studies, however, lack the ability to discern between the effect of the light cycle disruptions, and 
the subsequent disruptions in food intake. In this study, we have the unique opportunity to accurately 
measure both circadian rhythmicity using activity recording, as well as food intake patterns in mice. 
This allows for the analyses of these two variables independently, and therefore the severity that each 
one has.  
In this experiment, we subjected mice to either a control 12h light:12h dark light cycle (LD), or a 
chronically shifting light cycle disruption (CD), a replication of the model used in chapters 2 and 3. One 
group of mice were fed ad libitum, to assess the impact that this light cycle disruption had on food 
intake rhythms. Given the fact that a dissociation of activity rhythms and feeding patterns is likely the 
cause of metabolic dysfunction, a second group of mice had food restricted to the 12-hour dark period, 
thereby forcing feeding behaviour to conform to the normal active period in these nocturnal rodents. In 
the case of the CD animals, this meant that as the light cycle shifted, so did the 12-hour feeding window. 
To compare the effect of light cycle disruptions with food intake disruptions, on the endogenous 
circadian system, we challenged a group of animals in the control light cycle group to a shifting food 
regimen. In this, a 12-hour period of access to food was shifted by 6 hours every 6 days, analogues to 
the light cycle intervention described for CD animals. Lastly, a final CD group had food access 
restricted to a set 12-hour window, which did not change throughout the experiment. This meant that 
as their light cycle shifted, food timing remained the same, and the relationship between the light cycle 
and food access will become out-of-phase.  
The majority of this experiment was conducted at the University of Texas Southwestern, in Dallas, 
Texas, working with the JS Takahashi Lab. The reason for this was to allow access to specialised 
equipment that had been developed by members of the lab, to allow for simultaneous recording of 
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activity and food intake rhythms. As well as this, having the opportunity to work in collaboration with 
JS Takahashi, the founder of the mammalian circadian clock, gave access to a vast array of knowledge 
and assistance, for understanding circadian biology.   
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4 .2 Methods 
4.2.1 Animals 
C57BL/6J male mice raised at the UTSW in-house breeding colony (Mouse Breeding Core, Wakeland 
lab, UTSW Medical Center, Dallas, TX, USA) were used in this experiment. Animals were housed in 
a group housing facility (no more than 5 per cage) until the approximate age of 12 weeks, before being 
transferred into standard individual polycarbonate cages within isolation cabinets holding 12 cages 
each. Temperature and humidity were monitored within these cabinets and mice were housed under 
differing lighting conditions (green LEDs, ~100 lux). Water was provided ad libitum throughout the 
study from bottles located in the top of the cage. Bodyweights were recorded from every mouse on the 
4th day following the latest phase shift, between ZT6 and ZT12. This process required the handling of 
mice by an individual investigator using a small scale within the animals’ room. Cages were changed 
every 18 days, 4 days following the latest phase shift at the same time of weighing, in order to minimise 
disturbance in these animals. 
Body composition was measured using an EchoMRI-100H (EchoMRI LLC, TX, USA) which allowed 
for the measurement of fat mass, lean mass, free-water and total body water in live animals. The 
EchoMRI machine utilises a specialized Nuclear Magnetic Radiance/Magnetic Resonance Imaging 
(NMR/MRI)-based technology. Following shift 15, animals were measured for body composition at the 
same time as being weighed. Animals were inserted into a tube within the EchoMRI machine for a 
maximum of 40 seconds during recording, then immediately returned to their individual cages. Prior to 
termination, animals were once again measured in the EchoMRI machine in the same way as previous. 
Both lean mass and fat mass were analysed for body composition.  
4.2.2 Lighting and feeding conditions 
144 animals were split into 6 equal groups of 24 mice, with differing lighting and feeding conditions, 
and subsequently, differing phenotype and running wheel conditions as well. Two lighting conditions 
existed, the first, a 12h light:12h dark cycle was used as the control, which persisted throughout the 
study (LD light cycle, LD Cycle, LD) (figure 4.1). The second was a similar 12h light:12h dark cycle, 
however, this was advanced by 6 hours every 6 days. On the day of the advance, the 12-hour dark period 
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was shortened to 6 hours, in order to enable the shift (CD light cycle, CD Cycle, CD) (figure 4.2). This 
was a replication of the method used in chapters 2 and 3. Multiple feeding paradigms existed in order 
to assess the effects of feeding times on metabolic outcomes in this study. One group under each light 
condition were fed food ad libitum (LD ad lib, CD ad lib). One group from each light condition had 
food access restricted to the dark period. In animals under LD, this 12h period remained constant 
throughout the study (LD TR (Time Restricted) Night). However, given that those under CD light cycle 
had a dark period that would shift every 6 days, so did food access along with this dark period (CD TR 
Night).  Finally, the third group of mice under LD conditions had food access that was shifted in a 
similar way to the light cycle in the CD group. Food was restricted to a 12-hour period, which occurred 
every 24 hours, however, this was advanced by 6 hours every 6 days (LD TR Moving) (figure 4.1). The 
third group under the CD light cycle had food restricted to a specific 12-hour period relative to the 
initial lighting period (CD TR Locked) (Fig 4.2). This meant that as the light cycle would advance 
forward, food access stayed within the same time window throughout the study. Food access for each 
of these paradigms was controlled by the automated feeder system developed in the Takahashi Lab 
(Phenome Technologies, Skokie, IL, USA) (Acosta-Rodríguez et al., 2017). 
 
Figure 4.1. Light cycle and feeding regimen for animals under a control light cycle (LD). Light cycle 
was maintained at 12h light:12h dark for the entirety of the experiment (top). Orange bars indicate food 





Figure 4.2. Light cycle and feeding regimens of light cycle disrupted (CD) animals. Black and white 
bars (top) indicate light cycle changes throughout the experiment. At each shift, the light cycle was 
advanced by 6 hours. Orange bars indicate food access for each group, in relation to the light cycle and 
shift changes. White and grey bars indicate an identical light cycle, with feeding windows superimposed 
on top. 
 
4.2.3 Feeding and behavioural monitoring 
Throughout the experimental period of the study, mice were fed round precision pellets of 315 ± 4 mg 
each containing 3.35 kcal/g (Dustless Precision Pellets, Rodent, Grain-Based, F0170, BioServ, 
Flemington, NJ, USA). Pellet composition is equivalent to regular chow, with 10% kcal from fat, 25% 
kcal from protein and 65% kcal from carbohydrates (Table 4.1). Feeding behaviour was monitored by 
the automated feeder system that also controlled the duration, number and timing of food access. These 
automated feeding boxes would initially drop a single pellet of food from the food hopper, down a 
chute, leading to the base of the wire cage top where mice could access the pellet. Here, a second sensor 
would record when the mice would take the pellet from the cage top, wait ten minutes, and then release 
another pellet from the food hopper. This setup meant that in some instances, food that had been dropped 
during the feeding window (i.e., at ZT 23:59 in TR Night fed animals), could potentially remain in the 
top of the cage, available to the mouse, for the entirety of the light phase, or until the mouse chose to 
take this final pellet. This mean that some pellets were recorded as being eaten during a time in which 
food access was turned off, in the case of the groups with restricted feeding times. Some issues arose in 
animals that displayed hoarding behaviour, whereby animals would constantly take pellets from the 
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access point, without actually eating them, and proceed to hoard them in their cage. This behaviour was 
seen in less than 3% of animals and was corrected for by counting the number of pellets in their cage at 
the time of cage change, thereafter, being corrected for their total intake record.  
Mice had access to running wheels within their own individual cage, which were constantly monitored 
in order to count wheel revolutions. Infrared sensors recorded every revolution of the running wheels, 
regardless of direction. This data was then collected using the Actimetrics Software, at a time resolution 
of 1 minute (ClockLab, IL, USA). Four days following the 13th phase shift, half the animals from each 
group had their running wheels disabled, so that the wheels would no longer rotate. This decision was 
made because animals under the light cycle disruption were not showing weight gains, as had been 
observed in “chapter 2”. The main difference of this new study, in comparison to the last, was the 
presence of running wheels. Therefore, we postulated that it was in fact the running wheels that were 
causing this abrogation of weight gain in this new cohort of animals. Wheels were disabled by inserting 
a metal rod into the cage, weaving through the running wheel, so as to prevent any wheel movement. 
Wheels were not removed from the cages due to two reasons; animal ethics required that the mice have 
some form of enrichment within the cage and that removing the running wheels may cause a 
confounding effect of dramatically altering their cage environment. Both feeding activity and running 
wheel data were analysed using RStudio software for R.  
4.2.4 Diet comparison 
The diet used in this project differs to that used in previous experiments, due to availability and 
composition that was required for the diet. The equipment that was used to deliver the food to the 
animals for feeding, requires small precision pellets, about .3cm in diameter. In comparison to previous 
diets used within New Zealand (Chapters 2, 3), the Bioserv pellets have approximately the same fat 









 gm % kcal % gm % kcal % gm % kcal % 
Protein  19.2 20 21.3 25 26.2 20 
Carbohydrate 67.3 70 54.0 64.4 26.3 20 
Fat 4.3 10 3.8 10.1 34.9 60 
Fiber   4.0 -   
Moisture   <10 -   
 gm/kg kcal/kg gm/kg kcal gm/kg kcal/kg 
Maltodextrin 10 35 140   125 500 
Sucrose 350 1400   68.8 275 
Corn-starch 315 1260   0 0 
Monosaccharides   105    
Disaccharides 350  140  68.8  
Polysaccharides 385  278  125  
Kcal/gm 3.85 5.24 3.35 
Table 4.1. Comparison of diets used at the University of Otago (Column 1 and 3; LFD (D12450B) 
and HFD (D12492)) and the diet used at UTSouthwestern (Column 2; Chow Precision Pellets). Table 
displays available data provided by suppliers. 
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4.2.5 Acrophase analysis 
A very large amount of behavioural data has been collected over the course of this study, therefore 
finding reliable ways to analyse the meaning of this data had been challenging. In order to analyse the 
behavioural data, first a hypothesis is presented; feeding and running wheel activity in CD mice 
desynchronises throughout the course of the experiment, therefore mice under strict feeding regimens 
maintain synchrony. By assessing data by sight using ClockLab software, it was plain to see that there 
was a discrepancy in diurnal food intake between LD and CD animals that have been fed ad libitum. 
CD animals appear to consume more food during the light phase as emerged during the experiment. 
Therefore, if we compare the acrophase of the food intake rhythm and the running wheel activity 
rhythm, we should be able to see divergence of the two. Using RStudio to process the raw data allows 
us to work with very large data files in an instant and be consistent across the groups. First data was 
imported into RStudio for each animal, converted into Zeitgeber Time (ZT) and collated into the various 
groups. For each day, food intake data and running wheel data were fit to a sinusoidal term using 
regression: 
𝑦(𝑡) = 𝐴 ⋅ 𝑠𝑖𝑛(𝜔𝑡 + 𝜙) + 𝐶 
Where A is amplitude of the sinusoidal wave, ω is the frequency of that wave (24h in this case), t is the 
time variable (a single time point in the 24h cycle), ϕ is the phase (i.e., at what point the cosine waves 
passes through the y axis at t = 0), and C is the constant defining a mean area.  
Using the fit, we can then take the time at which the maximal value is reached (the acrophase) and 
compare this time point between the two measured variables (food intake and running wheel activity) 
(figure 4.3). This gives a difference in hours between the acrophase of food intake and that of running 
wheel activity. Taking this difference in time and plotting it as a cumulative value across the experiment 





Figure 4.3. Process in which data from the recording equipment is analysed within RStudio using R, to 






4.2.6 Exome sequencing 
Over the course of the study, it became apparent that some mice under the light cycle disruption had 
unexpected activity patterns. These were termed ‘NowShift’ mice (see results) and were characterised 
by an almost instantaneous shifting of activity pattern, following a shift in light cycle. This meant that 
the onset of activity was advanced by at least 3h or more, following a light cycle shift. Wildtype animals 
on the other hand were deemed as having a gradual shift in the onset of activity into the new light/dark 
cycle, averaging an advance of approximately 1h per day. The prevalence of ‘NowShift’ animals in all 
CD cycle groups was roughly 35% (6/24 in the ad lib group, 11/24 in the TR Night fed group and 8/24 
in the TR Locked fed group). Preliminary attempts were made to identify genetic differences using 
exome sequencing. 12 animals were selected based on the assessment of actogram activity (figure 4.4). 
On day 92 of the experiment, three days following the 15th phase shift, selected animals were moved 
into a separate room at ZT11. Animals were individually anaesthetised using Isoflurane via a precision 
vaporiser. Once animals were at a surgical level of anaesthesia, a 2 mm tail tip was sampled from each 
animal and placed in a collection tube. Sterile gauze pads were used in order to stem the flow of blood, 
and animals were placed back in their home cages and returned to their respective room. Tail tips were 
left in digestion buffer overnight at 65°C before being placed in RNase solution. 
Samples were then transferred into Phase Lock Gel Tubes (PLG Tubes) with the addition of Phenol-
Chloroform-Isoamyl solution (PCI, 25:24:1) and spun down for 5 minutes at 12,000g. Isopropanol was 
then added to the resulting aqueous solution, causing DNA to precipitate. DNA precipitate was washed 
in a stepwise manner using increasing concentrations of ethanol solution. Quantity and quality of gDNA 
was measured using a NanoDrop spectrophotometer (Thermo Scientific) and an Agilent TapeStation 














































































































































4.3.1 NowShift variant mice 
Over the duration of this study, it was found that a number of animals were not behaving in a typical 
way that was expected of C57BL/6J mice. This was in regard to how their running wheel behaviour 
reacted to the constantly changing lighting environment. Illustrated in figure 4.6, there are three separate 
actograms that are shown. Actograms are representations of running wheel and in this case, feeding 
activity, for an individual mouse. Each line indicates a 48-hour period of activity, and is double-plotted 
(i.e., 24-hour data is plotted twice). The actogram on the left-hand side is that of an animal under the 
LD cycle, fed ad libitum. The actogram in the middle of this figure is for a wildtype animal fed ad 
libitum. The black shaded boxes indicate the light/dark cycle and is therefore being advanced 
throughout the study as this animal is under the CD cycle. The black bars on each line indicate wheel 
running, and we find in this animal that its wheel running activity shifts gradually throughout the 
experiment, as the light cycle changes. A rough estimate would be that the period of activity is shifting 
by about one hour per day. In contrast, the actogram on the right-hand side represents an animal under 
the same lighting and feeding conditions, however, the activity of this animal appears to immediately 
shift (by approx. 6 hours) in accordance with the light cycle change. Therefore, animals that show this 
phenotype have been named as ‘NowShift’ mice. The prevalence of these animals in all CD cycle 
groups was roughly 35% (6/24 in the ad lib group, 11/24 in the TR Night fed group and 8/24 in the TR 
Locked fed group).  
Given this quite profound change in activity patterns, and the differences in many other metabolic 
measures, which will be explained subsequently, we believed that these animals would most likely have 
a variation within one of their genes that was contributing to this change. Therefore, we performed 




4.3.2 Exome sequencing 
Currently, a list of 42 variants that are the possible cause of the NowShift phenotype, have been filtered 
by hand, based on a number of criteria. Around 77,000 variants were found in the two groups of 
wildtype and NowShift animals. Of these, 16,391 were exclusive to the NowShift phenotype. 484 were 
identified to be exonic, with the potential to have an effect on protein coding. These 484 variants were 
then sampled using CircaDB (http://circadb.hogeneschlab.org/mouse, Hogenesch lab) in order to 
identify genes that display a circadian pattern in expression, resulting in 116 matches. Finally, variants 
with an allele depth of more than 20 for the variant itself revealed 42 variants that matched these criteria. 
This process is outlined in figure 4.7.  
gDNA from mice that had been identified to be either wildtype or ‘NowShift’ were pooled prior to 
exome sequencing, under the assumption that, because these animals are all inbred from the same strain, 
they will have near-identical DNA sequencing to their littermates, and therefore identification of the 
variant causing the ‘NowShift’ phenotype would be precisely evident. This is, however, not the case, 
Figure 4.5.  Representative double plotted actograms of mice under control lighting (LD cycle) or disrupted 
lighting (CD cycle) fed ad libitum (ad. lib). Each actogram is representative of a single mouse, black bars 
indicate running wheel activity and orange dots represent feeding. Wildtype (WT) mice under circadian 
disruption show a gradual shift in activity, caused by lighting shifts, of approximately 1 hour per day. Mice 
identified as ‘NowShift’ however, instantaneously shift their activity pattern into the new lighting schedule.  
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therefore, further analysis and processing of the exome sequencing data is needed in a way that takes 
into account a pooled data set.  
4.3.3 Impact of lighting and feeding paradigms on body weight and fat mass 
Animals were weighed every 6 days in order to assess changes in body weight across the entirety of the 
study. The previous studies to which this was based on involved weighing animals every single day, 
therefore this level of detail was no longer needed. From shift 13 onwards, half of the animals within 
each group had their wheels locked by obstruction within the cage. The results described below detail 
the comparisons of body weights between entire groups of animals, regardless of wheel status.  
The largest impact on body weight was found in ad libitum fed animals (figure 4.8, top row). Mice 
under LD cycle (LD ad lib) increased in body weight by 40.7 ± 4.1% from baseline. NowShift animals 
under CD cycle (CD ad lib NS) increased by 31.3 ± 6.2% from baseline and wildtype animals under 
77,626 variants identified by GATK between 
both wildtype and 'NowShift'
16,391 variants unique to 'NowShift' mice
484 exonic variants in 'NowShift' mice
116 variants for genes that display circadain 
oscillation (CircaDB, Hogenash Lab)
42 variants based on allele depth > 20  
Figure 4.6. Workflow of variant filtering from exome sequencing data of either wildtype or 
‘NowShift’ animals (GATK: Genome analysis tool kit) 
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the CD cycle (CD ad lib WT) increased body weight by 51 ± 5.3%. All body weight changes from 
baseline were highly significant (P < 0.001 for all three groups). Two-way ANOVA revealed a significant 
effect on body weight dependant on group (F (2, 45) = 7.52, P = 0.0015) and time (F (1, 45) = 182.6, P 
< 0.0001) with a significant interaction between the two variables (F (2, 45) = 3.83, P = 0.029). Post-
hoc analysis using Holm-Sidak’s multiple comparison test (alpha = 0.05) showed that ‘CD ad lib WT’ 
had a significantly higher body weight than both ‘LD ad lib’ (∆4.06g, P = 0.0072) and ‘CD ad lib 
NowShift’ (∆7.61g, P < 0.0001) mice at the final weight measurement (figure 4.9, top row). 
Additionally, ‘CD ad lib NowShift’ mice had a significantly lower body weight than ‘LD ad lib’ mice 
at termination (∆-3.55g, P = 0.015).  
Mice that were restricted to feeding only during the dark phase had similar body weights throughout 
the study (Fig 4.8, middle row). Mice under control lighting conditions (‘LD TR Night’) increased in 
body weight from baseline by 27.9 ± 4.3%. Mice under light cycle disruptions deemed wild type (‘CD 
TR Night WT’) increased by 21 ± 3.5% and those deemed NowShift (‘CD TR Night NS’) increased by 
23.6 ± 3.8%. Two-way ANOVA revealed no significant effect between groups F (2, 45) = 1.86, P = 0.17), 
a significant effect of time (F (1, 45) = 87.69, P < 0.0001) and no significant interaction effect between 
the two variables (F (2, 45) = 0.76, P = 0.47) (figure 4.9, middle row).  
Mice that had a 12 hour feeding window that was constantly moving, or locked to a fix time had the 
most variable body weight fluctuations given the nature of the feeding regimens (figure 4.8, bottom 
row). However, when comparing initial and final body weights, mice under LD cycle with shifting food 
access (‘LD TR Moving’) had a 17.9 ± 1.2% increase in body weight from baseline. Wildtype animals 
under light cycle disruption (‘CD TR Locked WT’) had a 23.8 ± 2.8% increase in body weight, and 
NowShift animals (‘CD TR Locked NS’) had a 19.0 ± 2.2% increase in body weight from baseline. 
Two-way ANOVA revealed no effect from group difference (F (2, 45) = 2.59, P = 0.085), a significant 
effect from time (F (1, 45) = 149.8, P < 0.0001) and no effect from interaction of the two variables (F 
(2, 45) = 1.56, P = 0.22) (figure 4.9, bottom row). Post-hoc analysis using Holm-Sidak’s multiple 
comparison test (alpha = 0.05) showed that ‘CD TR Locked WT’ mice had a significantly higher body 




Figure 4.7. Initial and final body weights of mice under differing either control lighting conditions (LD Cycle) 
or disrupted light conditions (CD Cycle). Groups are further split into groups that had their running wheels 
locked or kept unlocked. Mice fed ad. libitum differed the most in body weights; CD ad lib WT mice gained 
the most weight, over both LD ad lib and CD ad lib NS (top row). No differences were seen in the mice with 
feeding restricted to the night (TR Night, middle row). Finally, mice that had food availability shifting (LD 
Cycle TR Moving) or locked (CD Cycle TR Locked) showed only a small increase in body weight gain in CD 
TR Locked WT animals, when both locked and unlocked wheels were grouped together. Data show mean ± 
standard error of the mean. * P < 0.05. For all results with the same letter, the difference between the means is 





Figure 4.8. Body weight trajectory of mice subjected to multiple different paradigms. Data is shown as mean ± 
standard error of the mean for each group. Mice were fed either ad. libitum (ad lib), restricted to the dark phase 
(TR Night) or had feeding locked to a 12h window (TR Locked) or a 12h window that shifted by 6 h every 6 
days (TR Moving). Mice were further subjected to either control (LD cycle) light cycle or disrupted (CD cycle) 
light cycle. Mice in the CD groups are further separated by phenotype, either wildtype (WT), or NowShift (NS). 
From shift #13 onwards, half the animals from each group had their wheels either locked or were to remain 
unlocked. This is indicated by the greyed-out areas of the graph, the first grey column showing the average body 




Fat mass was analysed at two different time points within the study. The first occurred following the 
15th phase shift, and the second at the termination of the experiment (figure 4.10). At the initial time 
point, there was significant group-wise effect on percentage body fat, as measured by two-way ANOVA 
within the ad libitum fed animals (F(2, 27) = 5.242, P = 0.0119) (figure 4.10, left column). This was an 
increase in body fat percentage in wildtype light cycle disrupted animals, in comparison to animals 
under a control light cycle. This variation persisted at termination (F(2, 42) = 7.224, P = 0.0020). Across 
both time points, there was no effect seen from whether the wheels were locked or not (first time point: 
F(1, 27) = 1.012, P = 0.323; termination: F (1, 42) = 4.012, P = 0.051) and no interaction between the 
two variables (first time point: F(2, 27) = 0.7718, P = 0.4721; termination: F(2, 42) = 0.115 P = 0.8910). 
In animals fed only during the dark phase, two-way ANOVA revealed no variance between these three 
groups in percentage body fat at either time point (first: F (2, 26) = 0.430, P = 0.66), termination: F (2, 
42) = 1.011, P = 0.37) (figure 4.10, middle column). At both time points, there was no effect from wheel 
status (first: F (1, 26) = 3.66, P = 0.066, termination: F (1, 42) = 3.20, P = 0.081). No significant 
Figure 4.9. Comparison of fat percentage across all groups at two different time points. The first at shift 
number 15 and the second at termination. Each graph shows three different graph; mice under control lighting 
conditions (LD cycle), mice under light cycle disruption deemed wild type (CD WT) and mice under light 
cycle disruption deemed NowShift (CD NowShift). Results show mean ± standard error of the mean.  # P < 




interaction between the variables was found at either time point (First: F (2, 26) = 0.55, P = 0.58, 
Termination: F (2, 42) = 0.095, P = 0.91). 
For the final feeding paradigms (‘LD TR Moving’ and ‘CD TR Locked’), two-way ANOVA revealed no 
variance in percentage body fat between groups at either time point (first: F (2, 30) = 2.11, P = 0.14, 
termination: F (2, 41) = 2.88, P = 0.068) (figure 4.10, right column). Whether the wheels were locked 
or not had a significant effect on % body fat at both time points (first: F (1, 30) = 8.25, P = 0.0074, 
termination: F (1, 41) = 15.45, P = 0.0003). No significant interaction between variables was found at 





4.3.4 Food intake and running wheel activity 
4.3.4.1 Ad libitum fed animals 
Animals under LD conditions and fed ad libitum displayed robust diurnal variation in both running 
wheel activity and feeding activity throughout the entirety of the experiment (figure 4.11, 4.12). 
Although total running wheel counts diminished across the experiment, food intake remained constant 
at approximately 16 pellets a day.  
Mice fed ad libitum and kept under a disrupted light cycle (CD cycle) show an increased amount of 
feeding activity during the dark phase as the experiment progressed (figure 4.13, 4.14, 4.15, 4.16). This 
is apparent in the latter half of the experiment (days 97-160) in which a higher proportion of food intake 
is being conducted during the light phase. This was particularly apparent in wildtype animals, as diurnal 
rhythm in food intake appears to be further lost as the experiment runs on. However, in the NowShift 
animals, the diurnal variation that is lost between days 5-15 and 16-90 is not lost further at days 97-160. 
Total activity diminishes in both wildtype and NowShift animals. However, wildtype animals appear 
to undertake activity at later times during the dark phase in comparison to their baseline measurement 
at 5-15 days. This is not seen in NowShift animals, as diurnal rhythmicity in running wheel activity 
remains consistent at all three time periods. What is also evident in these animals is the effect of each 
light cycle shift. Stark reductions in both daily food intake and daily running wheel activity occur at 
random light cycle shifts. This leads to daily food intake counts being far more variable, and in a much 
wider range, in comparison to LD animals.   
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LD ad libitum fed animals 
Figure 4.10. Running wheel activity (top line) and food intake (bottom line) of LD animals fed ad 
libitum. Left column shows daily activity counts (revolutions/day) and food intake (pellets/day) across 
the entire experiment. Right column shows a 24h profile of activity and a 24h profile of food intake, 
averaged across 3 periods of time in the experiment (indicated in legend and as solid bars along the x 
axis of the graphs in the left column). Results show mean values for each group. Animals show a decline 
in activity across the experiment (top left); however, the rhythmicity of their activity remains constant 
(top right). Total food intake remains relatively constant across the experiment (bottom left), and diurnal 




Figure 4.11. Plotted acrophase for both food intake and running wheel activity for LD mice fed ad 
libitum, across the entire experiment (left). Animals display acrophase that is roughly between food 
intake and activity patterns throughout the experiment. Absolute difference in hours between the 
acrophase in food intake, and the acrophase of running wheel activity (right)
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Wildtype CD ad libitum fed animals 
 
Figure 4.12. Running wheel activity (top line) and food intake (bottom line) of CD animals fed ad 
libitum. Left column shows daily activity counts (revolutions/day) and food intake (pellets/day) across 
the entire experiment. Right column shows a 24h profile of activity and a 24h profile of food intake, 
averaged across 3 periods of time in the experiment (indicated in legend and as solid bars along the x 
axis of the graphs in the left column). Results show mean values for each group, red arrows indicate 
when a lighting shift took place. Animals show a decline in running wheel activity across the 
experiment (top left) as well as a shift in the average activity patterns across 24 hours (top right). Total 
food intake per day remains consistent across the experiment (bottom left), however, diurnal food intake 




Figure 4.13. Plotted acrophase for both food intake and running wheel activity for CD mice fed ad 
libitum with wildtype phenotype, across the entire experiment (left). Absolute difference in hours 
between the acrophase in food intake, and the acrophase of running wheel activity (right), which appear 
to increase across the experiment. Results show mean data.
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NowShift CD ad libitum fed animals 
 
Figure 4.14. Running wheel activity (top line) and food intake (bottom line) of CD animals fed ad 
libitum with the NowShift phenotype. Left column shows daily activity counts (revolutions/day) and 
food intake (pellets/day) across the entire experiment. Right column shows a 24h profile of activity and 
a 24h profile of food intake, averaged across 3 periods of time in the experiment (indicated in legend 
and as solid bars along the x axis of the graphs in the left column). Results show mean values for each 
group, red arrows indicate when a lighting shift took place. Running wheel activity appears to be more 
variable across the experiment (top left), however activity patterns remain unchanged (top right). Food 
intake remains constant throughout the experiment (bottom right). Food intake diurnal rhythmicity is 





Figure 4.15. Plotted acrophase for both food intake and running wheel activity for NowShift CD mice 
fed ad libitum, across the entire experiment (left). Activity acrophase shifts far quicker in comparison 
to wildtype animals of the same group, due to the instantaneous shifting phenotype of the NowShift 
animals. Absolute difference in hours between the acrophase in food intake, and the acrophase of 
running wheel activity (right). Results show mean values for each group, red arrows indicate when a 




4.3.4.2 TR Night Fed animals 
Mice that were fed during a 12h window throughout the dark period display differing results to those 
fed ad. libitum. It is important to take the mechanics of the food hopper system into account, to best 
explain these results. At the end of the feeding window, if a pellet has dropped, and not been taken by 
the mouse, it will sit in the top of the cage until it is removed, and once taken, the feeder will record 
this time. This means that there is the potential for a pellet to be available outside of the feeding window, 
and therefore can be taken at any time point throughout the following 12 hours. That being said, mice 
under the LD cycle show a very clear discrepancy between night time feeding and daytime feeding 
(figures 4.17 and 4.18). Mice under the CD cycle show a peculiar phenomenon, where most food 
consumption is during the dark period, when food is readily available (figures 4.19, 4.20, 4.21, 4.22). 
However, the last pellet of food is often left until the 6th hour of the light cycle, when these mice appear 
to wake up at this exact time point and consume the final pellet that has been sitting in the hopper from 
the previous night. This phenomenon becomes more apparent as the experiment comes to its conclusion, 




LD TR Night fed animals 
 
Figure 4.16. Running wheel activity and food intake profile of LD animals fed exclusively during the 
dark phase. Left column shows daily activity counts (revolutions/day) and food intake (pellets/day) 
across the entire experiment. Right column shows a 24h profile of activity and a 24h profile of food 
intake, averaged across 3 periods of time in the experiment (indicated in legend and as solid bars along 
the x axis of the graphs in the left column). Results show mean values for each group.  Running wheel 
activity is variable throughout the experiment (top left), however diurnal rhythmicity is maintained 
throughout the experiment (top right). Daily food intake diminishes in the first half of the experiment, 
then reaches a plateau towards the second half (bottom left). Due to animals being restricted to night 




Figure 4.17. Plotted acrophase for both food intake and running wheel activity for LD mice fed 
exclusively during the dark phase, across the entire experiment (left). Absolute difference in hours 
between the acrophase in food intake, and the acrophase of running wheel activity (right). The 
difference between the acrophase of each zeitgeber remains constant throughout the study, unlike in 
animals fed ad libitum. Results show mean values. 
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Wildtype CD TR Night fed animals 
 
Figure 4.18. Running wheel activity and food intake profile of wildtype CD animals fed exclusively 
during the dark phase. Left column shows daily activity counts (revolutions/day) and food intake 
(pellets/day) across the entire experiment. Right column shows a 24h profile of activity and a 24h profile 
of food intake, averaged across 3 periods of time in the experiment (indicated in legend and as solid 
bars along the x axis of the graphs in the left column). Results show mean values for each group, red 
arrows indicate when a lighting shift took place. Daily activity is extremely variable throughout the 
study (top left), with a trend towards greater activity in the later dark phase as the experiment progresses 
(top right). Daily food intake is also variable (bottom right); however, diurnal rhythmicity of food intake 




Figure 4.19. Plotted acrophase for both food intake and running wheel activity for wildtype CD mice 
fed exclusively during the dark phase, across the entire experiment (left). Absolute difference in hours 
between the acrophase in food intake, and the acrophase of running wheel activity (right). Food intake 
acrophase is more confined to the dark phase, despite the multiple light cycle shifts. Results show mean 
values, red arrows indicate when a lighting shift took place.
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NowShift CD TR Night fed animals 
 
Figure 4.20. Running wheel activity and food intake profile of NowShift CD animals fed exclusively 
during the dark phase. Left column shows daily activity counts (revolutions/day) and food intake 
(pellets/day) across the entire experiment. Right column shows a 24h profile of activity and a 24h profile 
of food intake, averaged across 3 periods of time in the experiment (indicated in legend and as solid 
bars along the x axis of the graphs in the left column). Results show mean values for each group, red 
arrows indicate when a lighting shift took place. Daily activity is maintained across the experiment (top 
left), as well as the diurnal rhythmicity in the activity itself (top right). Daily food intake is maintained 
across the experiment (bottom left) and diurnal rhythmicity is maintained due to the temporal restriction 




Figure 4.21. Plotted acrophase for both food intake and running wheel activity for NowShift CD mice 
fed exclusively during the dark phase, across the entire experiment (left). Absolute difference in hours 
between the acrophase in food intake, and the acrophase of running wheel activity (right). Results show 
mean values for each group, red arrows indicate when a lighting shift took place.
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4.3.4.3 TR Moving and TR Locked Fed Animals 
Mice that were fed either during a 12h window that was advanced by 6 hours every 6 days (LD Cycle 
TR Moving) (figure 4.23, 4.24) or locked to a 12h window regardless of shifting light cycle (CD TR 
Locked) showed an interesting pattern in both feeding and running wheel activity (figure 4.25, 4.26, 
4.27, 2.28). LD TR Moving mice concentrated their feeding closer to the dark phase in most cases. The 
activity pattern was also somewhat disturbed, in which, when food was available from ZT 6 to ZT 18, 
mice would increase running wheel activity in the later light phase (~ZT 8 – 12). Normally, running 
wheel activity is completely abolished during the light phase in mice, however, this feeding regimen 
was able to initiate running activity during these times. In CD TR Locked mice, feeding activity patterns 
generally concentrated around the times of the dark phase, similar to what is seen in the LD TR Moving 
group. Peak activity strictly followed the shifting lighting cycle, however, more activity during the light 
period was seen in the animals, in comparison to LD TR Moving animals. Interestingly, fat mass data 
showed in these mice that locking the running wheel had an effect of increased amount of fat mass in 
relation to body weight. This suggests that these animals are heavily reliant on the running wheels to 




LD TR Moving fed animals 
 
Figure 4.22. Running wheel activity and food intake profile of LD animals fed for a 12-hour period 
which shifted by 6 hours every 6 days throughout the experiment. Left column shows daily activity 
counts (revolutions/day) and food intake (pellets/day) across the entire experiment. Right column shows 
a 24h profile of activity and a 24h profile of food intake, averaged across 3 periods of time in the 
experiment (indicated in legend and as solid bars along the x axis of the graphs in the left column). 
Results show mean values for each group. Daily activity reduced across the experiment (top left), with 
a slight disturbance in the diurnal rhythmicity of activity pattern across the experiment (top right). Daily 
food intake was variable, due to the constantly rotating food access window (top left). Food intake was 





Figure 4.23. Plotted acrophase for both food intake and running wheel activity for LD mice fed at a 
fixed 12-hour period, which shifted throughout the entire experiment (left). Absolute difference in hours 
between the acrophase in food intake, and the acrophase of running wheel activity (right). Food intake 
acrophase shifted across the experiment as the food access window constantly changed. This meant that 




Wildtype CD TR Locked fed animals 
 
Figure 4.24. Running wheel activity and food intake profile of wildtype CD animals fed for a fixed 12-
hour period throughout the experiment. Left column shows daily activity counts (revolutions/day) and 
food intake (pellets/day) across the entire experiment. Right column shows a 24h profile of activity and 
a 24h profile of food intake, averaged across 3 periods of time in the experiment (indicated in legend 
and as solid bars along the x axis of the graphs in the left column). Results show mean values for each 
group, red arrows indicate when a lighting shift took place. Daily activity dramatically decreased across 
the experiment (top left), however, no obvious change in the diurnal rhythmicity of this activity was 
observed (top right). Daily food intake decreased slightly throughout the experiment (bottom left), with 




Figure 4.25. Plotted acrophase for both food intake and running wheel activity for wildtype CD mice 
fed at a fixed 12-hour period, across the entire experiment (left). Absolute difference in hours between 
the acrophase in food intake, and the acrophase of running wheel activity (right). Activity acrophase 
shifted with each light cycle shift, however food intake acrophase was almost always disconnected, due 
to the food access window allowed for these animals. Results show mean values, red arrows indicate 




NowShift CD TR Locked fed animals 
 
Figure 4.26. Running wheel activity and food intake profile of NowShift CD animals fed for a fixed 
12-hour period throughout the experiment. Left column shows daily activity counts (revolutions/day) 
and food intake (pellets/day) across the entire experiment. Right column shows a 24h profile of activity 
and a 24h profile of food intake, averaged across 3 periods of time in the experiment (indicated in legend 
and as solid bars along the x axis of the graphs in the left column). Results show mean values for each 
group, red arrows indicate when a lighting shift took place. Daily activity reduced across the experiment 
(top left), with no effect seen on diurnal rhythmicity of activity patterns (top right). Daily food intake 
decreased slightly throughout the experiment (bottom left) and food intake was concentrated to the dark 




Figure 4.27. Plotted acrophase for both food intake and running wheel activity for NowShift CD mice 
fed at a fixed 12-hour period, across the entire experiment (left). Absolute difference in hours between 
the acrophase in food intake, and the acrophase of running wheel activity (right). In comparison to 
wildtype animals of the same group, these NowShift animals show a smaller acrophase difference 
between activity and food intake, when the window of food access aligned with the light/dark cycle. 
Results show mean values for each group, red arrows indicate when a lighting shift took place. 
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4.3.5 Food intake and Running Wheel Synchrony 
To assess the relationship in diurnal rhythmicity of food intake and running wheel activity in the mice, 
the acrophases of these measured variables were calculated and compared. Acrophase is calculated by 
fitting a cosine wave to the data using regression and taking the time at which the wave is at its zenith. 
The cumulative absolute difference between the two acrophases, per day, has been used to identify the 
synchrony between these two measures. This means that a greater disparity between the acrophases of 
activity and food intake would give a larger value and would suggest that these two biological rhythms 
are out of phase with one another. 
In animals fed ad libitum, LD cycle animals show a smaller difference between activity and food intake 
acrophases, when compared to both CD cycle groups (figure 4.29). The cumulative slope of LD animals 
is less steep in comparison to CD cycle animals, indicating a smaller difference between the acrophase 
LD ad lib. 
CD ad lib. WT 
CD ad lib. NowShift 
LD ad lib. 
CD ad lib. WT 
CD ad lib. NowShift 
Figure 4.28. Absolute difference in hours, between the acrophase of food intake activity and running 
wheel activity in mice fed ad libitum (top). Cumulative absolute difference in the acrophase of food 
intake activity and running wheel activity in mice fed ad libitum (bottom). Animals under light cycle 
disruption show greater difference in acrophase between food intake and activity rhythms, in 




of food intake and running wheel activity. Between wildtype and NowShift animals, the cumulative 
difference between food intake and running wheel acrophase is similar across the experiment.  
In animals fed only during the dark phase, food intake and running wheel rhythms appear to be more 
dissociated in comparison to animals fed ad libitum (figure 4.30). Cumulative difference in LD TR 
Night animals was much higher in comparison to LD ad libitum fed animals at the termination of the 
experiment (~130 hours cumulative for LD TR Night versus ~70 hours cumulative for LD ad libitum). 
In CD NowShift animals, a similar trend was seen, where the absolute cumulative difference was much 
higher. This could potentially be caused by the rapid resetting that occurs in their running wheel activity, 
and a slower resetting of food intake rhythm. CD wildtype animals on the other hand appear to initially 
have an increased absolute cumulative difference but end with a similar trajectory to their ad libitum 
fed counterpart. Between the three groups that had food restricted to the dark phase, CD TR Night WT 
animals show the least difference in activity and food intake rhythms, whereas LD TR Night and CD 
TR Night WT animals end with similar values. 
Two groups of animals were not analysed in this way, due to the convoluted nature of their feeding 
regimes. Both LD TR Moving and CD TR Locked groups have greatly divergent food intake patterns, 
with the intention of causing continuous desynchrony. Attempting to analyse synchronous patterns 




Figure 4.29. Absolute difference in hours, between the acrophase of food intake activity and running 
wheel activity in mice fed during the dark phase (TR Night) (top). Cumulative absolute difference in 
the acrophase of food intake activity and running wheel activity in mice fed during the dark phase 
(bottom). Wildtype animals under light cycle disruptions show a reduction in the difference between 
acrophase of food intake and activity rhythms, towards the latter half of the study. Data show mean 
values for each group. 
LD TR Night 
CD TR Night WT 
CD TR Night NowShift 
LD TR Night 
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To determine the effects of light cycle disruption on both activity and food intake, mice were housed 
under a constantly shifting light cycle and granted food access at differing times. We aimed to identify 
the relationship between activity and food intake patterns, and how disruptions cause these two 
measured variables to become out of sync. Despite what we set out to do initially, there were many 
necessary alterations that played a role in shaping the experimental outcome. One was the instance in 
which almost 35% of the animals displayed a differing phenotype in terms of circadian entrainment, 
termed herein as NowShift animals. Additionally, running wheel access was removed in 50% of the 
mice halfway through the experiment, as results were not found to be consistent with earlier results. 
There was a significant difference in body weight and fat mass observed between ad libitum fed animals 
under control light cycle, as opposed to wildtype animals under the disrupted light cycle.   
4.4.1 NowShift animals 
In almost 35% of the animals within the CD cycle, we discovered an alternate phenotype being 
displayed. This phenotype was in reference to the way that the animals would entrain their running 
wheel activity to the new lighting environment. This was initially problematic given the fact that we 
had a large reduction in the number of animals that were viable for our original study. Nonetheless, it 
provided an interesting and unexpected finding. Light entrainment of the SCN occurs via light 
activation of photosensitive retinal ganglion cells (ipRGCs) which has been described in Chapter 1 
Section 1.1.3. Importantly, there is a mechanism of feedback control that ensures entrainment of the 
SCN can only occur at 1 hour per day. 
Several mouse models have been identified as having an absence of this negative control, in which 
phase advances and phase delays in light cycle are accompanied by an almost immediate entrainment. 
Salt inducible kinase 1 (SIK1) knockdown animals display an enhanced rate of entrainment to an 
advanced lighting schedule (61). This was found to be mediated by the CREB-regulated transcription 
coactivator 1 (CRTC1) which acts alongside CREB to cause transcription of both Per1 and Sik1. SIK1 
then in turn inhibits Per1 transcription by deactivation of CRTC1. Additionally, mice deficient in 
arginine vasopressin (AVP) V1a and V1b receptors also show a similar phenotype (164). These animals 
134 
 
entrain almost immediately to a new lighting environment, via a mechanism that is not yet fully 
understood, but is likely mediated by AVP interneuronal communication within the SCN itself.  
Our NowShift animals were displaying the exact same activity as observed in the two examples above. 
However, following sequencing of the exome in our NowShift animals, it was evident that there was 
no variation in the Sik1, AVPR1A or AVPR1B genes, therefore ruling out the possibility of the same 
mutation. Despite the vast number of variants that were identified in the NowShift animals, no particular 
genetic variations stood out as being likely to cause such a phenotype. Due to this, further analysis of 
the exome of these animals is needed to identify exactly what is causing this condition.  
4.4.2 Running wheel access 
Mice given access to running wheels as opposed to sedentary controls, show an advancement of several 
biological rhythms (135). This includes body temperature, with a marked elevation in the early hours 
of the night, due to immediate initiation of wheel running. Genes of the molecular clock including 
Bmal1 in the liver and Per1/2 in WAT were also advanced significantly, with a trend of advancement 
in the acrophase of most other core clock genes in various peripheral tissues. Perhaps therefore, animals 
subjected to advancements of light cycle would benefit from access to running wheels, in comparison 
to those that are sedentary, in terms of maintaining a healthy weight. Furthermore, a phase delay in light 
cycle could have a more detrimental impact on animals that have become accustomed to voluntary 
wheel running. Davidson and others originally showed that phase advances were more detrimental to 
aged mice survival, than phase delays, however, this data may be challenged, if mice are given access 
to running wheels (275). In this study, access to running wheels was believed to be contributing factor 
to the lack of weight gain that was expected in animals subjected to light advancements, given our 
previous results (246). It is possible that this phase advancing effect of running wheel activity has 
contributed to this lack in consistency. At the time of the 12th phase shift, a decision was needed to 
either end the experiment at the time point that was originally planned, or to extend the experiment 
under different experimental conditions. It was only until animals were denied access to running wheels, 
by locking running wheels, that weight effects were observed in mice fed ad libitum (figure 4.8).  
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 4.4.3 Body weight and fat mass 
Animals subjected to CD cycle showed an increase in body weight above those under LD cycle, 
specifically in animals fed ad libitum. This is in line with previous results by ourselves and others, that 
show light cycle disruptions to be directly detrimental to body weight regulation (246,263). In addition 
to this, we found that these animals had an increase in fat mass, relative to their body weight, in 
comparison to those under the control light cycle. These results were exclusive to animals displaying 
the wildtype phenotype, whereas those displaying the NowShift phenotype were protected against 
weight gain and increases in fat proportions. This increase in fat mass suggests that lighting disruptions 
cause body weight changes through an increase in fat mass within these mice. 
We hypothesised that this body weight dysregulation was caused in part by internal desynchrony of 
central and peripheral clocks. To combat this, we introduced a time-restricted feeding paradigm to 
animals under CD cycle, in which food was restricted to the dark phase. These animals did not show 
any differences in body weight in comparison to animals fed during the dark phase under the LD cycle. 
The rationale behind this decision was to force animals under CD cycle to conform to eat food only 
during their active phase. Previous studies have found that feeding enhances phase-shifting of mPer2 
mRNA expression in the heart, as well as accelerating the entrainment of running wheel activity to a 
new light/dark cycle (335). We believe that the overall outcome of this procedure forces both the activity 
rhythms and food intake rhythms to be synchronous with one another, leading to an internal 
environment that is closer to that of an animal under a control light cycle. 
4.4.4 Food intake vs light zeitgebers 
We aimed to compare the effect of light cycle disruptions or food intake disruptions on the endogenous 
circadian system in mice, and their relative impact on metabolism. We have shown that light cycle 
disruptions have a negative impact on metabolism, increasing body weight, fat composition and 
dysregulating glucose homeostasis. To assess the effect of disrupting the zeitgeber food, we challenged 
a cohort of mice to a shifting food intake paradigm. These animals were kept under a control light cycle 
of 12h/light 12h dark had a 12h window of food intake shifted by 6h every 6 days, analogous with the 
rotating light cycle (LD TR Moving). These animals had an increase in body weight of 17.9 ± 1.2 %. 
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When comparing this to animals fed ad libitum under a control light cycle (LD ad lib) that gained 40.7 
± 4.1%, there is a drastic difference in the amount of weight gain. This could be explained by a reduction 
in total food intake across the experiment. This food intake reduction is most possibly due to the 
inability of the mouse to predict food timing, due to access shifting across the experiment, as well as a 
restriction in food access to 12 hours. Our original aim of this experiment was to assess the endogenous 
circadian system at a molecular level by quantifying mRNA expression of circadian-related genes in 
both central and peripheral tissue. Our hypothesis, based on the current literature, proposed that light 
cycle disruption will have the biggest effect on the circadian rhythms of the SCN and other central 
nuclei, with the peripheral tissue lagging behind (344). Whereas disrupting the food intake cycle would 
affect the circadian rhythms of peripheral tissue, with little to no effect on central tissue (99). Brain 
tissue has been collected and processed for quantification of mRNA expression in the brains of these 
animals, however, circumstances beyond our control has meant that we could not perform the labour 
intensive in situ hybridisation experiments.  
In summary, the present study provides strong evidence that disruptions to the lighting environment 
have a direct effect on body weight regulation. Analyses of feeding and running wheel behaviour 
suggests that this is most likely caused by a desynchronisation of these two rhythms, likely causing 
internal desynchrony between both central and peripheral pacemakers. To prevent this, we introduced 
a time restricted food access, in order to maintain internal synchrony. Time restricted food access was 
sufficient to abrogate any weight gain that may have been caused by light cycle disruptions. In relation 
to humans who are complicit to light cycle disruptions, adjusting eating habits in order to maintain 






Chapter 5 : General Discussion 
5.1 The effect of light cycle disruption on metabolic hormone 
signalling – implications for human health 
We have described in detail the negative impact that light cycle disruptions have in mice. This was 
shown through perturbations in both leptin and insulin signalling pathways within the brain, as well as 
physiological effects on body weight and glucose homeostasis. We find these results in animals that 
have been held under a controlled environment, however, the question of how this relates to humans is 
still to be understood. Therefore, the following sections focus on the implication that these results have 
on human health.  
In the present study, it was shown that circadian perturbations can cause a disruption to hormonal 
signalling in the brain, specifically leptin and insulin signalling. Leptin treatment was unable to induce 
similar numbers of phosphorylated signal transducer and activator of transcription 3 (pSTAT3) 
responsive cells in the arcuate nucleus (ARC) of disrupted animals when compared to control animals. 
On the other hand, insulin was more potent to induce the number of phosphorylated Akt (pAkt) 
responsive cells in disrupted animals in comparison to control mice. Other affects caused by chronic 
light cycle disruption included body weight gain, and metabolic dysregulation, processes that are 
influenced by both leptin and insulin signalling.  
Leptin signalling is an integral part of energy homeostasis, a function which is conserved across 
mammalian species (345). Leptin is secreted into the blood stream from adipocytes, in a circadian 
manner (347), in proportion to adipose mass. Leptins binds to its receptor within regions of the 
hypothalamus in order to carry out its most important role, the regulation of food intake and energy 
expenditure (188). In metabolic diseases such as diet-induced obesity, resistance to central leptin 
signalling is thought to be a main factor in the exacerbation of the condition (198). However, it is 
contentious as to what the mechanism is that causes this resistance. There is an increase in suppressor 
of cytokine signalling 3 (SOCS3) within the neurons of the arcuate nucleus that coincides with leptin 
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resistance. However, it is thought that in diet induced obesity (DIO), a high amount of leptin in the 
blood contributes to the resistance seen in the brain. Research from our laboratory has identified a 
circadian component in the sensitivity of the ARC towards leptin signalling (348). The activation of 
STAT3 in the ARC was increased during the beginning of the light-, as opposed to the beginning of the 
dark cycle, whereas the opposite was true for animals fed a high fat diet. This implicates a circadian 
sensitivity to leptin at the level of the ARC, in which disruptions in the rhythmic release of leptin, may 
have a negative impact to central energy homeostasis. 
In our mouse model, we demonstrate that central leptin signalling is sensitive to circadian perturbations. 
Furthermore, these disruptions actually caused a deficit in leptin signalling that is similar to that of diet 
induced obesity, in which leptin signalling is not as effective in the ARC. Therefore, it is likely that 
individuals that are exposed to circadian perturbations will concede a negative impact on their leptin 
signalling system. Although it is difficult to analyse leptin signalling in the brains of these individuals, 
we can infer from the multitude of studies that show an increased prevalence of obesity in these 
individuals, that leptin resistance, caused by circadian disruption, is a likely contributing factor  
Central insulin signalling is thought to regulate glucose production in the liver (252) and regulate 
adipose tissue lipolysis (349). This is achieved via Akt/PI3K signal transduction and eventual activation 
of KATP channels in insulin receptor (IR) containing neurons of the hypothalamus. An increase in central 
signalling suppresses hepatic glucose production via the vagal nerve, leading to a decreased plasma 
glucose level (252). We found that mice that were subjected to light cycle disruptions had an increased 
response to insulin within the ARC. This was accompanied by an increase in plasma glucose levels, 
despite any change in circulating insulin levels. Interpreting this result has been complicated, but the 
increased insulin response in the brain is possibly a compensatory mechanism to the increased glucose 
levels. Results from chapter 2 show an increase in pAKT, but an increase in the inhibition of the 
upstream pathway at IRS1. Therefore, we can speculate that a third-party mechanism is driving this 
increase in pAKT, in response perhaps to elevated glucose levels, and diminished insulin signalling at 
the receptor. Whether or not this is clinically relevant in humans, remains to be addressed. Studies have 
suggested that increased insulin in the cerebrospinal fluid (CSF) by intranasal delivery, leads to 
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decreased food intake and lowers plasma glucose levels in humans (350). Again, intranasal insulin was 
shown to have a glucose lowering effect, as well as improving whole-body glucose homeostasis in lean 
men (351). In obese subjects however, the insulin sensitising effects were not detected. Researchers 
believed this response to be mediated by the parasympathetic output, as it correlated with a change in 
the high-frequency band of heart rate variability, as well as having an action in the hypothalamus, as 
assessed by functional magnetic resonance imaging. Diazoxide, a common treatment for low blood 
sugar, was shown to activate KATP channels in humans, and consequently lower glucose production 
(352). A follow up study by the same group showed that this effect is lost in patients with type 2 diabetes 
(353). This provided evidence that central insulin signalling was effective in the control of endogenous 
glucose production, and a disease such as type 2 diabetes negatively impacted this response within the 
brain. We have shown in a mouse model that insulin signalling is altered under light cycle disruption. 
If this can be translated to humans, those who undergo shift work have the potential to have altered 
central insulin signalling, leading to disrupted endogenous glucose production. Further investigation 
into the exact extent of central insulin signalling and subsequent control, is needed to examine how 
severe light cycle disruptions could affect humans.  
5.2 Circadian regulation of the glucoregulatory system 
We compared glucose tolerance in mice that were subjected to light cycle disruptions with those under 
control light cycle conditions. This experiment was designed based on the previous result, in which 
mice that were exposed to light cycle disruption had elevated fasting blood glucose levels almost 3-fold 
higher than controls. Through multiple glucose tolerance tests, it was determined that animals under 
light cycle disruptive conditions had impaired glucose tolerance compared to mice on a control light 
cycle.  
Glucose regulation is far easier to test in humans, as opposed to central hormonal signalling. There is a 
large number of studies that have looked at the effects of lighting and circadian disruptions on glucose 
regulation specifically. However, one factor that often confounds these studies is the loss of sleep that 
is experienced by participants. Chronic sleep loss experienced by shift workers is associated with 
impaired glucose tolerance and cardiovascular strain (354-356). As well as this, shift workers often 
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undergo misalignment of their sleeping patterns. An elegant study conducted in 2014 sought to identify 
the relationship of circadian misalignment and glucose tolerance, while being able to correct for the 
confounding effect of sleep loss (149). Researchers sleep restricted both control and circadian 
misaligned subjects and found that those who were misaligned had an impaired glucose tolerance. Prior 
studies had provided evidence for this loss in glucose tolerance by circadian misalignment, however, 
associating it as well to a loss of sleep (151,357).  
Our study was able to confirm the results obtained in the mouse model to be in line with results seen in 
humans, as glucose tolerance was impaired in these light cycle disrupted animals. We have shown that 
insulin signalling is altered in the brain under a light disruptive environment. . Animal studies have 
pointed towards cells of the pancreas being greatly dysregulated under circadian disruption, causing 
loss of glucose stimulated insulin release (GSIS) (238,286,317). Evidence in the literature suggests that 
human pancreatic cells contain an endogenous clock (358), and a study similar to the mice work using 
a small interfering RNA-mediated knockdown of CLOCK also showed a loss in GSIS in humans (359). 
Further attention must therefore be drawn to peripheral tissues when understanding the mechanism 
behind the loss of glucose homeostasis in individuals with compromised circadian rhythms. 
5.3 Food intake and behavioural rhythms 
Previous experiments have focused on the disruption of the light zeitgeber, and the consequences this 
has on metabolic health. Other zeitgebers exist, such as temperature, social interaction and food intake. 
The integration of these various cues within the body is thought to be driven mainly by the central 
circadian clock of the SCN (360). However, molecular clocks are found across an array of both central 
and peripheral tissue (12). Restricting food access to certain periods of the day has a profound effect on 
both physiology and behaviour. In mice, food access during the light phase only, causes a disruption to 
cyclical clock genes in peripheral tissue, while having no effect on the SCN (99). In a human based 
study, a 5hr delay of food timing resulted in a shift in the expression of Per2 mRNA rhythms in adipose 
tissue, accompanied additionally with a shift in plasma glucose rhythms (361). The delay in food intake 
had no effect on SCN outputs, however, measured by melatonin and cortisol release. Humans and mice 
therefore seem to share this commonality, in which timing of food intake can have profound effects on 
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the molecular clocks of the peripheral tissue, without altering the central circadian clock. Therefore, it’s 
likely that in humans, central and peripheral clocks can become out-of-sync with one another, in times 
of circadian disruption, likely causing the multitude of health problems that have been observed.  
In the present study, we aimed to investigate the role of both the zeitgebers light and food on the 
circadian control of metabolism. We found that light cycle disruptions were sufficient to cause a 
negative impact on metabolism, specifically in body weight and increased body fat. We found that a 
dissociation of food intake and activity rhythm progressed in animals under disruptive conditions. 
Qualitative studies have addressed the relationship between shift work and food intake in humans, 
describing interruptions and often skipped meals during shift work (362). Snacking behaviours 
throughout a nightshift were also described, due to increased food cravings and caffeine consumption. 
A study that addressed the question of whether food timing contributed to cardiometabolic syndrome, 
found that night-shift workers were more at risk (363). Night-shift workers had a higher consumption 
of food intake during work nights, as opposed to days-off, and this was associated with increased lipid 
levels, independent of food composition. Dietary Inflammatory IndexTM (DII) score was recorded for 
each group, however no difference was seen in this particular study. This was in contrast to a previous 
study that found a difference in DII between night-shift and day-shift workers (364). In particular, this 
study showed that individuals undertaking rotating shift work had a far higher DII score then those that 
only undertook nightshift or day-shift work.  
5.4 Melatonin 
Synthesised and released from the pineal gland and controlled rhythmically by the SCN, melatonin is 
thought to have a primary role in the sleep/wake cycle. Studies in humans have identified that 
polymorphisms in melatonin receptors relate to impairments in lipid metabolism, glucose stimulated 
insulin secretion, and increased risk of type 2 diabetes (88,310,365-368). The recent role of melatonin 
in energy balance has been confirmed in animal models, as activation of melatonin receptors in the 
periphery cause alterations in both leptin and insulin secretion, as well as their associated functions 
(86). Pancreatic β-cells express the melatonin receptor 1 (MT1) but not receptor 2 (MT2), and 
exogenous melatonin has been shown to have a variety of effects on β-cells. Some studies report an 
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inhibitory (224-226,369), neutral (227) or stimulatory effect (228) of melatonin on insulin secretion, 
however, the majority of studies confirm  an inhibitory effect on insulin secretion in rodents. This 
inhibitory effect is also confirmed by the fact that chronic melatonin administration in diabetic rats 
(Otsuka Long‐Evans Tokushima Fatty (370)) ameliorated hyperinsulinemia in vivo (229). Numerous 
other studies have shown a positive effect of melatonin administration on metabolism. Thomas and 
colleagues showed in 2016,  that under both circadian disruption and diet-induced obesity, chronic 
administration of melatonin in rats leads to improved activity rhythms, glucose tolerance, and attenuated 
β-cell failure (371). Similarly, in 2018, Heo and others showed that melatonin treatment in high-fat diet 
fed C57BL/6 mice caused a reduction in body weight increase, as well as improvements in hepatic 
insulin sensitivity, glucose tolerance and hepatic steatosis (372). These studies focus on the effects of 
melatonin in nocturnal animals. Interestingly, melatonin is secreted during the night time in both 
nocturnal and diurnal animals. Melatonin treatment in isolated human islets for instance, has in fact the 
opposite effect to that in nocturnal rodents, causing an increase in insulin secretion (230). This is an 
indication that melatonin, while being secreted in a similar fashion, is decoded differently in nocturnal 
and diurnal animals. 
MT1 and MT2 receptors are found on adipocytes in both inguinal and epididymal fat tissue of rats 
(373). Several effects of melatonin on this tissue have been identified. In 2001, Zalatan and others 
showed that melatonin treatment leads to the reduction of lypolytic activity in inguinal adipocytes, 
evidence supported by a later study that showed increased lipolysis in adipocyte explants (374). 
However, more recently in 2019, Liu and others demonstrated melatonin to increase lipolysis in 
intramuscular adipocytes, as well as leading to a reduction in intramuscular fat deposition, and an 
increase in thermogenesis by upregulation of  mitochondrial biogenesis and mitochondrial respiration 
(375). This suggests melatonin to have differing effects on adipocytes, dependant on tissue location.  
Secretion of melatonin from the pineal gland is under indirect control from the SCN, via cascading 
afferents from the paraventricular nucleus and the intermediolateral column (326). Although melatonin 
has typically been thought of as the sleep hormone, or the ‘hormone of darkness’, recent reports suggest 
an important role in energy balance (86). Despite its inherent circadian pattern and effects, it is often 
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overlooked in circadian research, given the fact that the most commonly used mouse strain, C57BL/6, 
is unable to produce sufficient melatonin (376). The most common mouse strain used for in vivo 
circadian research is the C57BL/6J model, which is lacking a functional N-acetyltransferase. This 
enzyme is essential for the acetylation of serotonin to form melatonin, a process occurring in the pineal 
gland (376). Given the evidence that melatonin plays an important role in maintaining a healthy 
circadian rhythm as well as metabolic health, animal experiments employing this particular (but most 
commonly used) strain may limit comparability with the human condition to a certain degree.  
Evidence in C57BL/6 mice has shown that administering melatonin actually phase advances molecular 
clocks in the SCN, when administered at ZT10, the usual time of melatonin onset (377). Melatonin has 
also been shown to be important for regulating molecular clocks in peripheral pacemakers, and has the 
ability to cause a phase advance in activity rhythms of C57BL/6 mice when given at CT0 during 
constant darkness (82). Furthermore, melatonin plays a role in glucoregulation (281), with the ability 
to maintain glucose rhythms under circadian disruptions (284) as well as maintaining β-cell health 
(378). This perhaps outlines the pivotal role of melatonin signalling to maintain a healthy metabolism, 
under circadian perturbations. Melatonin receptors are functional in C57BL/6 mice (377), therefore, 
giving correctly timed melatonin to these mice could see a reversal of the adverse effects of circadian 
disruptions that we have previously reported (246). In this way, C57BL/6 mice are a very good model 





5.5 Limitations and advantages of experiment design 
Experiments conducted for the purpose of this thesis were thought out and planned to provide answers 
to the questions posed by the literature review. However, often in hindsight, these experiments had their 
limitations that directly affected the results that were observed.  
The timing of the initial 6 glucose tolerance tests in chapter 3 were found to be potentially ineffective, 
given the nature of the experiment. The shifting light cycle meant that animals had an advantage in 
glucose tolerance when the test was being admitted. This potentially obscured the results that we 
recorded. However, this was acknowledged, with the final GTT taking place at a more appropriate time. 
The finding of this study is still significant and paves the way for future experiments of this nature. 
Experiments from chapter 2 and 3 were conducted in a very different way to those in chapter 4, more 
specifically in the lack of behavioural recordings. Circadian rhythm research often requires the ability 
to elucidate the timing of internal biological clocks. In chapter 4, I was lucky to have access to 
technology that provided accurate representation of both physical activity rhythms as well as food intake 
rhythms in animals. Had it not been for this specialised equipment, the identification of the NowShift 
variant would not have been possible. This therefore begs the question as to whether a similar phenotype 
may have been present in a number of animals used in chapters 2 and 3. However, this is unlikely, given 
the fact that most other studies conducted in C57BL/6 mice around the world that show behaviour 
recordings do not find a NowShift-like phenotype. Animals with the NowShift phenotype came from 
the animal breeding facility at UTSW, in Texas, USA. Whereas animals from chapters 2 and 3 were 
taken from the breeding facility at the University of Otago. Locomotor recordings from a small cohort 
of mice used within chapter 2 did not show a NowShift-like phenotype, suggesting that this possibility 
is even more unlikely.  
Although lacking the ability to record behavioural rhythms in chapters 2 and 3, chapter 4 was able to 
build on this already acquired knowledge. Had animals been given to running wheels in the experiment 
sin chapter 2, we may have not found a difference in body weight in light disrupted animals, for the 
reasons outlined in chapter 4. More specifically, access to running wheels may have caused a masking-
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like effect of body weight regulation that would have cancelled out the subtle changes caused by the 
lighting disruptions.  
5.6 Conclusion and future perspectives 
In summary, this thesis provides strong evidence for the link between disrupted circadian timing and 
the development of metabolic disease. Combining the data from the current study with the current data 
in the literature, it is evident that correct circadian timing is important for metabolic health. In vivo 
experiments which we have conducted show that several phase shifts in regular light cycle regimen is 
sufficient to induce gluco-dysregulation, body weight increase and other metabolic impairments. We 
provide evidence for a loss of synchronisation between central and peripheral rhythms, driven by a 
mismatched rhythmic food intake with the external light environment. When rhythmic food intake is 
reinstated, positive health outcomes are achieved.  
These results are yet to define which molecular pathways are most heavily affected by circadian 
disruptions. Further analysis of signalling pathways in the brain, as well as peripheral networks will 
further shed light on this matter. Additionally, temporally restricted feeding regimens should be 
implemented in the workplace of those conducting rotating shift work, or night-shift work, to better aid 






6.1 Exome Sequencing Solutions 
i) Digestion Buffer 
NaCl      100mM 
Tris 8.0      50mM 
EDTA 8.0    100mM 
SDS     1% 
ProteinaseK     10mg/ml (Novagen 70663-4) 
 
ii) RNase Solution 
Ambion (AM2286)   500 U/mL 
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